_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType,softwareName,softwareType,softwareVersion,programmingLanguage,sourceRepository,documentation,licenseType,containerized,maintainer
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,"Statistical analysis was performed using Matlab (MathWorks, Inc) and GraphPad Prism 7",0.8,Accept,Experimental Usage,Matlab,Analysis Software,,MATLAB,,,,,
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,"Statistical analysis was performed using Matlab (MathWorks, Inc) and GraphPad Prism 7 (GraphPad Software, Inc)",0.8,Accept,Experimental Usage,GraphPad Prism 7,Analysis Software,7,,,,,,
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,ABET II Software for Operant Control Lafayette Instrument Company Model 89501,0.85,Accept,Experimental Usage,ABET II Software for Operant Control,Analysis Software,,,,,,,
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,Fiber Photometry Trace Processing Gradinaru Lab FP_Session_Processing_2.m https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_Processing2.m,0.9,Accept,Experimental Usage,Fiber Photometry Trace Processing,Analysis Software,,MATLAB,https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_Processing2.m,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Sequence reads were mapped to the human reference genome (GRCh37/hg19) using Novoalign tool v3.02.06,0.95,Accept,Experimental Usage,Novoalign tool v3.02.06,Analysis Software,v3.02.06,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,followed by marking and removing PCR duplicates by PICARD tools v2.4.1,0.95,Accept,Experimental Usage,PICARD tools v2.4.1,Analysis Software,v2.4.1,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Local realignment around insertions/deletions was achieved by Genome Analysis Toolkit (GATK) v3.6-0,0.95,Accept,Experimental Usage,Genome Analysis Toolkit (GATK) v3.6-0,Analysis Software,v3.6-0,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Somatic single-nucleotide variants were identified using Mutect v1.1.4,0.95,Accept,Experimental Usage,Mutect v1.1.4,Analysis Software,v1.1.4,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Copy Number Variants were detected and plotted using CNVkit,0.9,Accept,Experimental Usage,CNVkit,Analysis Software,,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Clonality was addressed using SciClone,0.9,Accept,Experimental Usage,SciClone,Analysis Software,,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Protein separation and detection were performed using an automated capillary electrophoresis system (Simple Western system and Compass software; ProteinSimple),0.85,Accept,Experimental Usage,Simple Western system,Analysis Software,,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,"Cells were imaged every hour for 48 hours using the Incucyte FLR imaging system (Essen Bioscience, Ann Arbor, MI)",0.85,Accept,Experimental Usage,Incucyte FLR imaging system,Analysis Software,,,,,,,
PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...we implemented a recently described method called 'LMSz' to construct NF1-specific head circumference growth charts...,0.9,Accept,Experimental Usage,LMSz,Analysis Software,,,,,,,
PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,"...we fit generalized additive models for location, scale, and space (GAMLSS) with the normal distribution family...",0.85,Accept,Experimental Usage,GAMLSS,Package/Library,,R,,,,,
PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...GAMLSS model visualization was performed using customized R functions (https://github.com/BGDlab/gamlssTools)...,0.9,Accept,Experimental Usage,gamlssTools,Package/Library,,R,https://github.com/BGDlab/gamlssTools,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"Primary hippocampal (300,000 cells/well), RGC (300,000 cells/well), or DRG neurons (150,000 cells/well) from each of the strains assayed were plated on AXION Biosystems 48-well MEA plates",0.85,Accept,Experimental Usage,AXION Biosystems 48-well MEA plates,Analysis Software,,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,All neurons were recorded for 3 min at a 4.5 standard deviation threshold level and 5000 Hz as a digital filter using AXION Biosystems integrated studio (AxIS) version 2.5.1 software,0.95,Accept,Experimental Usage,AXION Biosystems integrated studio (AxIS) version 2.5.1,Analysis Software,2.5.1,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Representative traces of action potentials were extracted using the AXION Biosystems neural metric tool and Offline sorter x64 version 4 software,0.9,Accept,Experimental Usage,Offline sorter x64 version 4,Analysis Software,4,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"Images were acquired using Image Studio Lite Version 5.2 software, and LAS AF Lite 3.2.0 software and analyzed using ImageJ 1.53a software",0.9,Accept,Experimental Usage,ImageJ 1.53a,Analysis Software,1.53a,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"The analysis for this paper was generated using Partek Flow software, version 10.0 using publicly available datasets",0.95,Accept,Experimental Usage,"Partek Flow software, version 10.0",Analysis Software,10.0,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,RNA-seq reads were aligned to the Ensembl release 100 top-level assembly with STAR version 2.7.8a,0.95,Accept,Experimental Usage,STAR version 2.7.8a,Analysis Software,2.7.8a,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"All statistical tests were performed using GraphPad Prism software (versions v5, v_8.2.1, and v_9.3.1)",0.8,Accept,Experimental Usage,GraphPad Prism,Analysis Software,"v5, v_8.2.1, and v_9.3.1",,,,,,
PMID:40299482,10.3390/biomedicines13040907,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,,Apple Watch Ultra model 2 (application: Sleep++) was performed in all the patients with a total of three different measurements,0.8,Accept,Experimental Usage,Sleep++,Analysis Software,,,,,,,
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,using the Thermo Sequenase fluorescent labelled primer cycle sequencing kit (Amersham Biosciences) and analysed on an ALF-express automated DNA sequencer (Amersham Biosciences).,0.8,Accept,Experimental Usage,ALF-express automated DNA sequencer,Analysis Software,,,,,,,
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,"The sequence environment of all donor- and acceptor sites was analysed using Splice Site Prediction by Neural Network (SSPNN, URL address:",0.9,Accept,Experimental Usage,Splice Site Prediction by Neural Network (SSPNN),Web Application,,,,,,,
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The mfold computer program version 3.0 was used to predict the RNA secondary structure and to calculate the folding free energy,0.95,Accept,Experimental Usage,mfold computer program version 3.0,Analysis Software,3.0,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,The quantification of HF melanin density and DCT immunofluorescence staining intensity was performed with ImageJ software (National Institutes of Health),0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"Data statistical analyses were performed by unpaired two-tailed Student's t-test (Prism7, GraphPad)",0.85,Accept,Experimental Usage,Prism7 (GraphPad),Analysis Software,7,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,IncuCyte proliferation analysis was used to measure the effect of NF1 deficiency on cell proliferation,0.85,Accept,Experimental Usage,IncuCyte,Analysis Software,,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,We measured cellular energetics using Agilent Seahorse XF-96 Glyco Stress Test and Mito Stress Test assays,0.9,Accept,Experimental Usage,Agilent Seahorse XF-96,Analysis Software,,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,GENCODE was used to map FASTQ files to GRCh38 (release 33 with STAR v2.7.8a basic two-pass mode),0.9,Accept,Experimental Usage,STAR v2.7.8a,Analysis Software,v2.7.8a,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,principal component analysis was computed using iDEP 9.1,0.9,Accept,Experimental Usage,iDEP 9.1,Analysis Software,9.1,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Trim Galore v0.6.0 was used to trim sequencing adapters from demultiplexed FASTQ files,0.9,Accept,Experimental Usage,Trim Galore v0.6.0,Analysis Software,v0.6.0,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Lipid identifications were assigned using LipidSearch (v5.0, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage,LipidSearch v5.0,Analysis Software,v5.0,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Data was analyzed using Compound Discoverer (v 3.2, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage,Compound Discoverer v3.2,Analysis Software,v3.2,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Synergy was calculated using the SynergyFinder R package,0.9,Accept,Experimental Usage,SynergyFinder R package,Package/Library,,R,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"ATP metrics were calculated following Mookerjee et al., 2017 and using the CEAS R Package",0.9,Accept,Experimental Usage,CEAS R Package,Package/Library,,R,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,PCA analysis was performed using the FactoMineR R package,0.9,Accept,Experimental Usage,FactoMineR R package,Package/Library,,R,,,,,
PMID:34930951,10.1038/s41536-021-00195-3,A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,"ImageJ (Fiji, NIH) was used to track the center of n = 15–17 particles for each sample",0.9,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:34930951,10.1038/s41536-021-00195-3,A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,"A MATLAB program was then used to track the particles, calculate the instantaneous mean square displacement",0.85,Accept,Experimental Usage,MATLAB,Analysis Software,,MATLAB,,,,,
PMID:34930951,10.1038/s41536-021-00195-3,A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,"The phenotype of hRGC was analyzed using flow cytometry with the MACSQuant flow cytometer (Miltenyi, San Diego)",0.85,Accept,Experimental Usage,MACSQuant flow cytometer,Analysis Software,,,,,,,
PMID:34930951,10.1038/s41536-021-00195-3,A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,Digital images were obtained with an epifluorescence confocal microscope (Leica SP8) using 63x-oil objective,0.85,Accept,Experimental Usage,Leica SP8 confocal microscope,Analysis Software,,,,,,,
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,data were processed with FlowJo software (version X10.0.7),0.85,Accept,Experimental Usage,FlowJo software,Analysis Software,X10.0.7,,,,,,
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"measured at 450 nm using the SpectraMax M5 microplate reader (Molecular Devices, San Jose, CA, USA)",0.85,Accept,Experimental Usage,SpectraMax M5 microplate reader,Analysis Software,,,,,,,
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"An Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA)",0.9,Accept,Experimental Usage,Orbitrap Fusion Lumos mass spectrometer,Analysis Software,,,,,,,
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,The Image J software (version 1.51) was used to analyze the relative density,0.85,Accept,Experimental Usage,ImageJ software,Analysis Software,1.51,,,,,,
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,We used the STRING database (version 11.0) (https://cn.string-db.org/),0.85,Accept,Experimental Usage,STRING database,Database,11.0,,https://cn.string-db.org/,,,,
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,Cytoscape (version 3.7.2) was used to construct the network,0.85,Accept,Experimental Usage,Cytoscape,Analysis Software,3.7.2,,,,,,
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,analyses were performed using GraphPad Prism (version 9.5.0),0.85,Accept,Experimental Usage,GraphPad Prism,Analysis Software,9.5.0,,,,,,
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,"evaluated using an ex vivo µCT imaging system (Scanco µCT 40, Scanco Medical, Bassersdorf, Switzerland)",0.8,Accept,Experimental Usage,Scanco µCT 40,Analysis Software,,,,,,,
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,"positioned on the bottom two supports such that callus was directly below the top loading point at the end of the actuator (Dynamight 8841, Instron)",0.75,Accept,Experimental Usage,Dynamight 8841,Analysis Software,,,,,,,
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,"Histomorphometric measurements were performed using the Bioquant Analysis System (Nashville, TN, USA)",0.8,Accept,Experimental Usage,Bioquant Analysis System,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Time-corrected data were analyzed in SEDFIT 16.1 in terms of a continuous c(s) distribution of sedimenting species,0.9,Accept,Experimental Usage,SEDFIT 16.1,Analysis Software,16.1,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Protein partial specific volumes were calculated based on their composition in SEDNTERP,0.85,Accept,Experimental Usage,SEDNTERP,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Data were analyzed globally in terms of a single noninteracting species in SEDPHAT 14.0 to obtain the molar mass,0.9,Accept,Experimental Usage,SEDPHAT 14.0,Analysis Software,14.0,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Negatively-stained neurofibromin particles were autopicked using EMAN2 e2boxer using a box size of 326 pixels,0.9,Accept,Experimental Usage,EMAN2 e2boxer,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Reference-free 2D classification was carried out using the Iterative Stable Alignment and Clustering (ISAC) procedure implemented in a Sphire package,0.9,Accept,Experimental Usage,Sphire,Package/Library,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,All further analyses and visualizations were performed using Chimera,0.85,Accept,Experimental Usage,Chimera,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Full-length NF1 dimer data were low-pass filtered to 60 Å and used as a reference in Relion for refinement of the model,0.85,Accept,Experimental Usage,Relion,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Data reduction followed standard procedures using MantidPlot,0.85,Accept,Experimental Usage,MantidPlot,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,The reduced SAXS and SANS data were analyzed using the ATSAS tools PRIMUS and GNOM for Guinier and P(r) analysis,0.9,Accept,Experimental Usage,ATSAS,Package/Library,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,The DAMMIF program within ATSAS was used to generate ab initio shape reconstruction models,0.85,Accept,Experimental Usage,DAMMIF,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,A theoretical SAXS curve was generated from the final negatively-stained EM model of neurofibromin holoprotein using the ATSAS tool EM2DAM,0.85,Accept,Experimental Usage,EM2DAM,Analysis Software,,,,,,,
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,"Using the contrast module of MULCh, the NF1 sequence was used to calculate Δρ in H2O buffer",0.85,Accept,Experimental Usage,MULCh,Analysis Software,,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Mapping was performed using STAR 2.4.2a software with mouse genome (mm9),0.9,Accept,Experimental Usage,STAR 2.4.2a,Analysis Software,2.4.2a,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Differential expression analysis was performed with DESeq2 using default settings,0.9,Accept,Experimental Usage,DESeq2,Analysis Software,,R,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Gene set enrichment analysis (GSEA) was performed with the entire gene list using GSEA software 4.0.1 desktop (Broad Institute),0.9,Accept,Experimental Usage,GSEA software 4.0.1,Analysis Software,4.0.1,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,KEGG and gene ontology (GO) enrichment analysis was performed using the Signature Database (MSigDB) and DAVID 6.8,0.9,Accept,Experimental Usage,DAVID 6.8,Web Application,6.8,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Five micrograms of each SCX fraction and a non-fractioned sample were used for proteome profiling and analysed by MaxQuant (v1.5.3.30),0.9,Accept,Experimental Usage,MaxQuant (v1.5.3.30),Analysis Software,v1.5.3.30,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed on a LSM700 confocal microscope (Zeiss) with ZEN imaging software (Zeiss),0.85,Accept,Experimental Usage,ZEN imaging software,Analysis Software,,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed using a Zeiss Stereo Discovery V12 and the AxioVision 4.6 software (Zeiss),0.85,Accept,Experimental Usage,AxioVision 4.6 software,Analysis Software,4.6,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Images were acquired using a Fusion FX spectra gel documentation system (Vilber) with FUSION FX software,0.85,Accept,Experimental Usage,FUSION FX software,Analysis Software,,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Blots images were analysed with ImageJ grey value analysis tool,0.9,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,DatLab software (OROBOROS INSTRUMENTS) was used for data acquisition and analysis,0.85,Accept,Experimental Usage,DatLab software,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"Images of the hematoxylin-eosin sections were taken (20X magnification) using an Olympus BX-51 microscope using an Olympus DP71 digital camera, and DP Controller software",0.85,Accept,Experimental Usage,DP Controller software,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"Whole exome sequencing (WES), RNA sequencing (RNA-Seq), and copy number analysis (CNVkit) were performed on each sample",0.9,Accept,Experimental Usage,CNVkit,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"Exome libraries were captured with an IDT exome reagent, then pooled with a WGS library for sequencing on an Illumina HiSeq4000 with at least 1000x coverage",0.9,Accept,Experimental Usage,Illumina HiSeq4000,Other,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Genomic data were aligned against reference sequence hg38 via BWA-MEM with Base Quality Score Recalibration (BQSR),0.9,Accept,Experimental Usage,BWA-MEM,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Structural variants (SVs) and large indels were detected using manta,0.9,Accept,Experimental Usage,manta,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.9,Accept,Experimental Usage,VarScan2,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.9,Accept,Experimental Usage,Strelka2,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.9,Accept,Experimental Usage,MuTect2,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.9,Accept,Experimental Usage,Pindel,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"which includes best-practice variant filtering and annotation with VEP (Variant Effect Predictor, version 95)",0.9,Accept,Experimental Usage,VEP,Analysis Software,version 95,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Waterfall somatic variant plots were created with GenVisR by including somatic variants that occurred in each area,0.9,Accept,Experimental Usage,GenVisR,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,These variants were not reported as a somatic variant in COSMIC (Catalogue Of Somatic Mutations In Cancer) and ClinVar archive,0.9,Accept,Experimental Usage,COSMIC,Database,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,These variants were not reported as a somatic variant in COSMIC (Catalogue Of Somatic Mutations In Cancer) and ClinVar archive,0.9,Accept,Experimental Usage,ClinVar,Database,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"In order to predict clinical significance and predictions of the functional effects of these variants, each variant was reviewed on SIFT and Polyphen",0.9,Accept,Experimental Usage,SIFT,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"In order to predict clinical significance and predictions of the functional effects of these variants, each variant was reviewed on SIFT and Polyphen",0.9,Accept,Experimental Usage,Polyphen,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,SciClone and ClonEvol were utilized to attempt to perform a phylogeny inference,0.9,Accept,Experimental Usage,SciClone,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,SciClone and ClonEvol were utilized to attempt to perform a phylogeny inference,0.9,Accept,Experimental Usage,ClonEvol,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Pre/post quality control and full expectation-maximization (EM) quantification were run via Partek Flow,0.9,Accept,Experimental Usage,Partek Flow,Analysis Software,,,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Gene counts and transcript counts were normalized by CPM (counts per million) by using edgeR package,0.9,Accept,Experimental Usage,edgeR,Package/Library,,R,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Heatmap visualizations were created using gplots R package,0.9,Accept,Experimental Usage,gplots,Package/Library,,R,,,,,
PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,PantherDB was utilized to discover GO terms and pathways that may be affected by these genes,0.9,Accept,Experimental Usage,PantherDB,Database,,,,,,,
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"Drug–drug interactions were analyzed with CompuSyn software Version 1.0 (Informer Technologies, Los Angeles, CA, USA; software is available at https://www.compusyn.software.informer.com",0.95,Accept,Experimental Usage,CompuSyn software Version 1.0,Analysis Software,1.0,,,,,,
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"In vivo S462TY sciatic nerve tumor xenograft data were analyzed using IBM SPSS Statistics software version 29.0.1.0 (IBM, Armonk, NY, USA).",0.9,Accept,Experimental Usage,IBM SPSS Statistics software version 29.0.1.0,Analysis Software,29.0.1.0,,,,,,
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,Internally developed MR software SPIN (Signal Processing in MR (Version SVN Revision 1895); http://mrc.wayne.edu (accessed on 15 December 2023)) was used for tumor volume measurement.,0.95,Accept,Experimental Usage,SPIN (Signal Processing in MR Version SVN Revision 1895),Analysis Software,SVN Revision 1895,,http://mrc.wayne.edu,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,which were sequenced on the Illumina NovaSeq6000 sequencing machine using S4 flow cells,0.9,Accept,Experimental Usage,Illumina NovaSeq6000,Other,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Raw sequencing reads were mapped to the GRCh38 build of the human reference genome using BWA-MEM (46) version 0.7.17-r1188,0.85,Accept,Experimental Usage,BWA-MEM,Analysis Software,0.7.17-r1188,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"Aligned reads in BAM format were processed following the Genome Analysis Toolkit (GATK, version 4.1.8.0) Best Practices workflow",0.85,Accept,Experimental Usage,GATK,Analysis Software,4.1.8.0,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,NGSCheckMate was utilized using default options to verify that sequencing data from tumor–normal pairs corresponded to the same individual,0.85,Accept,Experimental Usage,NGSCheckMate,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"The germline short variant discovery workflow from GATK (version 4.1.8.0; ref. 47), Strelka2 (version 2.9.2; ref. 51)",0.85,Accept,Experimental Usage,Strelka2,Analysis Software,2.9.2,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,and VarDict (version 1.8.2; ref. 52) were used to detect germline SNVs and INDELs in the WGS data,0.85,Accept,Experimental Usage,VarDict,Analysis Software,1.8.2,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Annovar (version 2018Apr16) was used to annotate all variants (53),0.85,Accept,Experimental Usage,Annovar,Analysis Software,2018Apr16,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,All variants were also manually curated through visual inspection of raw sequencing reads using BamSnap (54),0.85,Accept,Experimental Usage,BamSnap,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,we called SVs in all matched normal samples using Manta (version 1.6.0; ref. 55),0.85,Accept,Experimental Usage,Manta,Analysis Software,1.6.0,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"LUMPY (version 0.2.13; ref. 56), SvABA (version 1.1.3; ref. 57), and Delly (version 0.8.3; refs. 57, 58)",0.85,Accept,Experimental Usage,LUMPY,Analysis Software,0.2.13,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"LUMPY (version 0.2.13; ref. 56), SvABA (version 1.1.3; ref. 57), and Delly (version 0.8.3; refs. 57, 58)",0.85,Accept,Experimental Usage,SvABA,Analysis Software,1.1.3,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"LUMPY (version 0.2.13; ref. 56), SvABA (version 1.1.3; ref. 57), and Delly (version 0.8.3; refs. 57, 58)",0.85,Accept,Experimental Usage,Delly,Analysis Software,0.8.3,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"In addition, we computed the sequencing coverage at 500-bp windows using mosdepth (59)",0.85,Accept,Experimental Usage,mosdepth,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"Somatic SNVs were detected using Mutect2 (GATK version 4.1.8.0), MuSE (version v1.0rc; ref. 60)",0.85,Accept,Experimental Usage,Mutect2,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"Somatic SNVs were detected using Mutect2 (GATK version 4.1.8.0), MuSE (version v1.0rc; ref. 60)",0.85,Accept,Experimental Usage,MuSE,Analysis Software,v1.0rc,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"To identify driver genes, we used the R package dNdScv (61)",0.85,Accept,Experimental Usage,dNdScv,Package/Library,,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Mutational signatures were extracted de novo using nonnegative matrix factorization (NMF) as implemented in the R package NMF (62),0.85,Accept,Experimental Usage,NMF,Package/Library,,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,assigned to existing ones using a cosine similarity cutoff of 0.85 using the R package MutationalPatterns (64),0.85,Accept,Experimental Usage,MutationalPatterns,Package/Library,,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Mutations at microsatellite loci were detected using MSIprofiler (https://github.com/parklab/MSIprofiler),0.85,Accept,Experimental Usage,MSIprofiler,Analysis Software,,,https://github.com/parklab/MSIprofiler,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"For WGS data, the software packages FACETS (version 0.12.1) and ascatNGS (version 2.5.1) were used to detect somatic copy-number alterations",0.85,Accept,Experimental Usage,FACETS,Analysis Software,0.12.1,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"For WGS data, the software packages FACETS (version 0.12.1) and ascatNGS (version 2.5.1) were used to detect somatic copy-number alterations",0.85,Accept,Experimental Usage,ascatNGS,Analysis Software,2.5.1,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"LogR and BAF values were calculated for all tumor samples with a corresponding retained normal sample. Tumor LogR values were corrected for GC content, and copy-number profiles were generated using ASCAT (68)",0.85,Accept,Experimental Usage,ASCAT,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"For WGS data, NMF as implemented in sigProfilerExtractor was used to extract de novo copy-number signatures",0.85,Accept,Experimental Usage,sigProfilerExtractor,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"In each case, the de novo signatures were decomposed into previously identified pan-cancer copy-number signatures (27) using the function sigProfilerSingleSample",0.85,Accept,Experimental Usage,sigProfilerSingleSample,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Chromothripsis events were detected using ShatterSeek (version 0.7) using recommended cutoff values (72),0.85,Accept,Experimental Usage,ShatterSeek,Analysis Software,0.7,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Sequencing reads were mapped to the transcriptome using the STAR aligner (version 2.7.4a; ref. 74),0.85,Accept,Experimental Usage,STAR,Analysis Software,2.7.4a,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Gene-expression counts were generated using HTSeq (v.0.6.1p1; ref. 75),0.85,Accept,Experimental Usage,HTSeq,Analysis Software,0.6.1p1,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Differential expression analysis was performed using DESeq2 (76),0.85,Accept,Experimental Usage,DESeq2,Package/Library,,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Gene fusions were detected using ARRIBA (version 2.1.0; ref. 77),0.85,Accept,Experimental Usage,ARRIBA,Analysis Software,2.1.0,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"TopHat-fusion (version 2.1.0; ref. 78), EricScript (version 0.5.5; ref. 79), and STAR-Fusion (version 1.10.1; ref. 80)",0.85,Accept,Experimental Usage,TopHat-fusion,Analysis Software,2.1.0,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"TopHat-fusion (version 2.1.0; ref. 78), EricScript (version 0.5.5; ref. 79), and STAR-Fusion (version 1.10.1; ref. 80)",0.85,Accept,Experimental Usage,EricScript,Analysis Software,0.5.5,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"TopHat-fusion (version 2.1.0; ref. 78), EricScript (version 0.5.5; ref. 79), and STAR-Fusion (version 1.10.1; ref. 80)",0.85,Accept,Experimental Usage,STAR-Fusion,Analysis Software,1.10.1,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Immune infiltration was estimated using consensusTME using the sarcoma cell-type–specific genes derived from TCGA (81),0.85,Accept,Experimental Usage,consensusTME,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Raw Methylation EPIC data were uniformly processed using the R package minfi (version 1.34.0; ref. 86),0.85,Accept,Experimental Usage,minfi,Package/Library,1.34.0,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,We performed clustering of each data type separately using ConsensusClusterPlus (89),0.85,Accept,Experimental Usage,ConsensusClusterPlus,Package/Library,,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"COCA, as implemented in the R package coca (91), was run on the same datasets used for ConsensusClusterPlus clustering",0.85,Accept,Experimental Usage,coca,Package/Library,,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,IchorCNA (92) was used to estimate the tumor fraction in cfDNA and genome-wide copy-number profiles,0.85,Accept,Experimental Usage,IchorCNA,Analysis Software,,,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Survival analysis was performed using the Cox proportional-hazards model as implemented in the R package survival (version 2.30; ref. 93),0.85,Accept,Experimental Usage,survival,Package/Library,2.30,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,we used the parsimony ratchet method (pratchet) as implemented in the R package phangorn (94),0.85,Accept,Experimental Usage,phangorn,Package/Library,,R,,,,,
PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,we used the maximum parsimony and neighbor-joining algorithms as implemented in the R package MesKit (95),0.85,Accept,Experimental Usage,MesKit,Package/Library,,R,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"Total body fat and lean tissue were assessed using a Bruker minispec LF90 TD‐NMR analyzer, which was calibrated prior to each use",0.85,Accept,Experimental Usage,Bruker minispec LF90 TD‐NMR analyzer,Analysis Software,,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,Indirect calorimetry was assessed using the Comprehensive Lab Animal Monitoring System (CLAMS),0.85,Accept,Experimental Usage,Comprehensive Lab Animal Monitoring System (CLAMS),Analysis Software,,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"Serial blood glucose measurements were made every 10 minutes for 120 minutes using a glucometer (AlphaTrak 2, Zoetis, Parsippany, NJ)",0.8,Accept,Experimental Usage,AlphaTrak 2,Analysis Software,,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"For Hemoglobin A1c measurements, blood samples were immediately measured using the A1C Now Diabetes Management HbA1C test kit (PTS Diagnostic, Indianapolis, IN)",0.8,Accept,Experimental Usage,A1C Now Diabetes Management HbA1C test kit,Analysis Software,,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"For lipoprotein, triglyceride, and cholesterol measurements, fresh serum was assayed using LDX Cholestech cartridges (Abbott, Chicago, IL)",0.8,Accept,Experimental Usage,LDX Cholestech cartridges,Analysis Software,,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"stored at −80°C until analysis using a Pro-diabetes multiplex assay from Bio-Rad (Bio-Rad, Hercules, CA)",0.8,Accept,Experimental Usage,Pro-diabetes multiplex assay,Analysis Software,,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,Image Pro Plus was used to quantify the area of lipid accumulation (Oil Red-O stained) in each section from the liver and skeletal muscle,0.85,Accept,Experimental Usage,Image Pro Plus,Analysis Software,,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"Analysis was performed using GraphPad Prism version 6.0h (La Jolla, CA, USA)",0.9,Accept,Experimental Usage,GraphPad Prism version 6.0h,Analysis Software,6.0h,,,,,,
PMID:41545416,10.1038/s41540-026-00647-w,Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.,,All simulations in this study were conducted using MATLAB (MathWorks) with the ode15s solver,0.85,Accept,Experimental Usage,MATLAB,Analysis Software,,MATLAB,,,,,
PMID:41545416,10.1038/s41540-026-00647-w,Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.,,"conducted using MATLAB (MathWorks) with the ode15s solver, which employs variable-step, variable-order numerical schemes",0.8,Accept,Experimental Usage,ode15s solver,Analysis Software,,MATLAB,,,,,
PMID:25851896,10.3988/jcn.2015.11.2.172,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,,"More than 200 cells were counted for each drug concentration using ImageJ software (version 1.48; National Institutes of Health, Behesda, MD, USA)",0.9,Accept,Experimental Usage,"ImageJ software (version 1.48; National Institutes of Health, Behesda, MD, USA)",Analysis Software,1.48,,,,,,
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,Fiber diameter and angle were measured using ImageJ (v1.53a) with at least 200 fibers per fiber type,0.8,Accept,Experimental Usage,ImageJ (v1.53a),Analysis Software,v1.53a,,,,,,
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,"The images were analyzed using NIH ImageJ (version 1.53a) software. Aspect ratio, which is the longest length of the cell divided by the shortest length",0.8,Accept,Experimental Usage,NIH ImageJ (version 1.53a),Analysis Software,version 1.53a,,,,,,
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,"transferred into a 96-well plate, and read using Thermo Scientific Multiskan GO at 570 and 600nm to obtain the absorption gradient",0.75,Accept,Experimental Usage,Thermo Scientific Multiskan GO,Analysis Software,,,,,,,
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,stimulus after it passed through the stimulation chamber (Voltage Out) were captured from Channel 1 and Channel 2 of an oscilloscope (Rigol),0.75,Accept,Experimental Usage,Rigol oscilloscope,Analysis Software,,,,,,,
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,connected to a Raspberry Pi running a Python script to store the data in near real time through the USB port connection,0.75,Accept,Experimental Usage,Raspberry Pi Python script,Analysis Software,,Python,,,,,
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"in a DNA Engine Peltier Thermal cycler (PTC-200; MJ Research, Watertown, MA) at 42°C for 1 minute",0.9,Accept,Experimental Usage,DNA Engine Peltier Thermal cycler (PTC-200),Other,,,,,,,
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"An ABI Prism 7,000 Sequence Detection System was used for all reactions with the following cycling parameters",0.95,Accept,Experimental Usage,"ABI Prism 7,000 Sequence Detection System",Analysis Software,,,,,,,
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,Results were analyzed using a Microsoft Excel program designed for Q-PCR quantitation based on internal control mRNA levels,0.8,Accept,Experimental Usage,Microsoft Excel program designed for Q-PCR quantitation,Analysis Software,,Excel,,,,,
PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,"To create the tumor models for the ground truth dataset, an image processing software (Simpleware ScanIP, Synopsys) was used.",0.95,Accept,Experimental Usage,Simpleware ScanIP,Analysis Software,,,,,,,
PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,The helper (DPP V1.0) was trained using proprietary AI- and ML-based algorithms and information.,0.9,Accept,Development,DPP V1.0,Analysis Software,V1.0,,,,,,
PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,"To create the tumor models an image processing software (Simpleware, Synopsys, Mountain View, CA) was used.",0.95,Accept,Experimental Usage,Simpleware,Analysis Software,,,,,,,
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A noncompartmental analysis was performed to estimate area under the concentration-time curve from time 0 to 12 hours (AUC 0-12h) after a single dose of mirdametinib using Phoenix WinNonlin (Version 8.1; Certara, Princeton, NJ).",0.85,Accept,Experimental Usage,Phoenix WinNonlin (Version 8.1),Analysis Software,8.1,,,,,,
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.85,Accept,Experimental Usage,NONMEM (version 7.2),Analysis Software,7.2,,,,,,
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.8,Accept,Experimental Usage,Perl speaks NONMEM version 3.6.2,Package/Library,3.6.2,Perl,,,,,
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.8,Accept,Experimental Usage,Pirana version 2.7.1,Analysis Software,2.7.1,,,,,,
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"The pain and QOL data were summarized with descriptive statistics (means, standard deviation [SD]) via SAS version 9.4 (Cary, NC).",0.8,Accept,Experimental Usage,SAS version 9.4,Analysis Software,9.4,,,,,,
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,A digital version of the cNF-Skindex was administered to the participants using the data capture system Castor EDC,0.85,Accept,Experimental Usage,Castor EDC,Web Application,,,,,,,
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,Statistical analyses were performed using SPSS version 28.0,0.8,Accept,Experimental Usage,SPSS version 28.0,Analysis Software,28.0,,,,,,
PMID:37378983,10.1001/jamanetworkopen.2023.20599,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,,"Assessments were completed at baseline, after treatment, and at 6- and 12-month follow-up via REDCap",0.8,Accept,Experimental Usage,REDCap,Web Application,,,,,,,
PMID:37378983,10.1001/jamanetworkopen.2023.20599,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,,"We used SAS, version 9.4 (SAS Institute Inc), for analyses",0.85,Accept,Experimental Usage,"SAS, version 9.4",Analysis Software,9.4,,,,,,
PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,,This work has created an openly accessible resource (www.synapse.org/SynodosNF2) of fully characterized isogenic schwannoma and meningioma cell systems,0.9,Accept,Development,www.synapse.org/SynodosNF2,Database,,,www.synapse.org/SynodosNF2,,,,
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"LabVIEW (National Instruments, cat. no. 784503–35)",0.8,Accept,Experimental Usage,"LabVIEW (National Instruments, cat. no. 784503–35)",Analysis Software,,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,All sequencing datasets were evaluated using FastQC (version 0.11.2) to ensure high quality,0.8,Accept,Experimental Usage,FastQC (version 0.11.2),Analysis Software,0.11.2,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We first built an index using all sgRNAs in each sample and then used Bowtie (version 1.0.0) to map the sgRNA sequences,0.8,Accept,Experimental Usage,Bowtie (version 1.0.0),Analysis Software,1.0.0,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We mapped the reads to the reference genomic sequence using BWA version 0.7.5 and SAMtools,0.8,Accept,Experimental Usage,BWA version 0.7.5,Analysis Software,0.7.5,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We mapped the reads to the reference genomic sequence using BWA version 0.7.5 and SAMtools (version 0.1.19),0.8,Accept,Experimental Usage,SAMtools (version 0.1.19),Analysis Software,0.1.19,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We then used VarScan2 (version 2.3) to identify insertions and deletions with the 'pileup2indel' mode,0.8,Accept,Experimental Usage,VarScan2 (version 2.3),Analysis Software,2.3,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We aligned RNA-seq reads to the mm10 genome using STAR (version 2.3.0e) with default parameters,0.8,Accept,Experimental Usage,STAR (version 2.3.0e),Analysis Software,2.3.0e,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We then determined differential expression using DESeq (version 1.18.0) and accounted for possible batch effects,0.8,Accept,Experimental Usage,DESeq (version 1.18.0),Package/Library,1.18.0,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ]",0.85,Accept,Experimental Usage,synapser,Package/Library,,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ]",0.85,Accept,Experimental Usage,tidyverse,Package/Library,,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ]",0.85,Accept,Experimental Usage,dplyr,Package/Library,,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ]",0.9,Accept,Experimental Usage,WGCNA,Package/Library,,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ], ggplot2 [ 28 ]",0.85,Accept,Experimental Usage,ggplot2,Package/Library,,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ], ggplot2 [ 28 ], enrichplot [ 29 ]",0.85,Accept,Experimental Usage,enrichplot,Package/Library,,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ], ggplot2 [ 28 ], enrichplot [ 29 ], and ConsensusClusterPlus [ 30 ]",0.9,Accept,Experimental Usage,ConsensusClusterPlus,Package/Library,,R,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,The drug screening data were contributed by Ferrer et al. using the Mechanism Interrogation PlatE (MIPE 4.0) library [ 6 ],0.9,Accept,Experimental Usage,Mechanism Interrogation PlatE (MIPE 4.0) library,Database,,,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,"We queried drug information from the ChEMBL database, a manually curated database of bioactive molecules maintained by the European Bioinformatics Institute",0.85,Accept,Experimental Usage,ChEMBL database,Database,,,,,,,
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,IDAPredict.2drug function package was used to predict the drug combination between DrugCluster pairs [ 23 ],0.9,Accept,Experimental Usage,IDAPredict.2drug function package,Package/Library,,,,,,,
PMID:41598414,10.3390/jcm15020475,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,,"Recorded images were analyzed in SkinAid cloud software, stored under patient ID with demographic and lesion details",0.8,Accept,Experimental Usage,SkinAid cloud software,Analysis Software,,,,,,,
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Confocal images were taken on either a Zeiss LSM 410 or LSM 510 microscope,0.8,Accept,Experimental Usage,Zeiss LSM 410,Other,,,,,,,
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Confocal images were taken on either a Zeiss LSM 410 or LSM 510 microscope,0.8,Accept,Experimental Usage,Zeiss LSM 510,Other,,,,,,,
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Wings were imaged under brightfield optics on a Zeiss Axioplan 2ie compound microscope,0.75,Accept,Experimental Usage,Zeiss Axioplan 2ie compound microscope,Other,,,,,,,
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,quantitative PCR performed using the LightCycler FastStart SYBR green system (Roche),0.85,Accept,Experimental Usage,LightCycler FastStart SYBR green system,Other,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Pressure-based cell lysis was performed for 60 cycles of 50 s at 30 °C and 310 MPa using the Barocycler NEP 2320 instrument (Pressure BioSciences, Easton, MA, USA)...",0.9,Accept,Experimental Usage,Barocycler NEP 2320,Other,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...A nanoflow high-performance liquid chromatography system Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany)...",0.9,Accept,Experimental Usage,Easy-nLC 1200,Other,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a nano-electrospray ionization source...",0.9,Accept,Experimental Usage,Q Exactive HF mass spectrometer,Other,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The data were acquired automatically using Thermo Xcalibur 4.1 software (Thermo Fisher Scientific) and processed with the Spectronaut Pulsar software...,0.95,Accept,Experimental Usage,Thermo Xcalibur 4.1,Analysis Software,4.1,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...processed with the Spectronaut Pulsar software (Biognosys, Schlieren, Switzerland). Pulsar is a search engine, integrated into Spectronaut for spectral library generation...",0.95,Accept,Experimental Usage,Spectronaut Pulsar,Analysis Software,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The Ki67 immunohistochemistry was performed using the BenchMark Ultra system (Roche)...,0.9,Accept,Experimental Usage,BenchMark Ultra system,Other,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...imaged using the NanoZoomer S60 digital slide scanner (Hamamatsu, Hamamatsu City, Japan)...",0.9,Accept,Experimental Usage,NanoZoomer S60 digital slide scanner,Other,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...and Pannoramic Midi FL slide scanner (3DHistech Ltd, Budapest, Hungary)...",0.9,Accept,Experimental Usage,Pannoramic Midi FL slide scanner,Other,,,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...All analyses were performed using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.95,Accept,Experimental Usage,R software version 4.0.0,Analysis Software,4.0.0,R,,,,,
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.95,Accept,Experimental Usage,lmerTest package version 3.1-2,Package/Library,3.1-2,R,,,,,
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,TaqMan Universal PCR Master Mix was then performed on an ABI PRISM 7900 Cycler (Applied Biosystems),0.75,Accept,Experimental Usage,ABI PRISM 7900 Cycler,Analysis Software,,,,,,,
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Images were collected using a DMR HC microscope...and evaluated using AxioVision 4.1 software (Zeiss, Jena, Germany)",0.8,Accept,Experimental Usage,AxioVision 4.1 software,Analysis Software,4.1,,,,,,
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Stained sections were analyzed using the BX51 microscope...and analySIS 5.0 software (Soft imaging system GmbH, Münster, Germany)",0.8,Accept,Experimental Usage,analySIS 5.0 software,Analysis Software,5.0,,,,,,
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,Target preparation and microarray hybridization were performed by the Siteman Cancer Center Multiplex Gene Analysis Core Facility using Affymetrix Mouse Genome 430 2.0 GeneChip microarrays,0.85,Accept,Experimental Usage,Affymetrix Mouse Genome 430 2.0 GeneChip,Analysis Software,,,,,,,
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"Statistical significance was determined with Student's t test using Spotfire DecisionSite for Functional Genomics (TIBCO Spotfire, Somerville, MA)",0.8,Accept,Experimental Usage,Spotfire DecisionSite for Functional Genomics,Analysis Software,,,,,,,
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"For NG2 immunofluorescence staining, the pixel intensity was determined using image analysis software MetaMorph (Molecular Devices, Downingtown, PA)",0.8,Accept,Experimental Usage,MetaMorph,Analysis Software,,,,,,,
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"α-tubulin (Sigma, St. Louis, MO) was employed for normalization and densitometric analysis using Gel-Pro Analyzer 4.0 (Media Cybernetics, Bethesda, MD)",0.8,Accept,Experimental Usage,Gel-Pro Analyzer 4.0,Analysis Software,4.0,,,,,,
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"Statistical analyses were performed using GraphPad Prism 4.0 software (GraphPad, La Jolla, CA)",0.8,Accept,Experimental Usage,GraphPad Prism 4.0,Analysis Software,4.0,,,,,,
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"Target sequencing was performed using the Haloplex custom target enrichment system (Agilent Technologies, CA, USA) on the MiSeq sequencing platform",0.8,Accept,Experimental Usage,MiSeq sequencing platform,Analysis Software,,,,,,,
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"The data were analysed using NextGENe software v.2.3.4.1 (Softgenetics, PA, USA) with the default settings",0.9,Accept,Experimental Usage,NextGENe software v.2.3.4.1,Analysis Software,v.2.3.4.1,,,,,,
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,The width and length of the cranio-cartilage were measured using ImageJ software,0.85,Accept,Experimental Usage,ImageJ software,Analysis Software,,,,,,,
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,GO analysis was performed using g:Profiler,0.9,Accept,Experimental Usage,g:Profiler,Web Application,,,,,,,
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,Venn diagrams were generated using BioVenn,0.9,Accept,Experimental Usage,BioVenn,Web Application,,,,,,,
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,Proximity maps were generated using PathVisio software,0.9,Accept,Experimental Usage,PathVisio software,Analysis Software,,,,,,,
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"Splice site prediction software (Alamut Visual Plus, version 1.5.1; Sophia Genetics) was used to identify variants likely to affect pre-mRNA splicing",0.9,Accept,Experimental Usage,"Alamut Visual Plus, version 1.5.1",Analysis Software,1.5.1,,,,,,
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Mice were placed 16.3 cm from a cesium-137 source (J.L. Shepherd & Associates, San Fernando, CA) and shielded with an iron collimator",0.85,Accept,Experimental Usage,"cesium-137 source (J.L. Shepherd & Associates, San Fernando, CA)",Other,,,,,,,
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,Complete blood counts were performed on blood samples obtained at the time of sacrifice by cardiac puncture and analyzed immediately on a Hemavet provided by the UCSF Mouse Pathology Core.,0.8,Accept,Experimental Usage,Hemavet,Analysis Software,,,,,,,
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Images were captured and merged using Openlab (Improvision, Waltham, MA).",0.85,Accept,Experimental Usage,"Openlab (Improvision, Waltham, MA)",Analysis Software,,,,,,,
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,PCR fragment analyses were performed by the UCSF Genome Core using Peak Scanner software from Applied Biosystems.,0.85,Accept,Experimental Usage,Peak Scanner software from Applied Biosystems,Analysis Software,,,,,,,
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Coverslips were mounted using Vectashield with DAPI (Vector Laboratories), and visualized with a Zeiss LSM 510 Meta confocal microscope.",0.85,Accept,Experimental Usage,Zeiss LSM 510 Meta confocal microscope,Other,,,,,,,
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,All analyses were performed on R 2.7.0.,0.85,Accept,Experimental Usage,R 2.7.0,Analysis Software,2.7.0,R,,,,,
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,Amplifications were run in a Stepone Plus Real-Time PCR System (Applied Biosystems),0.8,Accept,Experimental Usage,Stepone Plus Real-Time PCR System,Analysis Software,,,,,,,
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,Images were captured and analyzed using Axio Vision Rel. 4.8 software (Carl Zeiss MicroImaging),0.85,Accept,Experimental Usage,Axio Vision Rel. 4.8 software,Analysis Software,4.8,,,,,,
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,Statistical significance was determined by ANOVA followed by Bonferroni's posthoc test for multiple comparisons and student's t-test for two groups using Graphpad Prism 6 software,0.8,Accept,Experimental Usage,Graphpad Prism 6,Analysis Software,6,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"X-rays were taken using a piXarray 100 DSR System with Biopix Software (Version No: 1.0.6., Bioptics, Inc. Tucson, AZ)",0.8,Accept,Experimental Usage,piXarray 100 DSR System,Analysis Software,1.0.6,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"bone mineral density (BMD) of the axial bone was evaluated in vivo using pDEXA (PIXImus II; GE-Lunar Corp., Madison, WI)",0.8,Accept,Experimental Usage,PIXImus II,Analysis Software,,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"Whole axial bone was placed in the gantry of a XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner (Stratec Medizintechnik GmbH, Pforzheim, Germany) with Software Version 5.50",0.8,Accept,Experimental Usage,XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner,Analysis Software,5.50,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"biomechanical testing was conducted utilizing Testresouse R systems with MtestwR software version: R 1.4.2 (TestResources Inc. Shakopee, MN)",0.8,Accept,Experimental Usage,MtestwR software,Analysis Software,R 1.4.2,,,,,,
PMID:27081657,10.1002/acn3.288,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,,"fMRI data analyses were performed using tools from the FMRIB software library ( www.fmrib.ox.ac.uk/fsl ), version 5.0",0.9,Accept,Experimental Usage,FMRIB software library (FSL),Analysis Software,5.0,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"using in-house software running in MATLAB (MathWorks, Natick, MA, version 2016b)",0.85,Accept,Experimental Usage,MATLAB,Analysis Software,2016b,MATLAB,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,Burrows–Wheeler Aligner (version 0.7.8) was utilized to map the paired-end clean reads,0.9,Accept,Experimental Usage,Burrows–Wheeler Aligner,Analysis Software,0.7.8,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,SAMtools (version 1.0) is used for sorting the BAM file,0.9,Accept,Experimental Usage,SAMtools,Analysis Software,1.0,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,Single-nucleotide variant is then identified using GATK (version 3.8),0.9,Accept,Experimental Usage,GATK,Analysis Software,3.8,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,subsequently annotated using ANNOVAR (version 2015Dec),0.9,Accept,Experimental Usage,ANNOVAR,Analysis Software,2015Dec,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,CNV is detected by control-FREEC (version 9.9),0.9,Accept,Experimental Usage,control-FREEC,Analysis Software,9.9,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,acquired using BD FACS Canto II and further analyzed by FlowJo software,0.85,Accept,Experimental Usage,FlowJo,Analysis Software,,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,chromosome number was counted using ImageJ software,0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,We developed R codes and used RStudio (version 1.2.5033),0.9,Accept,Experimental Usage,RStudio,Analysis Software,1.2.5033,R,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"R package ""Analyses of Phylogenetics and Evolution"" (APE, version 5.2)",0.9,Accept,Experimental Usage,APE,Package/Library,5.2,R,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"MEGAX (version 0.1, for MAC) to generate SKY-based phylogenetic trees",0.9,Accept,Experimental Usage,MEGAX,Analysis Software,0.1,,,,,,
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,,organoid sizes were measured (12 organoids per line) using ImageJ software (version 1.51j8),0.9,Accept,Experimental Usage,ImageJ,Analysis Software,1.51j8,,,,,,
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,,DESeq2 (v1.18.0) package was used to normalize count data and for differential gene expression analysis,0.9,Accept,Experimental Usage,DESeq2,Package/Library,v1.18.0,R,,,,,
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,,Gene set enrichment analysis (GSEA) was performed using GSEA software v3.0 beta2,0.9,Accept,Experimental Usage,GSEA,Analysis Software,v3.0 beta2,,,,,,
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Heat maps were generated using XenoBase® version 3.5 from Affymetrix array data using MAS 5.0 normalization,0.85,Accept,Experimental Usage,XenoBase version 3.5,Analysis Software,3.5,,,,,,
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Microarray data was analyzed using Affymetrix expression console MAS 5.0 method,0.8,Accept,Experimental Usage,Affymetrix Expression Console MAS 5.0,Analysis Software,MAS 5.0,,,,,,
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,using StepOne Software v2.3 (Applied Biosystems) standard parameters,0.85,Accept,Experimental Usage,StepOne Software v2.3,Analysis Software,v2.3,,,,,,
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,gene list with significant expression deviation from the reference set are supplied directly to the Gene Targeted Therapy Map,0.8,Accept,Experimental Usage,Gene Targeted Therapy Map,Database,,,,,,,
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,"Z-score expression values were also supplied to two drug response pattern evaluation methods, PGSEA and CMAP",0.8,Accept,Experimental Usage,PGSEA,Analysis Software,,,,,,,
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,"Z-score expression values were also supplied to two drug response pattern evaluation methods, PGSEA and CMAP",0.8,Accept,Experimental Usage,CMAP,Analysis Software,,,,,,,
PMID:32642741,10.1093/noajnl/vdaa037,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,,"Postprocessing DTI analysis was performed using a previously described method for automated probabilistic tractography of the optic radiations. Briefly, using FSL version 5.0.7 (FMRIB)",0.85,Accept,Experimental Usage,FSL version 5.0.7,Analysis Software,5.0.7,,,,,,
PMID:32642741,10.1093/noajnl/vdaa037,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,,Probabilistic streamline fiber tracking (PROBTRACKX) was used with 1000 starting points seeded in each voxel of the lateral geniculate nucleus,0.8,Accept,Experimental Usage,PROBTRACKX,Analysis Software,,,,,,,
PMID:32642741,10.1093/noajnl/vdaa037,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,,Voxelwise statistical analysis of FA data was accomplished using Tract-Based Spatial Statistics (TBSS) in all participants adjusting for the natural logarithm of age,0.85,Accept,Experimental Usage,Tract-Based Spatial Statistics (TBSS),Analysis Software,,,,,,,
PMID:32642741,10.1093/noajnl/vdaa037,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,,b = 0 maps were registered to a standard space (Montreal Neurologic Institute 152 T1 map with 2 mm slice thickness),0.75,Accept,Experimental Usage,Montreal Neurologic Institute 152 T1 map,Database,,,,,,,
PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"postcontrast thin-sliced (≤ 3 mm) T1-weighted magnetic resonance (MR) sequences were uploaded into the iPlan Net software (Brainlab, Feldkirchen, Germany), and volumes were measured manually or in combination with semiautomated segmentation",0.9,Accept,Experimental Usage,"iPlan Net software (Brainlab, Feldkirchen, Germany)",Analysis Software,,,,,,,
PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"Statistical evaluation was performed using the Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",0.8,Accept,Experimental Usage,"Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",Analysis Software,10.0,,,,,,
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"directly sequenced through Sanger (Abi Prism 3700, ThermoFisher Scientific, Watham, MA, USA)",0.8,Accept,Experimental Usage,Abi Prism 3700,Analysis Software,,,,,,,
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,"libraries were run on a MiniSeq apparatus (Illumina, San Diego, CA, USA)",0.8,Accept,Experimental Usage,MiniSeq apparatus,Analysis Software,,,,,,,
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,Human Splicing Finder (HSF) Version 2.4.1 ( http://www.umd.be/HSF/ Assessing on 21 December 2020),0.9,Accept,Experimental Usage,Human Splicing Finder (HSF) Version 2.4.1,Web Application,2.4.1,,,,,,
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,Mutation taster ( http://www.mutationtaster.org/ Assessing on 21 December 2020),0.85,Accept,Experimental Usage,Mutation taster,Web Application,,,,,,,
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,Combined Annotation Dependent Depletion (CADD) v1.6 ( https://cadd.gs.washington.edu/ Assessing on 21 December 2020),0.9,Accept,Experimental Usage,Combined Annotation Dependent Depletion (CADD) v1.6,Web Application,v1.6,,,,,,
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,Protein sequence alignments were performed using Multalin ( http://multalin.toulouse.inra.fr/multalin/ Assessing on 28 December 2020),0.85,Accept,Experimental Usage,Multalin,Web Application,,,,,,,
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,Densitometric analyses were performed using the ImageJ (Image Processing and analysis in Java) software,0.9,Accept,Experimental Usage,ImageJ,Analysis Software,,Java,,,,,
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Target sites within the genes of interest were selected using Massachusetts Institute of Technology's CRISPR design tool (now unavailable, previously: crispr.mit.edu, ), or later, CRISPOR",0.9,Accept,Experimental Usage,CRISPOR,Web Application,,,,,,,
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,Sequencing data were demultiplexed and analyzed using CRISPResso or CRISPResso2,0.85,Accept,Experimental Usage,CRISPResso,Analysis Software,,,,,,,
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,Sequencing data were demultiplexed and analyzed using CRISPResso or CRISPResso2,0.85,Accept,Experimental Usage,CRISPResso2,Analysis Software,,,,,,,
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Logistic regressions were performed in JMP (JMP Pro 15.0.0, SAS Institute Inc., Cary, NC)",0.8,Accept,Experimental Usage,JMP Pro 15.0.0,Analysis Software,15.0.0,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,we used CRISPRscan to identify 3–6 gRNAs that target the gene of interest,0.85,Accept,Experimental Usage,CRISPRscan,Analysis Software,,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,the authors used Cell Ranger from 10x Genomics to map zebrafish reads from scRNAseq to the genome,0.85,Accept,Experimental Usage,Cell Ranger,Analysis Software,,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,Variable genes were identified and clustered with K-nearest neighbors and shared nearest neighbor modularity optimization through Seurat,0.85,Accept,Experimental Usage,Seurat,Package/Library,,R,,,,,
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,band intensities were quantified using UN-SCAN-IT gel 6.1 software,0.85,Accept,Experimental Usage,UN-SCAN-IT gel 6.1,Analysis Software,6.1,,,,,,
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"The software used was Olympus CellSens dimension, which is able to do deconvolution on captured z stacks",0.85,Accept,Experimental Usage,Olympus CellSens dimension,Analysis Software,,,,,,,
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"imaged using a 40X/1.4 NA objective and EasyRatioPro imaging software (PTI, NJ, USA)",0.85,Accept,Experimental Usage,EasyRatioPro imaging software,Analysis Software,,,,,,,
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"Sequence reads were aligned to human reference genome Ensembl GRCh37 (v.75), using STAR (v. 2.5.2a)",0.9,Accept,Experimental Usage,STAR,Analysis Software,v. 2.5.2a,,,,,,
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Differentially expressed genes in pair-wise comparisons were identified by edgeR's quasi-likelihood F test (v. 3.18.1),0.9,Accept,Experimental Usage,edgeR,Package/Library,v. 3.18.1,R,,,,,
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Quality checking of sequence reads was assessed by fastQC (v.0.10.1),0.8,Accept,Experimental Usage,fastQC,Analysis Software,v.0.10.1,,,,,,
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Synergy scores were generated using the web-based SynergyFinder application (https://synergyfinder.fimm.fi/),0.9,Accept,Experimental Usage,SynergyFinder,Web Application,,,https://synergyfinder.fimm.fi/,,,,
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Column scatter plots were generated using Graphpad Prism 8,0.85,Accept,Experimental Usage,GraphPad Prism 8,Analysis Software,8,,,,,,
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,reactions were performed using the QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific),0.85,Accept,Experimental Usage,QuantStudio 3 Real-Time PCR System,Analysis Software,,,,,,,
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,The target cell type was counted using the ImageJ Cell Counter extension (NIH),0.9,Accept,Experimental Usage,ImageJ Cell Counter extension,Plugin,,,,,,,
PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,,Statistical analysis was performed using GraphPad Prism 7 and R version 3.5.1.,0.8,Accept,Experimental Usage,GraphPad Prism 7,Analysis Software,7,,,,,,
PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,,Statistical analysis was performed using GraphPad Prism 7 and R version 3.5.1.,0.8,Accept,Experimental Usage,R version 3.5.1,Analysis Software,3.5.1,R,,,,,
PMID:32572180,10.1038/s41436-020-0873-7,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.,,"Statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC) and R version 3.5.0",0.8,Accept,Experimental Usage,SAS version 9.4,Analysis Software,9.4,,,,,,
PMID:32572180,10.1038/s41436-020-0873-7,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.,,"Statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC) and R version 3.5.0",0.8,Accept,Experimental Usage,R version 3.5.0,Analysis Software,3.5.0,R,,,,,
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,IC50 values were calculated by nonlinear regression analysis using GraphPad Prism 9.0 software (RRID: SCR_002798),0.9,Accept,Experimental Usage,GraphPad Prism,Analysis Software,9.0,,,,,,
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,The Bliss synergy scores were calculated using the Combenefit platform as previously described,0.85,Accept,Experimental Usage,Combenefit platform,Analysis Software,,,,,,,
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,Band intensity quantifications were done using Image Studio Lite software (RRID: SCR_013715),0.9,Accept,Experimental Usage,Image Studio Lite software,Analysis Software,,,,,,,
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,Primers were designed using the online NCBI Primer-BLAST tool (RRID: SCR_003095),0.85,Accept,Experimental Usage,NCBI Primer-BLAST tool,Web Application,,,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,we propose deep interactive networks (DINs) to address the above limitations. User interactions guide the model to recognize complicated tumors and quickly adapt to heterogeneous tumors.,0.95,Accept,Development,DINs (Deep Interactive Networks),Analysis Software,,Python,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,The structure of DINs follows the encoder-decoder scheme with skip connection like 3D U-Net. But 3D U-Net is originally evaluated to segment organs with fixed size and balance pixel spacing,0.85,Accept,Experimental Usage,3D U-Net,Analysis Software,,,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,DINs outperform automated methods by 44%–63% and outperform 'nnU-Net + Dim output 1' by 29%. The comparison between 'nnU-Net + Dim output 1' and 'DINs (DIM output 1)' indicates,0.85,Accept,Experimental Usage,nnU-Net,Analysis Software,,,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,Cai et al. perform volume measurements on the LRMRI data set using 3DQI software at Massachusetts General Hospital (MGH) and National Cancer Institute (NCI),0.9,Accept,Experimental Usage,3DQI software,Analysis Software,,,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,Cai et al. perform volume measurements on the LRMRI data set using 3DQI software at Massachusetts General Hospital (MGH) and National Cancer Institute (NCI) and MEDx software at NCI,0.9,Accept,Experimental Usage,MEDx software,Analysis Software,,,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,"We compare DINs with some conventional interactive segmentation methods, including Random Walk (RW), Graph Cut (GC) and Active Contour (AC)",0.8,Accept,Experimental Usage,Random Walk (RW),Analysis Software,,,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,"We compare DINs with some conventional interactive segmentation methods, including Random Walk (RW), Graph Cut (GC) and Active Contour (AC)",0.8,Accept,Experimental Usage,Graph Cut (GC),Analysis Software,,,,,,,
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,"We compare DINs with some conventional interactive segmentation methods, including Random Walk (RW), Graph Cut (GC) and Active Contour (AC)",0.8,Accept,Experimental Usage,Active Contour (AC),Analysis Software,,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,The CellTiter‐Glo assay (Promega; G7570) is a luminescent viability assay,0.8,Accept,Experimental Usage,CellTiter‐Glo assay (Promega; G7570),Other,,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,An autophagy assay kit (Abcam; ab139484) was used to measure autophagic vacuoles,0.8,Accept,Experimental Usage,autophagy assay kit (Abcam; ab139484),Other,,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,The Annexin V‐FITC apoptosis kit (Abcam; ab14085) was used to detect apoptosis,0.8,Accept,Experimental Usage,Annexin V‐FITC apoptosis kit (Abcam; ab14085),Other,,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,Caspase activity was assessed using the generic caspase activity assay kit (Abcam; ab112130),0.8,Accept,Experimental Usage,generic caspase activity assay kit (Abcam; ab112130),Other,,,,,,,
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software,0.85,Accept,Experimental Usage,Olympus BX61 upright light microscope,Analysis Software,,,,,,,
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software,0.85,Accept,Experimental Usage,Q imaging Retiga Exi camera,Analysis Software,,,,,,,
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software (Media Cybernetics),0.9,Accept,Experimental Usage,InVivo 3.2.0 software,Analysis Software,3.2.0,,,,,,
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Computerized quantitative morphometric analysis was performed using Image-Pro Plus software (Media Cybernetics),0.9,Accept,Experimental Usage,Image-Pro Plus software,Analysis Software,,,,,,,
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"The width and equatorial length of the testes were measured on testicular histological images using Image J1.45s, version 1.44p (NIH, Bethesda, MD)",0.9,Accept,Experimental Usage,"Image J1.45s, version 1.44p",Analysis Software,1.44p,,,,,,
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"Differences between Nf1+/- and Nf1+/+ groups were analyzed by 2-tailed Student's t tests and were graphed using GraphPad 5 Prism software (San Diego, Calif., USA)",0.85,Accept,Experimental Usage,GraphPad 5 Prism software,Analysis Software,5,,,,,,
PMID:37269078,10.1177/17407745231178839,Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.,,"Surveys were created in REDCap, a secure web-based data capture tool",0.9,Accept,Experimental Usage,REDCap,Web Application,,,,,,,
PMID:37269078,10.1177/17407745231178839,Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.,,Weighted Kappa statistic was used to measure the agreement of adolescents and caregiver responses,0.75,Accept,Experimental Usage,Weighted Kappa statistic,Analysis Software,,,,,,,
PMID:38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,,"The data were analyzed using IBM SPSS for Windows, version 28",0.85,Accept,Experimental Usage,"IBM SPSS for Windows, version 28",Analysis Software,version 28,,,,,,
PMID:38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,,A post-hoc power analysis was conducted using GPower 3.1 (n = 19),0.85,Accept,Experimental Usage,GPower 3.1,Analysis Software,3.1,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,Burrows-Wheeler Aligner was used to map the paired-end clean reads to the human reference genome (GRCh37/hg19),0.8,Accept,Experimental Usage,Burrows-Wheeler Aligner,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,After sorting with SAMtools and marking duplicates with the Broad Picard,0.8,Accept,Experimental Usage,SAMtools,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,Aligned reads were further processed using GATK to remove low mapping quality reads,0.85,Accept,Experimental Usage,GATK,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,Somatic SNVs and indels were identified in tumors with matched normal samples by integrating the results from five algorithms for variant calling: VarScan2,0.85,Accept,Experimental Usage,VarScan2,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"integrating the results from five algorithms for variant calling: VarScan2, Freebayes, Strelka, MuTect, and VarDict",0.85,Accept,Experimental Usage,Freebayes,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"integrating the results from five algorithms for variant calling: VarScan2, Freebayes, Strelka, MuTect, and VarDict",0.85,Accept,Experimental Usage,Strelka,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"integrating the results from five algorithms for variant calling: VarScan2, Freebayes, Strelka, MuTect, and VarDict",0.85,Accept,Experimental Usage,MuTect,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"integrating the results from five algorithms for variant calling: VarScan2, Freebayes, Strelka, MuTect, and VarDict",0.85,Accept,Experimental Usage,VarDict,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"Somatic variants were annotated using AnnoVar algorithm, which aggregates information from genomic and protein resources",0.85,Accept,Experimental Usage,AnnoVar,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"MutationTaster2, Polyphen2, Provean, and SIFT were applied to predict the pathogenicity of missense SNVs",0.85,Accept,Experimental Usage,MutationTaster2,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"MutationTaster2, Polyphen2, Provean, and SIFT were applied to predict the pathogenicity of missense SNVs",0.85,Accept,Experimental Usage,Polyphen2,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,"MutationTaster2, Polyphen2, Provean, and SIFT were applied to predict the pathogenicity of missense SNVs",0.85,Accept,Experimental Usage,SIFT,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,The reads were aligned to the human reference genome (GRCh37/hg19) using STAR and the expression was quantitated at gene level using featureCounts,0.85,Accept,Experimental Usage,STAR,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,The reads were aligned to the human reference genome (GRCh37/hg19) using STAR and the expression was quantitated at gene level using featureCounts,0.85,Accept,Experimental Usage,featureCounts,Analysis Software,,,,,,,
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,Binding affinity of mutant and corresponding wild-type peptides to the patient's germline HLA alleles was predicted using netMHCpan-4.0,0.9,Accept,Experimental Usage,netMHCpan-4.0,Analysis Software,4.0,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"We used the CatWalk XT (ver. 8, Noldus Information Technology, Wageningen, The Netherlands) system to study the functional recovery of the nerve",0.9,Accept,Experimental Usage,CatWalk XT,Analysis Software,ver. 8,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,A Grass neurostimulator was used to deliver stimuli starting with ten single electrical pulses followed by trains of pulses from 2 to 10 Hz,0.8,Accept,Experimental Usage,Grass neurostimulator,Analysis Software,,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,Digital recordings at 50 kHz (using Windaq DI-720 hardware with Pro+ software) were made,0.85,Accept,Experimental Usage,Windaq DI-720 hardware with Pro+ software,Analysis Software,,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"images captured with a Leica DMR III microscope and CCD camera running Metamorph software (Molecular Devices, Inc., Sunnyvale, CA)",0.85,Accept,Experimental Usage,Metamorph software,Analysis Software,,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"Using ImageJ software (NIH, Bethesda, MD), g-ratios were calculated on the EM micrographs",0.85,Accept,Experimental Usage,ImageJ software,Analysis Software,,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"Differences among means for each group were analyzed by using t-tests and one way ANOVA using SigmaPlot software (Systat, San Jose, CA)",0.8,Accept,Experimental Usage,SigmaPlot software,Analysis Software,,,,,,,
PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,,Images were acquired using a Nikon Eclipse E800 microscope,0.8,Accept,Experimental Usage,Nikon Eclipse E800 microscope,Other,,,,,,,
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,we used the non-B DNA database and the non-B DNA Motif Search Tool under preset search criteria for direct repeats,0.85,Accept,Experimental Usage,non-B DNA Motif Search Tool,Web Application,,,,,,,
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,we screened both datasets for the presence of direct and inverted repeats using the MEME suite software,0.85,Accept,Experimental Usage,MEME suite software,Analysis Software,,,,,,,
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,Both datasets were also investigated for the presence of retrotransposons by means of the UCSC Repeat Masker track,0.85,Accept,Experimental Usage,UCSC Repeat Masker,Web Application,,,,,,,
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,we performed BLASTN self-alignments of the respective regions,0.85,Accept,Experimental Usage,BLASTN,Analysis Software,,,,,,,
PMID:32642737,10.1093/noajnl/vdz050,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,,The hematoxylin and eosin (H&E)-stained slides were scanned using an Aperio XT scanner.,0.85,Accept,Experimental Usage,Aperio XT scanner,Analysis Software,,,,,,,
PMID:32642737,10.1093/noajnl/vdz050,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,,who entered free text of up to a 200 word description for each case into a REDcap database,0.8,Accept,Experimental Usage,REDcap database,Database,,,,,,,
PMID:32642737,10.1093/noajnl/vdz050,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,,"analyzed using the CaloPix viewer (TRIBVN-HEALTHCARE, Chatillon, France)",0.85,Accept,Experimental Usage,CaloPix viewer,Analysis Software,,,,,,,
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"L-[18F]FETrp was radiosynthesized in a custom-manufactured module purchased from PETCHEM Solutions Inc. (Pinckney, MI, USA)",0.85,Accept,Experimental Usage,PETCHEM module,Other,,,,,,,
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,An Agilent ChemStation software (version C.01.07) was used for data analysis,0.9,Accept,Experimental Usage,Agilent ChemStation software (version C.01.07),Analysis Software,C.01.07,,,,,,
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,Static and dynamic PET imaging in wild-type and NF1 tumor mice was performed in a PerkinElmer G4 microPET scanner,0.85,Accept,Experimental Usage,PerkinElmer G4 microPET scanner,Other,,,,,,,
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"ROIs were manually drawn with VivoQuant software version 4.0 (Invicro, Needham, MA, USA)",0.95,Accept,Experimental Usage,VivoQuant software version 4.0,Analysis Software,4.0,,,,,,
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"MS was carried out using an Ultimate 3000 UPLC system (Thermo Fisher, Germany) connected to an Orbitrap Velos Pro mass spectrometer",0.85,Accept,Experimental Usage,Ultimate 3000 UPLC system,Analysis Software,,,,,,,
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"MS was carried out using an Ultimate 3000 UPLC system (Thermo Fisher, Germany) connected to an Orbitrap Velos Pro mass spectrometer",0.85,Accept,Experimental Usage,Orbitrap Velos Pro mass spectrometer,Analysis Software,,,,,,,
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Andromeda search engine integrated in MaxQuant version 1.3.05 programme was used to identify the proteins,0.95,Accept,Experimental Usage,MaxQuant version 1.3.05,Analysis Software,1.3.05,,,,,,
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"LFQ data generated by Maxquant were processed using Microsoft Excel and specially developed proteomics software, Perseus",0.9,Accept,Experimental Usage,Perseus,Analysis Software,,,,,,,
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"Functional enrichment analysis was performed using Benjamini-Hochberg multiple correction testing integrated in to the database for annotation, visualization and integrated discovery (DAVID) software",0.9,Accept,Experimental Usage,DAVID software,Analysis Software,,,,,,,
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Confocal microscopy was performed using a Leica DMI6000B microscope,0.85,Accept,Experimental Usage,Leica DMI6000B microscope,Analysis Software,,,,,,,
PMID:39996452,10.1111/cns.70287,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,,This study was conducted on a Bruker 7.0 T scanner (Bruker BioSpin GmbH).,0.8,Accept,Experimental Usage,Bruker 7.0 T scanner,Other,,,,,,,
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,A comprehensive search strategy was deployed across the databases: PubMed/MEDLINE and Google Scholar.,0.8,Accept,Experimental Usage,PubMed/MEDLINE,Database,,,,,,,
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,A comprehensive search strategy was deployed across the databases: PubMed/MEDLINE and Google Scholar.,0.8,Accept,Experimental Usage,Google Scholar,Database,,,,,,,
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,"manual additions from SYNAPSE, the CTF data portal, and BioArchives, to collect technical reports and preprints.",0.85,Accept,Experimental Usage,SYNAPSE,Database,,,,,,,
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,"manual additions from SYNAPSE, the CTF data portal, and BioArchives, to collect technical reports and preprints.",0.85,Accept,Experimental Usage,CTF data portal,Database,,,,,,,
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,"manual additions from SYNAPSE, the CTF data portal, and BioArchives, to collect technical reports and preprints.",0.8,Accept,Experimental Usage,BioArchives,Database,,,,,,,
PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,Kaplan-Meier plots were generated in GraphPad Prism and p-values were determined by log-rank Mantel-Cox test.,0.8,Accept,Experimental Usage,GraphPad Prism,Analysis Software,,,,,,,
PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,Kaplan-Meier plots were generated in GraphPad Prism and p-values were determined by log-rank Mantel-Cox test.,0.9,Accept,Experimental Usage,log-rank Mantel-Cox test,Analysis Software,,,,,,,
PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,Kaplan-Meier plots were generated in GraphPad Prism and p-values were determined by log-rank Mantel-Cox test.,0.85,Accept,Experimental Usage,Kaplan-Meier plots,Analysis Software,,,,,,,
PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,"For patients in the institutional cohort whose samples underwent bulk RNA sequencing, whole exome sequencing and spatial transcriptomics profiling",0.9,Accept,Experimental Usage,bulk RNA sequencing,Analysis Software,,,,,,,
PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,"For patients in the institutional cohort whose samples underwent bulk RNA sequencing, whole exome sequencing and spatial transcriptomics profiling",0.9,Accept,Experimental Usage,whole exome sequencing,Analysis Software,,,,,,,
PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,"For patients in the institutional cohort whose samples underwent bulk RNA sequencing, whole exome sequencing and spatial transcriptomics profiling",0.9,Accept,Experimental Usage,spatial transcriptomics profiling,Analysis Software,,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,System control and data collection were performed on a PC laptop using MATLAB (Mathworks) via direct USB connection...,0.85,Accept,Experimental Usage,MATLAB,Analysis Software,,MATLAB,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,An Arduino was used for transistor–transistor logic and pulse-width modulation signals for control of the LD and shutter servos...,0.8,Accept,Experimental Usage,Arduino,Command-line Tool,,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,"sections were cut on a Leica CM1950 Clinical Cryostat, captured on Superfrost™ Plus Microscope Slides...",0.75,Accept,Experimental Usage,Leica CM1950 Clinical Cryostat,Other,,,,,,,
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,"photographed on a JOEL-10 CX electron microscope at 1000–50,000 magnification",0.8,Accept,Experimental Usage,JOEL-10 CX electron microscope,Other,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,Amplified biotinylated cRNA (1.5 µg) was hybridized to HumanRef-8_v2 Sentrix BeadChips.,0.9,Accept,Experimental Usage,HumanRef-8_v2 Sentrix BeadChips,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"dried, and scanned in an Illumina BeadStation 500 scanner.",0.85,Accept,Experimental Usage,Illumina BeadStation 500 scanner,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,Image acquisition and initial image analysis were done with Illumina BeadScan and BeadStudio applications.,0.8,Accept,Experimental Usage,BeadScan,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,Image acquisition and initial image analysis were done with Illumina BeadScan and BeadStudio applications.,0.8,Accept,Experimental Usage,BeadStudio,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,Twenty-one select transcripts plus an endogenous control (GAPDH) were interrogated by qPCR in all 79 samples that were analyzed on microarrays on 384-well microfluidic cards,0.75,Accept,Experimental Usage,384-well microfluidic cards,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"In those cases in which family data were available, SNVs were checked for Mendelian segregation with PedCheck",0.85,Accept,Experimental Usage,PedCheck,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,Hardy-Weinberg equilibrium (HWE) proportions were tested with PEDSTATS on 70 unrelated individuals.,0.85,Accept,Experimental Usage,PEDSTATS,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"""Tiled Regression"" as implemented in TRAP (Tiled Regression Analysis Package) was used to identify the set of independent significant variants",0.9,Accept,Experimental Usage,TRAP (Tiled Regression Analysis Package),Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"For genotyping DPH2 SNPs rs4660761 and rs7161, we used genotyping calls obtained from Illumina Human OmniQuad-1M SNP-arrays.",0.85,Accept,Experimental Usage,Illumina Human OmniQuad-1M SNP-arrays,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,SNP-array analysis was done according to the manufacturer's protocol using GenomeStudio (v. 2010.2) software,0.9,Accept,Experimental Usage,GenomeStudio (v. 2010.2),Analysis Software,v. 2010.2,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"A targeted, multiplex PCR primer panel was designed using the custom Ion Ampliseq Designer v3.0",0.85,Accept,Experimental Usage,Ion Ampliseq Designer v3.0,Analysis Software,v3.0,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"Individual samples were barcoded, pooled, templated, and sequenced on the Ion Torrent PGM Sequencer",0.85,Accept,Experimental Usage,Ion Torrent PGM Sequencer,Analysis Software,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,We also used the online tools HaploReg (http://www.broadinstitute.org/mammals/haploreg/haploreg.php) and RegulomeDB,0.8,Accept,Experimental Usage,HaploReg,Web Application,,,,,,,
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,We also used the online tools HaploReg and RegulomeDB (http://regulome.stanford.edu) as a complementary analysis,0.8,Accept,Experimental Usage,RegulomeDB,Web Application,,,,,,,
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,Raw files were processed for label-free quantification by MaxQuant (version 1.6.10.43) LFQ using the Uniprot/Swiss-Prot mouse database,0.9,Accept,Experimental Usage,MaxQuant (version 1.6.10.43),Analysis Software,1.6.10.43,,,,,,
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,LFQ intensities for kinases with at least two peptides were imported into Perseus (version 1.6.10.50),0.9,Accept,Experimental Usage,Perseus (version 1.6.10.50),Analysis Software,1.6.10.50,,,,,,
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"Data were acquired uncompensated and exported as FCS 3.0 files for analysis using FlowJo Software (version 9.9.6,Tree Star Inc)",0.9,Accept,Experimental Usage,FlowJo Software (version 9.9.6),Analysis Software,9.9.6,,,,,,
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,AXL immunohistochemistry was analyzed using the IHC Profiler plugin for ImageJ (version 1.47),0.9,Accept,Experimental Usage,ImageJ (version 1.47),Analysis Software,1.47,,,,,,
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"representative image were generated using HALO Image Analysis Software (version 2.3, Indica Labs)",0.9,Accept,Experimental Usage,HALO Image Analysis Software (version 2.3),Analysis Software,2.3,,,,,,
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"The microelectronic biosensor XCELLigence Real Time Cell Analysis System (RTCA, Roche Diagnostics GmbH",0.9,Accept,Experimental Usage,XCELLigence Real Time Cell Analysis System,Analysis Software,,,,,,,
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,Measurements were performed on epifluorescent images using Image J (NIH),0.8,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,Data analysis was done using R [42],0.8,Accept,Experimental Usage,R,Analysis Software,,R,,,,,
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Nuclei were labeled with DAPI (Sigma-Aldrich) and microscopic images acquired with ImageJ software (NIH),0.85,Accept,Experimental Usage,ImageJ software (NIH),Analysis Software,,,,,,,
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Flow cytometry was performed on a FACSCanto (Becton Dickinson) and analyzed using FlowJo software,0.85,Accept,Experimental Usage,FlowJo software,Analysis Software,,,,,,,
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,The DNA purity was determined using a NanoDrop one spectrophotometer and quantified with a Qubit 2.0 Fluorometer,0.8,Accept,Experimental Usage,NanoDrop one spectrophotometer,Analysis Software,,,,,,,
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,The DNA purity was determined using a NanoDrop one spectrophotometer and quantified with a Qubit 2.0 Fluorometer using the Qubit dsDNA HS Assay Kit,0.8,Accept,Experimental Usage,Qubit 2.0 Fluorometer,Analysis Software,,,,,,,
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"DNA was cropped into approximately 300-bp fragments using focused ultrasonicators (Covaris M220, United States)",0.8,Accept,Experimental Usage,Covaris M220,Analysis Software,,,,,,,
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"Sequencing was carried out on an Illumina HiSeq X Ten System (Illumina, San Diego, CA, United States)",0.9,Accept,Experimental Usage,Illumina HiSeq X Ten System,Analysis Software,,,,,,,
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,"An ABI PRISM 3730XL analyzer (Applied Biosystems, Foster City, CA, United States) was used for Sanger sequencing",0.85,Accept,Experimental Usage,ABI PRISM 3730XL analyzer,Analysis Software,,,,,,,
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,Primers were designed based on the mutation sites found using Primer 3.0,0.85,Accept,Experimental Usage,Primer 3.0,Analysis Software,3.0,,,,,,
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,images were acquired and analyzed using an Olympus FV10i confocal microscope,0.8,Accept,Experimental Usage,Olympus FV10i confocal microscope,Analysis Software,,,,,,,
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,reactions were run in triplicate with an Applied Biosystems 7000 series machine (Invitrogen),0.8,Accept,Experimental Usage,Applied Biosystems 7000 series machine,Analysis Software,,,,,,,
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,Copy number estimates were extracted from the microarray image files using Feature Extraction 10.5 (Agilent),0.85,Accept,Experimental Usage,Feature Extraction 10.5,Analysis Software,10.5,,,,,,
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,data were analyzed in Agilent Genomic Workbench 6.5 (Agilent),0.85,Accept,Experimental Usage,Agilent Genomic Workbench 6.5,Analysis Software,6.5,,,,,,
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,Nuclei area was measured using Image J software,0.85,Accept,Experimental Usage,Image J software,Analysis Software,,,,,,,
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,analyzed with FACS Calibur and CellQuestPro software (BD Biosciences),0.85,Accept,Experimental Usage,CellQuestPro software,Analysis Software,,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"FASTQ sequencing reads were processed, aligned to the mouse genome (mm10), and converted to digital gene expression matrices using the Drop-seq tools (version 1.12)",0.9,Accept,Experimental Usage,Drop-seq tools (version 1.12),Analysis Software,1.12,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"For 10X Genomics datasets, we used Cellranger v5.0.1 to align reads to the hg19 human reference sequence",0.9,Accept,Experimental Usage,Cellranger v5.0.1,Analysis Software,v5.0.1,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"For each sample dataset, unsupervised clustering was performed using R package Seurat (version 3.1.0)",0.9,Accept,Experimental Usage,Seurat (version 3.1.0),Package/Library,3.1.0,R,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,scREF is a reference-based toolkit for single-cell analysis for mapping a query RNA-seq dataset onto a reference,0.85,Accept,Experimental Usage,scREF,Analysis Software,,,https://github.com/jumphone/scRef/archive/master.zip,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,We used CIBERSORTx to perform deconvolution analysis of bulk tumor data against Lats1/2-mut advanced SN tumor cell types,0.9,Accept,Experimental Usage,CIBERSORTx,Analysis Software,,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Malignant cells were identified by inferring large-scale chromosomal CNVs in each single cell based on a moving averaged expression profiles across chromosomal intervals by inferCNV,0.9,Accept,Experimental Usage,inferCNV,Analysis Software,,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Cell-state transition directions were inferred by VECTOR based on the observation that quantile polarization of a cell's principal component values,0.9,Accept,Experimental Usage,VECTOR,Analysis Software,,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Slingshot is a top performer for cellular trajectory from scRNA-seq data. We used Slingshot to model the pseudotime trajectory,0.9,Accept,Experimental Usage,Slingshot,Package/Library,,R,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,we used the R package CytoTRACE version 0.3.3 to predict differentiation status of SC lineage cells from mouse and human scRNA-seq data,0.9,Accept,Experimental Usage,CytoTRACE version 0.3.3,Package/Library,0.3.3,R,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"ArchR was used for all scATAC-seq analyses according to default parameters, including quality control and cell filtering",0.9,Accept,Experimental Usage,ArchR,Package/Library,,R,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"We used CellChat to infer the intercellular communication from scRNA-seq data for further data exploration, analysis, and visualization",0.9,Accept,Experimental Usage,CellChat,Package/Library,,R,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"were used to query the Washington University DGIdb (version 3.0.2), with a focus on expert-curated collections of druggable genes",0.9,Accept,Experimental Usage,DGIdb (version 3.0.2),Database,3.0.2,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,The same sets of genes were also queried in OmicsNet and visualized for relationships among genes and transcription factors,0.85,Accept,Experimental Usage,OmicsNet,Web Application,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The raw sequence reads were first trimmed using Trim Galore (version 0.6.10) to remove any primer adapter contamination,0.9,Accept,Experimental Usage,Trim Galore (version 0.6.10),Analysis Software,0.6.10,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The trimmed sequence reads were further analyzed using Broad's Genome Analysis ToolKit (version 4.6.0) following their Best Practices Guidelines,0.9,Accept,Experimental Usage,Broad's Genome Analysis ToolKit (version 4.6.0),Analysis Software,4.6.0,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle,0.9,Accept,Experimental Usage,BWA (version 0.7.17-r1188),Analysis Software,0.7.17-r1188,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) was then applied,0.9,Accept,Experimental Usage,Picard tools (version 3.2.0),Analysis Software,3.2.0,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Both Delly and Manta were used to identify structural variants from these alignments to identify any type of off-target effects,0.85,Accept,Experimental Usage,Delly,Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Both Delly and Manta were used to identify structural variants from these alignments to identify any type of off-target effects,0.85,Accept,Experimental Usage,Manta,Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"For the global proteomics studies this system ran in-line with a Thermo Q Exactive HFx mass spectrometer, equipped with a Nanospray FlexTM ion source",0.85,Accept,Experimental Usage,Thermo Q Exactive HFx mass spectrometer,Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"the same model of HPLC ran in-line with a Thermo Velos Pro Orbitrap mass spectrometer, equipped with a Nanospray ion source",0.85,Accept,Experimental Usage,Thermo Velos Pro Orbitrap mass spectrometer,Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The XCalibur RAW files were collected in profile mode, centroided and converted to MzXML using ReAdW v. 3.5.1",0.9,Accept,Experimental Usage,ReAdW v. 3.5.1,Analysis Software,3.5.1,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The mgf files were then created using MzXML2Search (included in TPP v. 3.5) for all scans,0.9,Accept,Experimental Usage,MzXML2Search (included in TPP v. 3.5),Analysis Software,3.5,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The data were searched using MACOT for the global studies, and SEQUEST (Thermo Fisher Scientific) for the PPI studies",0.85,Accept,Experimental Usage,MASCOT,Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The data were searched using MACOT for the global studies, and SEQUEST (Thermo Fisher Scientific) for the PPI studies",0.85,Accept,Experimental Usage,SEQUEST,Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The list of peptide IDs generated based on SEQUEST or MASCOT search results were filtered separately using Scaffold (Protein Sciences, Portland Oregon)",0.9,Accept,Experimental Usage,"Scaffold (Protein Sciences, Portland Oregon)",Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Subcellular localization was assessed for the PPI's using the Human Protein Atlas (proteinatlas.org) Subcellular section (Protein Atlas version 23.0),0.9,Accept,Experimental Usage,Human Protein Atlas (proteinatlas.org),Database,23.0,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Further Pathway analysis was conducted using QIAGEN Ingenuity Pathway Analysis (IPA),0.9,Accept,Experimental Usage,QIAGEN Ingenuity Pathway Analysis (IPA),Analysis Software,,,,,,,
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,750 K cells/ml were added into each chamber of an O2K system (Oroboros Instruments). Cells were permeabilized by addition of digitonin,0.85,Accept,Experimental Usage,O2K system (Oroboros Instruments),Analysis Software,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"0.2 nmol of HDR were pulsed for 20 ms at 1,800 V using the Neon Transfection System (Thermo)",0.8,Accept,Experimental Usage,Neon Transfection System,Other,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Cells were run through a CytoFLEX flow cytometer (Beckman Coulter) using the Cytexpert software,0.85,Accept,Experimental Usage,CytoFLEX flow cytometer,Analysis Software,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,FlowJo software was used to determine cell purity,0.85,Accept,Experimental Usage,FlowJo software,Analysis Software,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,RT-qPCR was performed using the Bio-Rad CFX96 Real-Time System (Bio-Rad) using technical replicates,0.85,Accept,Experimental Usage,Bio-Rad CFX96 Real-Time System,Analysis Software,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Samples were sequenced on an Illumina NovaSeq 6000 using a 150 paired end flow cell,0.85,Accept,Experimental Usage,Illumina NovaSeq 6000,Analysis Software,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"The RNA sequencing data were mapped to the Ensembl Sus Scrofa genome 11.1, release 103 using HISAT2",0.9,Accept,Experimental Usage,HISAT2,Analysis Software,36,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"mapped to the Ensembl Sus Scrofa genome 11.1, release 103 using HISAT2 and quantified with StringTie",0.9,Accept,Experimental Usage,StringTie,Analysis Software,37,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,All graphs were generated using R and tidyverse,0.85,Accept,Experimental Usage,R,Analysis Software,38,R,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,All graphs were generated using R and tidyverse,0.85,Accept,Experimental Usage,tidyverse,Package/Library,,R,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"Bands were imaged using the Li-Cor Odyssey Fc Imaging System, quantified by densitometry",0.85,Accept,Experimental Usage,Li-Cor Odyssey Fc Imaging System,Analysis Software,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Images were acquired using a Cytation 5 cell imaging reader (BioTek),0.85,Accept,Experimental Usage,Cytation 5 cell imaging reader,Analysis Software,,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,All graphs and statistical analyses were performed using GraphPad Prism V9,0.85,Accept,Experimental Usage,GraphPad Prism V9,Analysis Software,V9,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,PERGs were recorded and analysed at 12 weeks of age using the Celeris ERG stimulator (Diagnosys),0.8,Accept,Experimental Usage,Celeris ERG stimulator (Diagnosys),Analysis Software,,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"The analysis for this Article was generated using Partek Flow software, v.9.0",0.9,Accept,Experimental Usage,Partek Flow software (v.9.0),Analysis Software,v.9.0,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,RNA-seq reads were aligned to the Ensembl release 100 top-level assembly with STAR v.2.7.3a,0.9,Accept,Experimental Usage,STAR (v.2.7.3a),Analysis Software,v.2.7.3a,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Differentially expressed gene analysis was then performed using DESeq2 method,0.85,Accept,Experimental Usage,DESeq2,Package/Library,,R,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Images were taken using a Zeiss Axio Imager M2 and quantified using ImageJ (v.2.0.0),0.9,Accept,Experimental Usage,ImageJ (v.2.0.0),Analysis Software,v.2.0.0,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Cell proliferation was determined by dividing the number of EdU+ cells by the number of DAPI+ cells using Cell Profiler (v.3.1.9),0.9,Accept,Experimental Usage,Cell Profiler (v.3.1.9),Analysis Software,v.3.1.9,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Images were taken using a Zeiss Axio Imager M2 and the Stereo Investigator software (mbfbioscience v2019),0.9,Accept,Experimental Usage,Stereo Investigator software (mbfbioscience v2019),Analysis Software,v2019,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,imaged on a Bio-Rad Gel Doc imager using Image Lab software (v.6),0.9,Accept,Experimental Usage,Image Lab software (v.6),Analysis Software,v.6,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,and analysed using Image Studio Lite (v.5.0.21),0.9,Accept,Experimental Usage,Image Studio Lite (v.5.0.21),Analysis Software,v.5.0.21,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Whole-cell voltage recordings were performed at room temperature on primary cultured hippocampal neurons using an EPC 10 Amplifier (HEKA Electronics, Germany)",0.85,Accept,Experimental Usage,EPC 10 Amplifier,Analysis Software,,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Electrodes were pulled from thin-walled borosilicate glass capillaries (Warner Instruments, Hamden, CT) with a P-97 electrode puller (Sutter Instrument, Novato, CA)",0.8,Accept,Experimental Usage,P-97 electrode puller,Analysis Software,,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Analysis was performed using Fitmaster and origin8.1 (OriginLab Corporation, MA)",0.85,Accept,Experimental Usage,Fitmaster,Analysis Software,,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Analysis was performed using Fitmaster and origin8.1 (OriginLab Corporation, MA)",0.85,Accept,Experimental Usage,origin8.1,Analysis Software,8.1,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"fluorescence of resorufin was measured in a Victor 3 V multilabel plate reader (Perkin Elmer, Shelton, CT)",0.85,Accept,Experimental Usage,Victor 3 V multilabel plate reader,Analysis Software,,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,The morphometric analysis of neurite lengths of transfected green fluorescent cells was performed with Nikon Elements software,0.9,Accept,Experimental Usage,Nikon Elements software,Analysis Software,,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,Sholl analysis was performed with ImageJ using an automated Sholl analysis plugin,0.9,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,Sholl analysis was performed with ImageJ using an automated Sholl analysis plugin,0.85,Accept,Experimental Usage,automated Sholl analysis plugin,Plugin,,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"Methylation profiling was performed on bisulfite-treated DNA using the Illumina Infinium MethylationEPIC BeadChip array (Illumina, San Diego, USA)",0.9,Accept,Experimental Usage,Illumina Infinium MethylationEPIC BeadChip array,Analysis Software,,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Generated raw methylation files were imported and preprocessed with the statistical programming language R using the minfi package (Bioconductor),0.85,Accept,Experimental Usage,minfi package,Package/Library,,R,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Unsupervised consensus hierarchical clustering was performed with ConsensusClusterPlus package (Bioconductor),0.85,Accept,Experimental Usage,ConsensusClusterPlus package,Package/Library,,R,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Differentially methylated probes were identified using limma based modeling approach (Bioconductor),0.85,Accept,Experimental Usage,limma,Package/Library,,R,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,read pairs were aligned to the hg19 reference genome using BWA-MEM v 0.7.12 with default parameters,0.9,Accept,Experimental Usage,BWA-MEM v 0.7.12,Command-line Tool,v 0.7.12,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.72 and GATK v3.6.0",0.9,Accept,Experimental Usage,GATK v3.6.0,Command-line Tool,v3.6.0,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.9,Accept,Experimental Usage,Mutect V1.1.6,Command-line Tool,V1.1.6,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.9,Accept,Experimental Usage,Strelka v1.0.13,Command-line Tool,v1.0.13,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Sequence data was processed and aligned to human reference genome (hg38) using STAR aligner (v.2.6.0),0.9,Accept,Experimental Usage,STAR aligner (v.2.6.0),Command-line Tool,v.2.6.0,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Data was normalized by counts-per-million (CPM) and then subjected to trimmed means of M (TMM) using edgeR (v.3.22.3),0.85,Accept,Experimental Usage,edgeR,Package/Library,v.3.22.3,R,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Fusion genes for cohort of PNSTs were identified using FusionCatcher v1.1.0 with default parameters,0.9,Accept,Experimental Usage,FusionCatcher v1.1.0,Command-line Tool,v1.1.0,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"CellRanger (10× Genomics) analysis pipeline was used for library demultiplexing, read alignment to human genome GRCh38",0.85,Accept,Experimental Usage,CellRanger,Pipeline,,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"The raw gene expression matrix was normalized, and variance stabilized by SCTransform in Suerat version 3.0",0.9,Accept,Experimental Usage,Seurat version 3.0,Package/Library,version 3.0,R,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Pseudotime analysis was performed as previously described using Monocle2,0.85,Accept,Experimental Usage,Monocle2,Package/Library,,R,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,CNAs of neoplastic and non-neoplastic cells were inferred from the snRNA-seq data using inferCNV (v.1.1.1),0.9,Accept,Experimental Usage,inferCNV (v.1.1.1),Package/Library,v.1.1.1,R,,,,,
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Mouse optic glioma neurospheres, Nf1−/− TVZ NSCs (TVZ_Cre) and wild-type TVZ NSCs (TVZ_LacZ) RNA was subjected to Affymetrix GeneChip Mouse Genome 430 2.0 Array hybridization",0.9,Accept,Experimental Usage,Affymetrix GeneChip Mouse Genome 430 2.0 Array,Analysis Software,,,,,,,
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,the resulting data analyzed using Partex Genomics Suite Version 6.6 beta,0.9,Accept,Experimental Usage,Partex Genomics Suite Version 6.6 beta,Analysis Software,6.6 beta,,,,,,
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Densitometry quantification was done using ImageJ software and normalized to GAPDH,0.8,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,The heatmap was generated using CRAN's pheatmap package ( http://cran.r-project.org/web/packages/pheatmap/index.html ),0.8,Accept,Experimental Usage,pheatmap package,Package/Library,,R,http://cran.r-project.org/web/packages/pheatmap/index.html,,,,
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ),0.8,Accept,Experimental Usage,Limma package,Package/Library,,R,http://www.bioconductor.org,,,,
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ) and GeneSpring GXv7.3.1 (Agilent Technologies),0.8,Accept,Experimental Usage,GeneSpring GXv7.3.1,Analysis Software,v7.3.1,,,,,,
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"All data analysis was done using Calcusyn software (CalcuSyn Version 2.1, BioSoft)",0.8,Accept,Experimental Usage,CalcuSyn Version 2.1,Analysis Software,Version 2.1,,,,,,
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,"The SSTMean method consisted of 4 main steps that were implemented in a Matlab script (Version 9.9.0, Natick, MA).",0.85,Accept,Development,"Matlab script (Version 9.9.0, Natick, MA)",Analysis Software,9.9.0,MATLAB,,,,,
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,"For each MRI slice, the tumor was identified by drawing its contour(s) using the pencil tool from FSLeyes",0.8,Accept,Experimental Usage,FSLeyes,Analysis Software,,,,,,,
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,A semi-automatic segmentation technique based on mean magnetic resonance imaging (MRI) intensity thresholding (SSTMean) was developed,0.9,Accept,Development,SSTMean,Analysis Software,,,,,,,
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,compared to a similar and previously published technique based on minimum image intensity thresholding (SSTMini),0.85,Accept,Experimental Usage,SSTMini,Analysis Software,,,,,,,
PMID:32383545,10.15252/embr.201949117,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,"After background subtraction, Pearson's co‐localization coefficient was calculated with the ImageJ Co‐localization Analysis plugin",0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,raw reads were quality filtered using fastp v.0.2,0.9,Accept,Experimental Usage,fastp v.0.2,Analysis Software,v.0.2,,,,,,
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17,0.9,Accept,Experimental Usage,BWA v.0.7.17,Analysis Software,v.0.7.17,,,,,,
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,Aligned reads were deduplicated with Samtools v.1.7,0.9,Accept,Experimental Usage,Samtools v.1.7,Analysis Software,v.1.7,,,,,,
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,Genomic coverage was estimated using MosDepth,0.85,Accept,Experimental Usage,MosDepth,Analysis Software,,,,,,,
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,copy number–based estimation of tumor fraction were then performed using the ichorCNA tool (Broad v.0.2.0),0.95,Accept,Experimental Usage,ichorCNA tool (Broad v.0.2.0),Analysis Software,v.0.2.0,,,,,,
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,read-pair fragment sizes for cfDNA samples were calculated using deepTools bamPEFragmentSize,0.9,Accept,Experimental Usage,deepTools bamPEFragmentSize,Analysis Software,,,,,,,
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,This multi-institutional study used fragment size analysis and ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA,0.9,Accept,Experimental Usage,ultra-low-pass whole genome sequencing (ULP-WGS),Analysis Software,,,,,,,
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Single-guide RNAs (sgRNAs) were designed using CRISPOR software (http://crispor.tefor.net),0.9,Accept,Experimental Usage,CRISPOR software,Web Application,,,http://crispor.tefor.net,,,,
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Data were analyzed using FlowJo software (FlowJo LLC),0.85,Accept,Experimental Usage,FlowJo software,Analysis Software,,,,,,,
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,All data were processed using GraphPad Prism 9,0.85,Accept,Experimental Usage,GraphPad Prism 9,Analysis Software,9,,,,,,
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,The time spent near each wire cup was recorded and scored with the automated AnyMaze software,0.9,Accept,Experimental Usage,AnyMaze software,Analysis Software,,,,,,,
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,neurofibromin-immunoreactive (NF1-ir) cells and pERK-immunoreactive (pERK-ir) cells were counted by a blinded observer using ImageJ software (NIH),0.9,Accept,Experimental Usage,ImageJ software,Analysis Software,,,,,,,
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,Analysis was performed using GraphPad Prism version 5.0d (GraphPad Software),0.9,Accept,Experimental Usage,GraphPad Prism version 5.0d,Analysis Software,5.0d,,,,,,
PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,SPR measurements were performed with Biacore T100 biosensor system (GE Heathcare Bioscience),0.8,Accept,Experimental Usage,Biacore T100 biosensor system,Analysis Software,,,,,,,
PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,"fitted using a Langmiur interaction model (ProteON Manager software, Bio-rad Laboratories)",0.85,Accept,Experimental Usage,ProteON Manager software,Analysis Software,,,,,,,
PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,Data were digitized with a Digidata 1322 A interface and pClamp software suite,0.85,Accept,Experimental Usage,pClamp software suite,Analysis Software,,,,,,,
PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,"analyzed using LAS AF (Leica Microsystems, Wetzlar, Germany) and ImageJ ® software",0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,"Statistical significance was determined using Origin ® 8 (OriginLab, Northampton, MA)",0.85,Accept,Experimental Usage,Origin 8,Analysis Software,8,,,,,,
PMID:35614131,10.1038/s41418-022-01020-0,The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation.,,Protein quantification and assessment of significance was determined in Prism 6.0,0.85,Accept,Experimental Usage,Prism 6.0,Analysis Software,6.0,,,,,,
PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,internal consistency reliability was measured with Cronbach's alpha,0.85,Accept,Experimental Usage,Cronbach's alpha,Analysis Software,,,,,,,
PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA)",0.9,Accept,Experimental Usage,SPSS 18,Analysis Software,18,,,,,,
PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA) and SAS 9.3 version for Windows (SAS Institute Inc., Cary, NC, USA)",0.9,Accept,Experimental Usage,SAS 9.3,Analysis Software,9.3,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Targeted next-generation sequencing was performed using the UCSF500 NGS Panel as previously described,0.9,Accept,Experimental Usage,UCSF500 NGS Panel,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Sequence reads were mapped to the reference human genome build GRCh37 (hg19) using the Burrows-Wheeler aligner (BWA),0.8,Accept,Experimental Usage,BWA,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Recalibration and deduplication of reads was performed using the Genome Analysis Toolkit (GATK),0.8,Accept,Experimental Usage,GATK,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Single nucleotide variant and small insertion/deletion mutation calling was performed with FreeBayes,0.8,Accept,Experimental Usage,FreeBayes,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,"Single nucleotide variant and small insertion/deletion mutation calling was performed with FreeBayes, Unified Genotyper, and Pindel",0.8,Accept,Experimental Usage,Unified Genotyper,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,"Single nucleotide variant and small insertion/deletion mutation calling was performed with FreeBayes, Unified Genotyper, and Pindel",0.8,Accept,Experimental Usage,Pindel,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Large insertion/deletion and structural alteration calling was performed with Delly,0.8,Accept,Experimental Usage,Delly,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Variant annotation was performed with Annovar,0.8,Accept,Experimental Usage,Annovar,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,"Single nucleotide variants, insertions/deletions, and structural variants were visualized and verified using Integrative Genome Viewer",0.8,Accept,Experimental Usage,Integrative Genome Viewer,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Genome-wide copy number and zygosity analysis was performed by CNVkit,0.8,Accept,Experimental Usage,CNVkit,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Genome-wide copy number and zygosity analysis was performed by CNVkit and visualized using NxClinical (Biodiscovery),0.8,Accept,Experimental Usage,NxClinical,Analysis Software,,,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Methylation data were preprocessed using the combineArrays function within the minfi package (v.1.38.0) in R Bioconductor,0.9,Accept,Experimental Usage,minfi,Package/Library,v.1.38.0,R,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Dimensionality reduction using t-distributed stochastic neighbor embedding (tSNE) was performed by Rtsne (v.0.15),0.9,Accept,Experimental Usage,Rtsne,Package/Library,v.0.15,R,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,The tSNE plot was visualized with ggplot2 (v.3.3.5),0.8,Accept,Experimental Usage,ggplot2,Package/Library,v.3.3.5,R,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,The lmFit function from the Limma package (v.3.40.6) was applied on a log-transformed b value matrix,0.9,Accept,Experimental Usage,Limma,Package/Library,v.3.40.6,R,,,,,
PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Visualization was performed using the R package ComplexHeatmap (v.2.8.0),0.9,Accept,Experimental Usage,ComplexHeatmap,Package/Library,v.2.8.0,R,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,All flow cytometry was performed on a FACS Calibur (BD),0.8,Accept,Experimental Usage,FACS Calibur,Analysis Software,,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,Acquisition and data analysis was performed using CellQuest Pro software (BD),0.85,Accept,Experimental Usage,CellQuest Pro software,Analysis Software,,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Peripheral blood was analyzed using a HemaVet Mascot 800 hematology analyzer (CDC Technologies, Oxford, CT)",0.8,Accept,Experimental Usage,HemaVet Mascot 800 hematology analyzer,Analysis Software,,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Graphing and statistical analysis was performed with Prism 4.0 (GraphPad Software, La Jolla, CA)",0.85,Accept,Experimental Usage,Prism 4.0,Analysis Software,4.0,,,,,,
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"microarray images were automatically analysed using Feature extractionTM software, version 9.5.1.1 (Agilent Technologies)",0.9,Accept,Experimental Usage,Feature extractionTM software,Analysis Software,9.5.1.1,,,,,,
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,The limma package was also used for differential expression and multiple testing was controlled using the false discovery rate,0.9,Accept,Experimental Usage,limma package,Package/Library,,R,,,,,
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"The live-cell imaging system, IncuCyte (Essen BioScience Ltd, Herts., UK) was used to monitor the migration of cells",0.85,Accept,Experimental Usage,IncuCyte,Analysis Software,,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,ONT reads meeting a minimum Q-value of 10 were size- and chimera-filtered with Filtlong v0.2.0,0.9,Accept,Experimental Usage,Filtlong v0.2.0,Command-line Tool,v0.2.0,,https://github.com/rrwick/Filtlong,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,ONT reads meeting a minimum Q-value of 10 were size- and chimera-filtered with Filtlong v0.2.0 and Porechop v0.2.4,0.9,Accept,Experimental Usage,Porechop v0.2.4,Command-line Tool,v0.2.4,,https://github.com/rrwick/Porechop,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Filtered reads were assembled with Flye v2.5, enforcing a 10,000 bp overlap minimum",0.9,Accept,Experimental Usage,Flye v2.5,Analysis Software,v2.5,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,Approximately 20× PacBio subread coverage was used with GCpp v1.0.0-1807624 to independently error-correct the ONT-based Flye assembly,0.9,Accept,Experimental Usage,GCpp v1.0.0-1807624,Analysis Software,v1.0.0-1807624,,https://github.com/PacificBiosciences/gcpp,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The resulting error-corrected haploid assembly was deduplicated with purge_haplotigs commit be7e44b,0.9,Accept,Experimental Usage,purge_haplotigs,Command-line Tool,,,https://bitbucket.org/mroachawri/purge_haplotigs/src/master/,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Juicer v1.6.2 and 3D-DNA v180114 were used to scaffold the deduplicated, error-corrected assembly with the Hi-C data",0.9,Accept,Experimental Usage,Juicer v1.6.2,Analysis Software,v1.6.2,,https://github.com/aidenlab/juicer,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Juicer v1.6.2 and 3D-DNA v180114 were used to scaffold the deduplicated, error-corrected assembly with the Hi-C data",0.9,Accept,Experimental Usage,3D-DNA v180114,Analysis Software,v180114,,https://github.com/aidenlab/3d-dna,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,We assessed the quality of our genome assembly using BUSCO v5.7.0 with mammalia_odb10,0.9,Accept,Experimental Usage,BUSCO v5.7.0,Analysis Software,v5.7.0,,https://busco.ezlab.org/,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,We assessed the quality of our genome assembly using BUSCO v5.7.0 with mammalia_odb10 and QUASTv5.0.2,0.9,Accept,Experimental Usage,QUASTv5.0.2,Analysis Software,v5.0.2,,https://quast.sourceforge.net/,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,Putative genes in the WMSTM draft genome were identified using Liftoff v1.6.3 with default parameters,0.9,Accept,Experimental Usage,Liftoff v1.6.3,Analysis Software,v1.6.3,,https://github.com/agshumate/Liftoff,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,aligned it to the S. scrofa reference coding sequence using the align sequences feature in SnapGeneTM Version 7.2.1,0.9,Accept,Experimental Usage,SnapGeneTM Version 7.2.1,Analysis Software,7.2.1,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The WMSTM and human amino acid sequences were then input into AlphaFold 3 for structural predictions,0.9,Accept,Experimental Usage,AlphaFold 3,Web Application,,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"The structural predictions from WMSTM and human proteins were aligned using PyMOL (The PyMOL Molecular Graphics System, Version 3.0.5 Schrödinger, LLC.)",0.9,Accept,Experimental Usage,PyMOL Version 3.0.5,Analysis Software,3.0.5,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"Adapters, low-quality bases, and primers were trimmed from reads to obtain a Phred score of 20 via the trimming software Skewer (v0.2.2.b)",0.9,Accept,Experimental Usage,Skewer v0.2.2.b,Command-line Tool,v0.2.2.b,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The Tassel pipeline (version 2) was used to process sequence reads to single nucleotide polymorphism (SNP) genotypes,0.9,Accept,Experimental Usage,Tassel pipeline version 2,Pipeline,version 2,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,demultiplexed reads were aligned to the WMSTM draft genome using Bowtie2,0.85,Accept,Experimental Usage,Bowtie2,Command-line Tool,,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The population-wide inbreeding coefficient F was calculated with VCFtools (v.0.1.16),0.9,Accept,Experimental Usage,VCFtools v.0.1.16,Command-line Tool,v.0.1.16,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,Beagle v4.1 was used to perform whole genome phasing and to impute missing data,0.9,Accept,Experimental Usage,Beagle v4.1,Analysis Software,v4.1,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,A mid-point rooted topology was created from the VCF data using RAxML,0.85,Accept,Experimental Usage,RAxML,Analysis Software,,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,A mid-point rooted topology was created from the VCF data using RAxML and visualized with itol v6.9.1,0.9,Accept,Experimental Usage,itol v6.9.1,Web Application,v6.9.1,,https://itol.embl.de/,,,,
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Sorting was performed with the FACS Aria Fusion Special Order System (Becton Dickinson),0.85,Accept,Experimental Usage,FACS Aria Fusion Special Order System (Becton Dickinson),Other,,,,,,,
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"Smart-seq2 whole transcriptome amplification, library construction, and sequencing were performed as previously published",0.9,Accept,Experimental Usage,Smart-seq2,Pipeline,,,,,,,
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"We performed Louvain clustering on the centered matrix with the top 7000 genes using the ""igraph"" package with default parameters.",0.85,Accept,Experimental Usage,igraph,Package/Library,,R,,,,,
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Doublets were identified by combining the results of two methods that were published recently and implemented in R packages—scdDblFinder,0.9,Accept,Experimental Usage,scdDblFinder,Package/Library,,R,,,,,
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,scdDblFinder and the doubletCells algorithm from scran,0.9,Accept,Experimental Usage,scran,Package/Library,,R,,,,,
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Quantification of staining intensity was performed in QuPath,0.9,Accept,Experimental Usage,QuPath,Analysis Software,,,,,,,
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,Targeted next generation sequencing data from 2745 cancer samples...were collected with ACE (Advanced Cohort Explorer).,0.85,Accept,Experimental Usage,ACE (Advanced Cohort Explorer),Database,,,,,,,
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,cancer genomics databases including GENIE (Genomics Evidence Neoplasia Information Exchange),0.9,Accept,Experimental Usage,GENIE (Genomics Evidence Neoplasia Information Exchange),Database,v.7.0,,,,,,
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,databases in cBioPortal including TCGA (The Cancer Genome Atlas),0.9,Accept,Experimental Usage,cBioPortal,Web Application,,,,,,,
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,databases in cBioPortal including TCGA (The Cancer Genome Atlas),0.9,Accept,Experimental Usage,TCGA (The Cancer Genome Atlas),Database,,,,,,,
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,Variants with less than 2 Catalogue of Somatic Mutations in Cancer counts were excluded as passenger alterations.,0.85,Accept,Experimental Usage,Catalogue of Somatic Mutations in Cancer,Database,,,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Data preprocessing and normalization was performed using minfi version 1.30 in R version 3.6.0,0.85,Accept,Experimental Usage,minfi,Package/Library,1.30,R,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,"Data were normalized, and variance stabilized by SCTransform in Seurat version 3.0",0.85,Accept,Experimental Usage,Seurat,Package/Library,3.0,R,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,"Library demultiplexing, read alignment to human genome GRCh38, and unique molecular identifier (UMI) quantification was performed in Cell Ranger version 1.3.1",0.85,Accept,Experimental Usage,Cell Ranger,Analysis Software,1.3.1,,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Reads were aligned to GRCh38 using the splice-aware aligner HISAT2 version 2.0.3,0.85,Accept,Experimental Usage,HISAT2,Analysis Software,2.0.3,,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Differential expression analysis was performed using DESeq2 using the Wald test,0.85,Accept,Experimental Usage,DESeq2,Package/Library,,R,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Peptide and protein identification searches were performed using the MaxQuant data analysis algorithm,0.85,Accept,Experimental Usage,MaxQuant,Analysis Software,,,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Label-free quantification and statistical testing were performed using the MSstats statistical R-package,0.85,Accept,Experimental Usage,MSstats,Package/Library,,R,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,All PRM data was analyzed by Skyline 4.2.0.19072,0.85,Accept,Experimental Usage,Skyline,Analysis Software,4.2.0.19072,,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Transcription factor motif deviations in the setting of genetic or therapeutic perturbations were quantified using the ChromVAR wrapper in Signac,0.85,Accept,Experimental Usage,ChromVAR,Package/Library,,R,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Preprocessing of single-nuclei RNA and ATAC data was performed using Signac v1.8.0,0.85,Accept,Experimental Usage,Signac,Package/Library,1.8.0,R,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,"To evaluate whether we could identify single nuclei CNVs from prospective schwannomas that demonstrated loss of chromosome 22q based on DNA methylation profiling, we applied CONICS",0.85,Accept,Experimental Usage,CONICS,Analysis Software,,,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Gene ontology analysis of probes was performed by extracting the associated gene body annotation from each probe using the Bioconductor package IlluminaHumanMethylationEPICanno.ilm10b2.hg19 and inputting the gene lists grouped based on the results of hierarchical clustering into Enrichr,0.85,Accept,Experimental Usage,Enrichr,Web Application,,,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,a methylation-based classifier using differentially methylated probes from our discovery cohort of 66 tumors was used to construct a support vector machine (SVM) using caret version 6.0 in R version 3.6.0,0.85,Accept,Experimental Usage,caret,Package/Library,6.0,R,,,,,
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,UMAP was performed on significant (p < 0.05) principal components (determined by JackStraw analysis) and batch-corrected using Harmony,0.85,Accept,Experimental Usage,Harmony,Package/Library,,R,,,,,
PMID:39858077,10.3390/cancers17020295,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,,"diaries and pill bottles (including empty ones) were collected, and MEMS TM cap data were uploaded to Aardex MEMS TM Adherence Software (ElectronReader 0.9.9).",0.85,Accept,Experimental Usage,Aardex MEMS Adherence Software (ElectronReader 0.9.9),Analysis Software,0.9.9,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Purity of DNA was assessed by spectrophotometry using NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA)",0.9,Accept,Experimental Usage,NanoDrop 2000,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,DNA yields were determined using a double stranded DNA (dsDNA) broad range (BR) kit on a Qubit ® fluorometer (Thermo Fisher Scientific),0.85,Accept,Experimental Usage,Qubit fluorometer,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"DNA was sheared into 200 bp fragments on a Bioruptor ® sonicator (Diagenode, Denville, NJ, USA)",0.8,Accept,Experimental Usage,Bioruptor sonicator,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,NGS was performed on Ion Torrent Personal Genome Machine—Ion Torrent PGM™ (Thermo Fisher Scientific),0.95,Accept,Experimental Usage,Ion Torrent Personal Genome Machine—Ion Torrent PGM™,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Primary analyses of NGS data were performed using Torrent Suite software on the Ion Torrent Browser,0.9,Accept,Experimental Usage,Torrent Suite software,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,reads were aligned to the reference sequence using TMAP (Torrent Mapping Alignment Program),0.85,Accept,Experimental Usage,TMAP,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"For variant interpretation, Ingenuity ® Variant Analysis™ software (Qiagen) and SNPnexus web server were used",0.9,Accept,Experimental Usage,Ingenuity Variant Analysis software,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"For variant interpretation, Ingenuity ® Variant Analysis™ software (Qiagen) and SNPnexus web server were used",0.85,Accept,Experimental Usage,SNPnexus web server,Web Application,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Variants were also viewed manually on Integrative Genomics Viewer (IGV—version 2.3.40; Broad Institute, Cambridge, MA, USA)",0.9,Accept,Experimental Usage,Integrative Genomics Viewer,Analysis Software,2.3.40,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"on Alamut ® Visual (version 2.6.1e; Interactive Biosoftware, Rouen, France) to eliminate strand bias and reduce false positive calls",0.9,Accept,Experimental Usage,Alamut Visual,Analysis Software,2.6.1e,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"To predict the potential effect of the mutation on the structure and function of the protein codified by the NF1 gene (neurofibromin), PolyPhen2 and SIFT were applied",0.85,Accept,Experimental Usage,PolyPhen2,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"To predict the potential effect of the mutation on the structure and function of the protein codified by the NF1 gene (neurofibromin), PolyPhen2 and SIFT were applied",0.85,Accept,Experimental Usage,SIFT,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,we also used the online Human Splicing Finder ( http://www.umd.be/HSF/ ),0.85,Accept,Experimental Usage,Human Splicing Finder,Web Application,,,http://www.umd.be/HSF/,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"All variants were confirmed by Sanger sequencing in an AB3130 Genetic Analyzer (Applied Biosystems, Carlsbad, CA, USA)",0.9,Accept,Experimental Usage,AB3130 Genetic Analyzer,Analysis Software,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Primers were designed using NCBI's Primer BLAST tool,0.85,Accept,Experimental Usage,NCBI's Primer BLAST tool,Web Application,,,,,,,
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,the sequences were analyzed with the Sequencing Analysis software (version 5.4; Applied Biosystems),0.85,Accept,Experimental Usage,Sequencing Analysis software,Analysis Software,5.4,,,,,,
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,...Data was acquired using FACSCanto II (BD Bioscienses) flow cytometer and at least 20.000 events were analyzed...,0.8,Accept,Experimental Usage,FACSCanto II (BD Bioscienses),Analysis Software,,,,,,,
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...at least 20.000 events were analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software...",0.8,Accept,Experimental Usage,FACSDiva (BD Biosciences),Analysis Software,,,,,,,
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software...",0.9,Accept,Experimental Usage,FlowJo 7.6.5,Analysis Software,7.6.5,,,,,,
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Images were analyzed using ImageJ software v.1.49 (NIH, USA), and the percentage of stained area in each picture was obtained...",0.9,Accept,Experimental Usage,"ImageJ software v.1.49 (NIH, USA)",Analysis Software,v.1.49,,,,,,
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...the cell number was determined using Countess II FL Automated Cell Counter (ThermoFisher Scientific, MA, USA)...",0.8,Accept,Experimental Usage,"Countess II FL Automated Cell Counter (ThermoFisher Scientific, MA, USA)",Analysis Software,,,,,,,
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Statistical analysis was performed using Statistical Package for Social Sciences software (SPSS v. 20.0; Chicago, IL, USA)...",0.8,Accept,Experimental Usage,SPSS v. 20.0,Analysis Software,v. 20.0,,,,,,
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"hiPSCs were karyotyped using the iScan machine (Illumina, CA, USA)",0.75,Accept,Experimental Usage,iScan machine,Analysis Software,,,,,,,
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,The analysis was performed using the Karyostudio 1.3 software (Illumina),0.85,Accept,Experimental Usage,Karyostudio 1.3 software,Analysis Software,1.3,,,,,,
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Cell motility was assessed using the IncuCyte cell migration kit (Sartorius, Göttingen, Germany) and an Incucyte Zoom live cell analysis system",0.85,Accept,Experimental Usage,IncuCyte Zoom live cell analysis system,Analysis Software,,,,,,,
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"RNA sequencing analysis was generated using Partek Flow software, v10.0",0.9,Accept,Experimental Usage,Partek Flow software,Analysis Software,v10.0,,,,,,
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,RNA sequencing reads were aligned to the hg38 Ensembl release 105 assembly with STAR v2.7.8a,0.85,Accept,Experimental Usage,STAR,Analysis Software,v2.7.8a,,,,,,
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Differential genetic analysis was then performed using DESeq2 (Love et al., 2014)",0.85,Accept,Experimental Usage,DESeq2,Package/Library,,R,,,,,
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Images were 3D-rendered using Imaris software (Imaris 9, Oxford Instruments, Abingdon, UK)",0.9,Accept,Experimental Usage,Imaris software,Analysis Software,9,,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,We interrogated the methylation profiles of 45 CNFs and 17 PNFs from NF1 subjects with the Illumina EPIC 850K methylation array.,0.9,Accept,Experimental Usage,Illumina EPIC 850K methylation array,Analysis Software,,,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Data were analyzed using a modified workflow that is similar to the ChAMP methylation array analysis procedure in R (v3.5.1),0.9,Accept,Experimental Usage,ChAMP,Package/Library,v2.18.3,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Differentially methylated loci between cutaneous and plexiform neurofibromas were identified using a hierarchical generalized linear mixed model (GLMM) approach with a logit link function as implemented in glmmTMB (v0.2.2),0.85,Accept,Experimental Usage,glmmTMB,Package/Library,v0.2.2,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Differentially methylated regions were called using DMRcate (v1.18.0),0.85,Accept,Experimental Usage,DMRcate,Package/Library,v1.18.0,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Chromatin compartments were computed at 100 kb resolution as previously described and implemented in compartmap (v1.65.71),0.85,Accept,Experimental Usage,compartmap,Package/Library,v1.65.71,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Enrichment of pathways and gene ontology (GO) terms was performed using the gometh function within the missMethyl (v1.16.0) package in R,0.85,Accept,Experimental Usage,missMethyl,Package/Library,v1.16.0,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Tissue purity was estimated by PAMES (v0.2.3),0.85,Accept,Experimental Usage,PAMES,Package/Library,v0.2.3,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Copy number alterations were computed using SeSAMe (v1.3.2) with minor modifications for plotting functionality,0.85,Accept,Experimental Usage,SeSAMe,Package/Library,v1.3.2,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,"Sequencing lanes were merged, followed by alignment with STAR (v2.7.0f) to b37",0.9,Accept,Experimental Usage,STAR,Analysis Software,v2.7.0f,,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Reverse-stranded gene counts were read into R (v3.6.1) using edgeR (v3.27.14),0.85,Accept,Experimental Usage,edgeR,Package/Library,v3.27.14,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Pairwise comparisons of beta-regressions calculated by betareg (v3.1–2),0.85,Accept,Experimental Usage,betareg,Package/Library,v3.1-2,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Pairwise comparisons of beta-regressions calculated by betareg (v3.1–2) were done using emmeans (v1.4.2),0.85,Accept,Experimental Usage,emmeans,Package/Library,v1.4.2,R,,,,,
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,"For all correlation plots, data were fit by stat_smooth using loess with span = 1 using ggplot2 (v3.2.1)",0.85,Accept,Experimental Usage,ggplot2,Package/Library,v3.2.1,R,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,All RNA-Seq data were aligned to mm10 using TopHat with default settings,0.8,Accept,Experimental Usage,TopHat,Analysis Software,,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,We used Cuff-diff to (1) estimate FPKM values for known transcripts and (2) analyze differentially expressed transcripts,0.8,Accept,Experimental Usage,Cuff-diff,Analysis Software,,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,"GO-analysis of gene expression changes was performed using Gene Set Enrichment (GSEA, http://www.broadinstitute.org/gsea/index.jsp )",0.8,Accept,Experimental Usage,GSEA,Analysis Software,,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,We used ToppCluster ( https://toppcluster.cchmc.org/ ) to construct the network of genes belonging to over-represented GO-term categories,0.8,Accept,Experimental Usage,ToppCluster,Web Application,,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,peak calling was performed using Model-based analysis of ChIP-seq (MACS) version 1.4.2 ( http://liulab.dfci.harvard.edu/MACS ) with default parameters,0.9,Accept,Experimental Usage,MACS version 1.4.2,Analysis Software,1.4.2,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,"WIG files were generated with MACS, which were subsequently visualized using EaSeq ( Lerdrup et al., 2016 )",0.8,Accept,Experimental Usage,EaSeq,Analysis Software,,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,Motif discovery was performed by HOMER software,0.8,Accept,Experimental Usage,HOMER software,Analysis Software,,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,The heatmap in Figure 7J was generated based on log2 [FPKM] by AltAnalyze ( AltAnalyze.org ) with normalization of rows relative to row mean,0.8,Accept,Experimental Usage,AltAnalyze,Analysis Software,,,,,,,
PMID:27021207,10.1002/ajmg.a.37623,Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy.,,"...Due to the small sample size, the Wilcoxon signed rank test was used to assess changes on the outcome measures from baseline to 3 months",0.75,Accept,Experimental Usage,Wilcoxon signed rank test,Analysis Software,,,,,,,
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"All participants underwent imaging of the lumbosacral plexus at the same 3-T scanner (PRISMAfit, Siemens Healthineers, Erlangen, Germany)",0.85,Accept,Experimental Usage,PRISMAfit,Analysis Software,,,,,,,
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"Image postprocessing was performed via MATLAB (The MathWorks, Inc., 2024: MATLAB, version R2024a Update 3, retrieved from https://www.mathworks.com/)",0.8,Accept,Experimental Usage,MATLAB,Analysis Software,R2024a Update 3,MATLAB,,,,,
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"The two readers independently performed three-dimensional selection of the volume of interest by manual segmentation of the DRG of levels L5 and S1 via 3D Slicer (The Slicer Community 2024: 3D Slicer, version 5.6.2)",0.9,Accept,Experimental Usage,3D Slicer,Analysis Software,5.6.2,,https://www.slicer.org/,,,,
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"Statistical analyses and visualisations were performed with R (The R Foundation for Statistical Computing 2024: R: A language for Data Analysis and Graphics, version 4.4.1)",0.8,Accept,Experimental Usage,R,Analysis Software,4.4.1,R,https://www.r-project.org/,,,,
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"Statistical analyses and visualisations were performed with R and GraphPad Prism (GraphPad Prism version 9.4.0, GraphPad Software)",0.8,Accept,Experimental Usage,GraphPad Prism,Analysis Software,9.4.0,,,,,,
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,Central vessel dropout area was quantified from the digital images using the ImageJ software (http://imagej.nih.gov/ij/),0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,http://imagej.nih.gov/ij/,,,,
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,neovascular area was determined using the Swift_NV macro for ImageJ,0.8,Accept,Experimental Usage,Swift_NV macro,Plugin,,ImageJ macro,,,,,
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Analysis was performed using GraphPad Prism version 6.0h (La Jolla, CA, USA)",0.85,Accept,Experimental Usage,GraphPad Prism version 6.0h,Analysis Software,6.0h,,,,,,
PMID:34646065,10.1155/2021/9386823,Survival and ,,The data were extracted from an EPIC electronic medical record service and from the Enneking/Anspach Research Center database,0.8,Accept,Experimental Usage,EPIC electronic medical record service,Database,,,,,,,
PMID:34646065,10.1155/2021/9386823,Survival and ,,The data were extracted from an EPIC electronic medical record service and from the Enneking/Anspach Research Center database,0.8,Accept,Experimental Usage,Enneking/Anspach Research Center database,Database,,,,,,,
PMID:34646065,10.1155/2021/9386823,Survival and ,,"All data were analyzed using statistical software (SPSS 25, IBM Co. Armonk, NY)",0.8,Accept,Experimental Usage,SPSS 25,Analysis Software,25,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,SimNIBS 3.2 ( https://simnibs.github.io/simnibs/build/html/index.html ) was used to estimate the electric field induced by tDCS,0.9,Accept,Experimental Usage,SimNIBS 3.2,Analysis Software,3.2,,https://simnibs.github.io/simnibs/build/html/index.html,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,The headreco pipeline was used to segment the different tissue types and create a finite element mesh,0.85,Accept,Experimental Usage,headreco pipeline,Pipeline,,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"the T1-weighted anatomical images were segmented into gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) using SPM8",0.9,Accept,Experimental Usage,SPM8,Analysis Software,8,,http://www.fil.ion.ucl.ac.uk/spm/,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Quantification was conducted using the Advanced Magnetic Resonance (AMARES) routine in the Java-based magnetic resonance user's interface (jMRUI5.1, EU project)",0.9,Accept,Experimental Usage,jMRUI5.1,Analysis Software,5.1,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Image processing and statistical analysis was carried out using SPM12 (Wellcome Department of Imaging Neuroscience, London)",0.9,Accept,Experimental Usage,SPM12,Analysis Software,12,,http://www.fil.ion.ucl.ac.uk/spm,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,segmented using the DARTEL (diffeomorphic anatomical registration through an exponentiated lie algebra) toolbox,0.85,Accept,Experimental Usage,DARTEL,Package/Library,,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"In order to examine the effect of the stimulation on the DLPFC, a region of interest (ROI) analysis was performed using Marsbar",0.85,Accept,Experimental Usage,Marsbar,Package/Library,,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,The task was programmed in-house using E-Prime software,0.85,Accept,Experimental Usage,E-Prime,Analysis Software,,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,participants were asked to complete the computerised Corsi block task on the Psychology Experiment Building Language (PEBL),0.85,Accept,Experimental Usage,Psychology Experiment Building Language (PEBL),Analysis Software,,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,Psychopy2 software was used to display the stimuli and to record responses,0.85,Accept,Experimental Usage,Psychopy2,Analysis Software,2,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,Statistical analyses were performed in SPSS version25 and R version 1.2,0.85,Accept,Experimental Usage,SPSS version25,Analysis Software,25,,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,Statistical analyses were performed in SPSS version25 and R version 1.2,0.85,Accept,Experimental Usage,R version 1.2,Analysis Software,1.2,R,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"linear mixed modelling was used to estimate the effect group and stimulation on the ROI beta values and for the fMRI task accuracy, RT and IES using the 'nlme' package",0.85,Accept,Experimental Usage,nlme package,Package/Library,,R,,,,,
PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Image processing and statistical analysis was carried out using SPM12 (Wellcome Department of Imaging Neuroscience, London; http://www.fil.ion.ucl.ac.uk/spm ) and MATLAB R2014a",0.85,Accept,Experimental Usage,MATLAB R2014a,Analysis Software,R2014a,MATLAB,,,,,
PMID:26822862,10.1038/srep20010,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,,"The uniform designs were generated and analysed with JMP (SAS Institute Inc., Cary, North Carolina, USA) using a Gaussian process with a Gaussian covariance function.",0.85,Accept,Experimental Usage,JMP,Analysis Software,,Statistical software,,,,,
PMID:26822862,10.1038/srep20010,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,,"Next, the computer simulations were performed with these parameter combinations, utilizing high-performance computational resources provided by the VSC (Flemish Supercomputer Center).",0.8,Accept,Experimental Usage,VSC (Flemish Supercomputer Center),Other,,,,,,,
PMID:26822862,10.1038/srep20010,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,,The sprouting behaviour of the endothelial cells is derived from the agent-based model of Bentley et al. and is captured with eight intracellular variables,0.75,Accept,Citation Only,agent-based model of Bentley et al.,Other,,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"3-dimensional fluorescence images using Imaris × 64 version 9.6–9.9 (Bitplane, Zurich, Switzerland) algorithms",0.95,Accept,Experimental Usage,Imaris × 64 version 9.6–9.9,Analysis Software,9.6–9.9,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"IGOR Pro 6.37 (Lake Oswego, USA) was used for data analysis",0.9,Accept,Experimental Usage,IGOR Pro 6.37,Analysis Software,6.37,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,MaxQuant version 1.6.10.43 [ 12 ] was used whilst enabling TMTpro 16-plex reporter ion quantitation,0.95,Accept,Experimental Usage,MaxQuant version 1.6.10.43,Analysis Software,1.6.10.43,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,two-sample moderated t-tests were applied (limma R package; [ 56 ],0.85,Accept,Experimental Usage,limma R package,Package/Library,,R,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"one-way ANOVA tests with Bonferroni post hoc tests were employed using Prism 7 (GraphPad Software, San Diego, CA, USA)",0.9,Accept,Experimental Usage,Prism 7,Analysis Software,7,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We performed exome sequencing on five malignant meningiomas on the Illumina HiSeq2000 platform using Agilent SureSelect Human All Exon kits.,0.85,Accept,Experimental Usage,Illumina HiSeq2000,Analysis Software,,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"We used wANNOVAR web server to annotate and prioritize variants, identified candidate genes with recurrent mutations",0.9,Accept,Experimental Usage,wANNOVAR web server,Web Application,,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,2 μg purified genomic DNA was extracted and randomly fragmented using Covaris E210 to generate DNA fragments around 200 to 300 bp,0.8,Accept,Experimental Usage,Covaris E210,Analysis Software,,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We used SeqMule (http://seqmule.usc.edu/) pipeline as our primary variant calling pipeline.,0.9,Accept,Experimental Usage,SeqMule,Pipeline,,,http://seqmule.usc.edu/,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"In SeqMule pipeline, BWA (Li and Durbin, 2009) was used for sequence alignment",0.85,Accept,Experimental Usage,BWA,Analysis Software,,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"GATK (McKenna) and SAMtools (et al., 2010 Li) were used to generate variant calls and to identify consensus calls for analysis.",0.85,Accept,Experimental Usage,GATK,Analysis Software,,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"GATK (McKenna) and SAMtools (et al., 2010 Li) were used to generate variant calls and to identify consensus calls for analysis.",0.85,Accept,Experimental Usage,SAMtools,Analysis Software,,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,we decided to use VarScan2 as our primary variant calling tools for targeted region sequencing data analysis given sufficient sequencing depth.,0.85,Accept,Experimental Usage,VarScan2,Analysis Software,,,,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,The sequencing traces were manually visualized in Codon Code Aligner software (http://www.codoncode.com/aligner/) to confirm the presence of candidate mutations.,0.85,Accept,Experimental Usage,Codon Code Aligner,Analysis Software,,,http://www.codoncode.com/aligner/,,,,
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,Twelve pairs of primers were designed using primer 3 (v. 0.4.0) (http://bioinfo.ut.ee/primer3-0.4.0/).,0.9,Accept,Experimental Usage,primer 3 (v. 0.4.0),Web Application,v. 0.4.0,,http://bioinfo.ut.ee/primer3-0.4.0/,,,,
PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,,"Genotyping was performed using a real-time PCR system in the allelic discrimination mode (Stratagene Mx3005 – MxPro QPCR-Software, 2007)",0.8,Accept,Experimental Usage,Stratagene Mx3005 – MxPro QPCR-Software,Analysis Software,2007,,,,,,
PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,,All statistical procedures were performed in SPSS 20.0,0.75,Accept,Experimental Usage,SPSS 20.0,Analysis Software,20.0,,,,,,
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"The total integrated intensity of RFP was monitored over the course of 72 hours, taking measurements every 2 hours with the Incucyte S3 Live-Cell Analysis System (Sartorius, Gottingen, Germany)",0.9,Accept,Experimental Usage,Incucyte S3 Live-Cell Analysis System,Analysis Software,,,,,,,
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,We used the percent viability compared to untreated cells to calculate a synergy score for each of the analyzed combinations (https://synergyfinder.fimm.fi/),0.95,Accept,Experimental Usage,synergyfinder,Web Application,,,https://synergyfinder.fimm.fi/,,,,
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,IC50 and Lethal Dose 50 (LD50) values and 95% confidence intervals were calculated to assess drug sensitivity (GraphPad Prism 9 software),0.85,Accept,Experimental Usage,GraphPad Prism 9,Analysis Software,9,,,,,,
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"cDNA samples were then subjected to qPCR amplification on an ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",0.85,Accept,Experimental Usage,"ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",Analysis Software,1.1,,,,,,
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,Images were acquired with an Olympus FV1000 point scanning confocal microscope (UCSD School of Medicine Light Microscopy Facility,0.8,Accept,Experimental Usage,Olympus FV1000 point scanning confocal microscope,Analysis Software,,,,,,,
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"Samples were analyzed on a FACScan (Becton Dickinson, Franklin Lakes, NJ), and data were analyzed for DNA content using Flowjo software",0.8,Accept,Experimental Usage,FlowJo software,Analysis Software,,,,,,,
PMID:40352015,10.7759/cureus.82033,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,,A new modeling method known as the Risk-Calibrated Superspase Linear Integer Model (Risk-SLIM) was created to reduce the variability in risk assessment using machine learning techniques.,0.85,Accept,Experimental Usage,Risk-Calibrated Superspase Linear Integer Model (Risk-SLIM),Analysis Software,,Python,,,,,
PMID:40352015,10.7759/cureus.82033,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,,"All statistics and models were conducted in Python version 3.10 (Python Software Foundation, Wilmington, Delaware, US).",0.8,Accept,Experimental Usage,Python version 3.10,Analysis Software,3.10,Python,,,,,
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,Statistical analysis was performed using the SPSS 17.0 statistics software,0.8,Accept,Experimental Usage,SPSS 17.0,Analysis Software,17.0,,,,,,
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,Images were generated using Imaris software (Bitplane AG),0.85,Accept,Experimental Usage,Imaris software,Analysis Software,,,,,,,
PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,,"All data were analyzed using SPSS 12.0 (SPSS Inc, Chicago, Illinois)",0.8,Accept,Experimental Usage,SPSS 12.0,Analysis Software,12.0,,,,,,
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,Bioluminescence signals from the virus-encoded luciferase activity were detected using an IVIS 50 system (Caliper),0.8,Accept,Experimental Usage,IVIS 50 system,Analysis Software,,,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...78 sequence variants have been found by searching PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez) and Google...,0.8,Accept,Experimental Usage,PubMed,Database,,,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...78 sequence variants have been found by searching PubMed and Google (http://google.com/)...,0.8,Accept,Experimental Usage,Google,Web Application,,,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...the online batch position check tool Mutalyzer 2.0 (http://www.mutalyzer.nl/) was used to confirm genomic position of all SPRED1 gene variants...,0.9,Accept,Experimental Usage,Mutalyzer 2.0,Web Application,2.0,,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,"...SQL tables (MySQL, Inc.) were organized to represent SPRED1 mutation status, associated phenotype, literature references...",0.85,Accept,Experimental Usage,MySQL,Database,,,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...PHP coding was performed in-house for dynamic HTML display to render pages and display SQL tables...,0.8,Accept,Experimental Usage,PHP,Analysis Software,,PHP,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...Graphics were generated using FusionCharts v3 (www.fusioncharts.com)...,0.9,Accept,Experimental Usage,FusionCharts v3,Analysis Software,v3,,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...SPRED1 mutations were added to the database and edited using phpmyadmin (www.phpmyadmin.net)...,0.85,Accept,Experimental Usage,phpmyadmin,Web Application,,,,,,,
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...Web pages are hosted on a Mac OS X Apache server...,0.8,Accept,Experimental Usage,Mac OS X Apache server,Web Application,,,,,,,
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,DESeq2 (version 1.12.4) was used to determine differentially expressed genes (DEGs) between two samples,0.9,Accept,Experimental Usage,DESeq2 (version 1.12.4),Package/Library,1.12.4,R,,,,,
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,"paired-end sequencing of the library was performed on HiSeq XTen sequencers (Illumina, San Diego, CA, USA)",0.85,Accept,Experimental Usage,HiSeq XTen sequencers,Other,,,,,,,
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,"Real-time quantitative PCR detection was performed...on a LightCycler ® 480 II Real-Time PCR System (Roche, Mannheim, Germany)",0.85,Accept,Experimental Usage,LightCycler 480 II Real-Time PCR System,Other,,,,,,,
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,"Statistical analyses were conducted with PRISM (version 8, GraphPad Software, Inc., San Diego, CA, USA)",0.8,Accept,Experimental Usage,PRISM (version 8),Analysis Software,8,,,,,,
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,Optical sections spanning the full depth of the 3D structures were acquired from four contiguous fields (2 × 2) using either an upright Zeiss LSM 780 confocal microscope,0.8,Accept,Experimental Usage,Zeiss LSM 780 confocal microscope,Analysis Software,,,,,,,
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"or an inverted Leica Stellaris 5 system (Leica Microsystems, Deerfield, IL, USA) equipped with a Tokai Hit stage-top incubator",0.8,Accept,Experimental Usage,Leica Stellaris 5 system,Analysis Software,,,,,,,
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Image stacks were processed and reconstructed in 3D using Volocity software (Version 7.0.0; PerkinElmer, Waltham, MA, USA) for visualization and quantification",0.9,Accept,Experimental Usage,Volocity software (Version 7.0.0),Analysis Software,7.0.0,,,,,,
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Fluorescence intensity of P-glycoprotein was quantified using ImageJ 1.54g software (National Institutes of Health, Bethesda, MD, USA).",0.85,Accept,Experimental Usage,ImageJ 1.54g software,Analysis Software,1.54g,,,,,,
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Absorbance was measured at 570 nm with background correction at 690 nm using a SpectraMax Plus 384 microplate reader (Molecular Devices, San Jose, CA, USA).",0.8,Accept,Experimental Usage,SpectraMax Plus 384 microplate reader,Analysis Software,,,,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,The pipeline for PN identification was developed in-house using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite,0.85,Accept,Experimental Usage,Insight Toolkit,Package/Library,,,www.itk.org/,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,"using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite, Slicer ( www.slicer.org/ )",0.85,Accept,Experimental Usage,Slicer,Analysis Software,,,www.slicer.org/,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,"Image texture was quantified using Law's texture energy measures (LTEM), grey-level run length (GLRL), and neighborhood grey-tone difference matrices",0.8,Accept,Experimental Usage,Law's texture energy measures,Analysis Software,,,,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,"while image texture was quantified using Law's texture energy measures, grey-level co-occurrence matrices, and neighborhood grey-tone difference matrices",0.8,Accept,Experimental Usage,grey-level co-occurrence matrices,Analysis Software,,,,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,"Image texture was quantified using Law's texture energy measures (LTEM), grey-level run length (GLRL), and neighborhood grey-tone difference matrices (NGTM)",0.8,Accept,Experimental Usage,neighborhood grey-tone difference matrices,Analysis Software,,,,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,Normality of the feature was tested using the Jarque-Bera normality test and the Levene's test was used to test for equal variances,0.75,Accept,Experimental Usage,Jarque-Bera normality test,Analysis Software,,,,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,Normality of the feature was tested using the Jarque-Bera normality test and the Levene's test was used to test for equal variances between the sets,0.75,Accept,Experimental Usage,Levene's test,Analysis Software,,,,,,,
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,therefore feature reduction was performed using k-medoid clustering to remove statistically significant features were highly inter-correlated,0.75,Accept,Experimental Usage,k-medoid clustering,Analysis Software,,,,,,,
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,Collected data were processed with NMRPipe (Delaglio et al. 1995),0.8,Accept,Experimental Usage,NMRPipe,Analysis Software,,,,,,,
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,analyzed by using CcpNMR (Vranken et al. 2005) software,0.8,Accept,Experimental Usage,CcpNMR,Analysis Software,,,,,,,
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,"A TALOS+ prediction (Shen et al. 2009) was conducted using the HN, N, C', Cα, and Cβ chemical shifts",0.85,Accept,Experimental Usage,TALOS+,Analysis Software,,,,,,,
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"All data analysis was done using Calcusyn software (CalcuSyn Version 2.1, BioSoft)",0.9,Accept,Experimental Usage,CalcuSyn Version 2.1,Analysis Software,2.1,,,,,,
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,Densitometry quantification was done using ImageJ software and normalized to GAPDH,0.9,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Data processing was done using the RELION (32) software package.,0.9,Accept,Experimental Usage,RELION,Analysis Software,,C++,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Collected movie frames were motion-corrected and dose-weighed using MotionCorr (33),0.85,Accept,Experimental Usage,MotionCorr,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,followed by contrast transfer function estimation using CTFFIND4 (34),0.85,Accept,Experimental Usage,CTFFIND4,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,"Published models of GRD and Sec-PH (PDB: 1nf1 and 2d4q, respectively) were rigid-body fitted in the density using Chimera.",0.85,Accept,Experimental Usage,Chimera,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,The core of the NF1 dimer was completely manually modeled in Coot (35),0.85,Accept,Experimental Usage,Coot,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Structure refinement was done in Phenix (37).,0.85,Accept,Experimental Usage,Phenix,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Iterative manual inspection and rebuilding of the 3D model in Coot relied on real-space difference maps calculated in Servalcat (38).,0.85,Accept,Experimental Usage,Servalcat,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Quantification of Western Blot bands was performed using Image-Studio (Li-COR),0.8,Accept,Experimental Usage,Image-Studio,Analysis Software,,,,,,,
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,All data collection was performed with SerialEM.,0.8,Accept,Experimental Usage,SerialEM,Analysis Software,,,,,,,
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,followed by sequencing using the MiSeq‐M01450 instrument (150‐base paired end mode; Illumina),0.9,Accept,Experimental Usage,MiSeq-M01450,Other,,,,,,,
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Sequence reads were aligned to the reference sequence (GRCh37) using bwa‐mem v0.7.10,0.95,Accept,Experimental Usage,bwa-mem v0.7.10,Analysis Software,v0.7.10,,,,,,
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,"followed by variant calling using GATK, version 1.0.4705",0.95,Accept,Experimental Usage,"GATK, version 1.0.4705",Analysis Software,1.0.4705,,,,,,
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Copy number variants (CNVs) were identified via an NGS‐based detection tool (VisCap),0.9,Accept,Experimental Usage,VisCap,Analysis Software,,,,,,,
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Confirmation of CNVs was done using ddPCR as previously described,0.85,Accept,Experimental Usage,ddPCR,Analysis Software,,,,,,,
PMID:34065204,10.3390/ijms22105367,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,"analyzed using MOD Fit LT software (Verity Software House, Topsham, ME, USA)",0.8,Accept,Experimental Usage,MOD Fit LT software,Analysis Software,,,,,,,
PMID:34065204,10.3390/ijms22105367,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,Densitometry quantification was performed using ImageJ (NIH),0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,Whole-exome sequencing FastQ files were trimmed by using Trimmomatic v 0.39,0.8,Accept,Experimental Usage,Trimmomatic v0.39,Analysis Software,v0.39,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,aligned against reference sequence hg38 via Burrows-Wheeler Aligner–Maximal Exact Match (BWA-MEM),0.8,Accept,Experimental Usage,BWA-MEM,Analysis Software,,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,Genomic analysis toolkit (GATK) V4.2 base quality score recalibration was also used to process BAM files,0.8,Accept,Experimental Usage,GATK V4.2,Analysis Software,V4.2,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,Somatic single-nucleotide variants (SNVs) and small indels were detected using VarScan2,0.8,Accept,Experimental Usage,VarScan2,Analysis Software,,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Somatic single-nucleotide variants (SNVs) and small indels were detected using VarScan2, Strelka2",0.8,Accept,Experimental Usage,Strelka2,Analysis Software,,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Somatic single-nucleotide variants (SNVs) and small indels were detected using VarScan2, Strelka2, MuTect2",0.8,Accept,Experimental Usage,MuTect2,Analysis Software,,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Somatic single-nucleotide variants (SNVs) and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.8,Accept,Experimental Usage,Pindel,Analysis Software,,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,RNA reads were quantified using the Salmon algorithm,0.8,Accept,Experimental Usage,Salmon algorithm,Analysis Software,,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Raw counts were normalized, and the DESeq2 package was used to call the differentially expressed genes",0.8,Accept,Experimental Usage,DESeq2,Package/Library,,R,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Exploratory data analysis, including UpSet plots, Venn Diagram creation, and heatmaps of expression values, were performed using the Python package MAGINE",0.8,Accept,Experimental Usage,MAGINE,Package/Library,,Python,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Data analysis was performed using FlowJo 10.8, and cell cycle distribution was assigned by using the implemented models",0.8,Accept,Experimental Usage,FlowJo 10.8,Analysis Software,10.8,,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Images were captured every 15 min using a time-lapse image software (PhenoCapture 3.3),0.8,Accept,Experimental Usage,PhenoCapture 3.3,Analysis Software,3.3,,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Images were captured every 15 min using a time-lapse image software (PhenoCapture 3.3) and analyzed using Fiji 2.0,0.8,Accept,Experimental Usage,Fiji 2.0,Analysis Software,2.0,,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Metabolic rate and activity were measured using the Sleep and Activity Metabolic Monitor (SAMM) system (Sable Systems International).,0.85,Accept,Experimental Usage,Sleep and Activity Metabolic Monitor (SAMM) system,Analysis Software,,,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Total feeding was measured over 24 h and analyzed by Noah.py,0.8,Accept,Experimental Usage,Noah.py,Analysis Software,,Python,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Leica TCS SP8 confocal microscope with LAS X software was used to obtain images.,0.8,Accept,Experimental Usage,LAS X software,Analysis Software,,,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,"After washing, WesternBright Quantum HRP substrate (Advansta) was added to the membranes and images were captured with AlphaImager HP system (ProteinSimple)",0.8,Accept,Experimental Usage,AlphaImager HP system,Analysis Software,,,,,,,
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,Identification of TAPDANCE CISs and gene centric CISs from sequenced transposon-genomic DNA PCR products,0.8,Accept,Experimental Usage,TAPDANCE,Analysis Software,,,,,,,
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,Statistical comparisons were done using R/Bioconductor packages and GeneSpring GX v7.3.1 (Agilent Technologies),0.9,Accept,Experimental Usage,GeneSpring GX v7.3.1,Analysis Software,v7.3.1,,,,,,
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,The data were processed with GenoCNA to segment the genome and determine copy number status,0.85,Accept,Experimental Usage,GenoCNA,Analysis Software,,,,,,,
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,automated colony counts were done using ImageJ software,0.8,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,Images were acquired using AxioVision software,0.8,Accept,Experimental Usage,AxioVision,Analysis Software,,,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,resulting sequencing files were run through the Cell Ranger pipeline v7.1.0,0.9,Accept,Experimental Usage,Cell Ranger pipeline v7.1.0,Pipeline,v7.1.0,,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"Data analysis was completed using R (v 4.3.0–v 4.3.1) Seurat [ 24 ,  25 ] (v4.3.0–v5)",0.9,Accept,Experimental Usage,Seurat v4.3.0–v5,Package/Library,v4.3.0–v5,R,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"To account for technical and sample variation, Harmony batch correction was conducted",0.85,Accept,Experimental Usage,Harmony,Package/Library,,R,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,Ingenuity pathway analysis (IPA) was also used to identify pathways that differ on treatment,0.9,Accept,Experimental Usage,Ingenuity Pathway Analysis (IPA),Analysis Software,,,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"By connecting scanpy [ 28 ], palantir, and scFates [ 29 ] packages",0.85,Accept,Experimental Usage,scanpy,Package/Library,,Python,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"By connecting scanpy [ 28 ], palantir, and scFates [ 29 ] packages",0.85,Accept,Experimental Usage,palantir,Package/Library,,Python,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"By connecting scanpy [ 28 ], palantir, and scFates [ 29 ] packages",0.85,Accept,Experimental Usage,scFates,Package/Library,,Python,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"After processing our snRNA-seq dataset in Seurat, downstream analysis in CellChat was conducted",0.9,Accept,Experimental Usage,CellChat,Package/Library,,R,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,samtools and velocyto were used to generate the.loom spliced/unspliced output,0.85,Accept,Experimental Usage,velocyto,Command-line Tool,,Python,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,the downstream analysis was performed using the scanpy and scvelo [ 31 ] packages,0.85,Accept,Experimental Usage,scvelo,Package/Library,,Python,,,,,
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"Cell communication was assessed by RNA velocity, Scriabin, and CellChat analyses",0.85,Accept,Experimental Usage,Scriabin,Package/Library,,,,,,,
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"Paired-end sequencing resulting in 100 bases from each end of the fragments was performed using Illumina HiSeq 2,500 (Illumina, San Diego, CA).",0.85,Accept,Experimental Usage,"Illumina HiSeq 2,500",Other,,,,,,,
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,Somatic mutations were identified using VariantDx custom software for identifying mutations in matched tumor and normal samples from whole exome sequencing (WES).,0.85,Accept,Experimental Usage,VariantDx,Analysis Software,,,,,,,
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"primary processing of sequence data for both tumor and normal samples were performed using Illumina CASAVA software (v1.8), including masking of adapter sequences.",0.9,Accept,Experimental Usage,Illumina CASAVA software (v1.8),Analysis Software,v1.8,,,,,,
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,Sequence reads were aligned against the human reference genome (version hg19) using ELAND software.,0.85,Accept,Experimental Usage,ELAND software,Analysis Software,,,,,,,
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"Functional consequences were predicted using snpEff and a custom database of CCDS, RefSeq and Ensembl annotations",0.85,Accept,Experimental Usage,snpEff,Analysis Software,,,,,,,
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,Extracted cell-free DNA was analyzed with custom designed droplet digital PrimePCR assays using the BioRad QX200 droplet digital PCR system,0.85,Accept,Experimental Usage,BioRad QX200 droplet digital PCR system,Other,,,,,,,
PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"RealSeqS uses a single primer pair to amplify about 750,000 loci scattered throughout the genome",0.9,Accept,Experimental Usage,RealSeqS,Analysis Software,,,https://zenodo.org/record/3656943#.YaZZCdDMKUk.32,,,,
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"The sequenced reads were mapped to the hg19 by Burrows-Wheeler Aligner (BWA version 0.7.15, default parameters, BWA-MEM algorithm)",0.85,Accept,Experimental Usage,BWA version 0.7.15,Command-line Tool,0.7.15,,,,,,
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were identified via GATK MuTect2 (version 4.1, default parameters)",0.85,Accept,Experimental Usage,GATK MuTect2 (version 4.1),Analysis Software,4.1,,,,,,
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were annotated with software ANNOVAR (version 2016-02-01, default parameters)",0.85,Accept,Experimental Usage,ANNOVAR (version 2016-02-01),Analysis Software,2016-02-01,,,,,,
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,The indel frequencies of TGFBR2 and PDCD1 were measured by TIDE (Tracking Indels by Decomposition) analysis,0.85,Accept,Experimental Usage,TIDE (Tracking Indels by Decomposition),Analysis Software,,,,,,,
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,qPCR reactions were performed with the CFX Connect System (Bio-Rad Laboratories),0.8,Accept,Experimental Usage,CFX Connect System,Analysis Software,,,,,,,
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,Chemiluminescence was detected using ChemiDoc XRS (Bio-Rad),0.8,Accept,Experimental Usage,ChemiDoc XRS,Analysis Software,,,,,,,
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,images were taken with EVOS Cell Imaging Systems (Thermo Fisher Scientific),0.8,Accept,Experimental Usage,EVOS Cell Imaging Systems,Analysis Software,,,,,,,
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,All analyses were performed using the JMP Pro software package (SAS Institute Japan Ltd.),0.8,Accept,Experimental Usage,JMP Pro software,Analysis Software,,,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"7 T scanner (BioSpec 70/30 USR; Bruker, USA)",0.8,Accept,Experimental Usage,BioSpec 70/30 USR,Analysis Software,,,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"preclinical LP-100 FUS system (FUS Instruments, Canada)",0.8,Accept,Experimental Usage,LP-100 FUS system,Analysis Software,,,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,MRI images were transferred into MATLAB with Aedes software for manual segmentation,0.85,Accept,Experimental Usage,Aedes software,Analysis Software,,MATLAB,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"All statistical analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC)",0.85,Accept,Experimental Usage,SAS 9.4,Analysis Software,9.4,,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"B-GA12S HP gradients running ParaVision 6.0.1, Bruker BioSpin",0.85,Accept,Experimental Usage,ParaVision 6.0.1,Analysis Software,6.0.1,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,quality trimming via Trimmomatic (v0.33),0.85,Accept,Experimental Usage,Trimmomatic (v0.33),Analysis Software,v0.33,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,alignment via HISAT2 (v2.1.0),0.85,Accept,Experimental Usage,HISAT2 (v2.1.0),Analysis Software,v2.1.0,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,gene count quantification via StringTie (v1.3.4d),0.85,Accept,Experimental Usage,StringTie (v1.3.4d),Analysis Software,v1.3.4d,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"Differential expression analysis was performed using R statistical software (v4.3.1), tidyverse (v2.0.0), and DESeq2 (v1.42.0)",0.85,Accept,Experimental Usage,DESeq2 (v1.42.0),Package/Library,v1.42.0,R,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,Pathway analysis was performed using GeneAnalytics(v),0.8,Accept,Experimental Usage,GeneAnalytics(v),Web Application,v,,,,,,
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,colonies were counted using the cell counter tool of ImageJ (NIH United States 2014),0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,The SPSS program (IBM SPSS Statistics Standard) was applied,0.8,Accept,Experimental Usage,IBM SPSS Statistics Standard,Analysis Software,,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"MALDI IMS experiments were performed on a Bruker AutoFlex III mass spectrometer (Bruker Daltonics Billerica, MA, USA)",0.9,Accept,Experimental Usage,Bruker AutoFlex III mass spectrometer,Analysis Software,,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,The 2-D IMS data sets were collected using FlexImaging 4.0 (Bruker Daltonics),0.9,Accept,Experimental Usage,FlexImaging 4.0,Analysis Software,4.0,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"All 33 individual 2-D IMS data sets were combined into a single 3-D IMS data set in MATLAB (Mathworks Inc., Natick, MA)",0.85,Accept,Experimental Usage,MATLAB,Analysis Software,,MATLAB,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,This was accomplished using the standard functions provided by the Bioinformatics Toolbox in MATLAB,0.8,Accept,Experimental Usage,Bioinformatics Toolbox,Package/Library,,MATLAB,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"The 3-D stack visualization of Figure 1e was generated using Sliceomatic by Eric Ludlam (The Mathworks Inc., Natick, MA, USA)",0.8,Accept,Experimental Usage,Sliceomatic,Analysis Software,,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"LC-MS/MS experiments were performed on a Thermo LTQ Velos Orbitrap mass spectrometer (Thermo Scientific, Waltham, MA, USA)",0.9,Accept,Experimental Usage,Thermo LTQ Velos Orbitrap mass spectrometer,Analysis Software,,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,sequence tags of around 4–5 amino acids that were subsequently searched using TagIdent (http://web.expasy.org/tagident/),0.85,Accept,Experimental Usage,TagIdent,Web Application,,,http://web.expasy.org/tagident/,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,Proteins with matching intact molecular weights and containing the sequence observed were processed using protein prospector MS-product (http://prospector.ucsf.edu/prospector/mshome.htm),0.85,Accept,Experimental Usage,protein prospector MS-product,Web Application,,,http://prospector.ucsf.edu/prospector/mshome.htm,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"Scaffold (Proteome Software, Portland, Oregon, USA) was used to analyze and validate protein identifications",0.85,Accept,Experimental Usage,Scaffold,Analysis Software,,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"validate protein identifications derived from SEQUEST (Thermo Scientific, Waltham, MA, USA) database searching",0.85,Accept,Experimental Usage,SEQUEST,Analysis Software,,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"Images were subsequently acquired on a Nikon Eclipse E600 microscope equipped with an optical camera (Leica, Buffalo Grove, IL, USA) and Leica LAS EZ image analysis software",0.85,Accept,Experimental Usage,Leica LAS EZ image analysis software,Analysis Software,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,The gene expression profile GSE108524 of the NF2-associated VSs and normal nerve groups was obtained from the NCBI GEO database.,0.85,Accept,Experimental Usage,GSE108524,Database,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,These microarray data were based on GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version],0.9,Accept,Experimental Usage,GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0,Analysis Software,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"GEO2R (http://www.ncbi.nlm.nih.gov/geo/geo2r/), a web tool based on the analysis of variance or t-test, was used to identify DEGs",0.85,Accept,Experimental Usage,GEO2R,Web Application,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"The Database for Annotation, Visualization, and Integrated Discovery (DAVID) (Version 6.8, https://david.ncifcrf.gov/) was used to perform GO and KEGG pathway enrichment analysis",0.9,Accept,Experimental Usage,DAVID,Web Application,6.8,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"We submitted DEGs in Search Tool for the Retrieval of Interacting Genes database (STRING, http://www.string-db.org/) to screen the PPI pairs",0.85,Accept,Experimental Usage,STRING,Database,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,visualized the interaction using Cytoscape software (Version 3.7.0.),0.9,Accept,Experimental Usage,Cytoscape,Analysis Software,3.7.0,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"Finally, CentiScaPe and Molecular Complex Detection (MCODE), a Cytoscape plugin, were utilized to screen PPI network key genes.",0.8,Accept,Experimental Usage,CentiScaPe,Plugin,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"CentiScaPe and Molecular Complex Detection (MCODE), a Cytoscape plugin, were utilized to screen PPI network key genes.",0.85,Accept,Experimental Usage,MCODE,Plugin,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,the hub genes were mapped onto the Drug-Gene Interaction database (DGIdb; http://www.dgidb.org) to obtain potential drug target genes,0.85,Accept,Experimental Usage,DGIdb,Database,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"In addition, ClinicalTrials.gov (https://clinicaltrials.gov) was used to identify whether drugs have been previously investigated",0.8,Accept,Experimental Usage,ClinicalTrials.gov,Database,,,,,,,
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,Statistical analysis was conducted by SPSS 20.0 software.,0.8,Accept,Experimental Usage,SPSS 20.0,Analysis Software,20.0,,,,,,
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,"RNA was extracted and cRNA were hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix) for analysis of over 47,000 transcripts",0.85,Accept,Experimental Usage,Human Genome U133 Plus 2.0 Array,Analysis Software,,,,,,,
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,"RT-qPCR was performed in the DNA Engine Opticon 2 Continuous Fluorescence Detection System (Bio-Rad, Hercules, CA, USA)",0.8,Accept,Experimental Usage,DNA Engine Opticon 2 Continuous Fluorescence Detection System,Analysis Software,,,,,,,
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,The Bioconductor limma package [20] was used to preprocess the expression data from Human Genome U133 Plus 2.0 Affymetrix Array,0.9,Accept,Experimental Usage,Bioconductor limma package,Package/Library,,R,,,,,
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,We screened a collection of compounds from the NCATS Mechanism Interrogation PlatE (MIPE) library,0.85,Accept,Experimental Usage,NCATS Mechanism Interrogation PlatE (MIPE) library,Database,,,,,,,
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"Combination Index values for the combinations were calculated using CompuSyn Software, based on Chou-Talalay calculations",0.85,Accept,Experimental Usage,CompuSyn Software,Analysis Software,,,,,,,
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The IC50 was calculated using GraphPad Prism Version 6 (La Jolla, CA).",0.8,Accept,Experimental Usage,GraphPad Prism Version 6,Analysis Software,6,,,,,,
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Optical sections of 9 or 16 contiguous fields, unless otherwise indicated, through the entire depth of the 3D structures were acquired using Zeiss LSM 780",0.8,Accept,Experimental Usage,Zeiss LSM 780,Analysis Software,,,,,,,
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"acquired using Zeiss LSM 780 (Carl Zeiss Microscopy, Jena, Germany) or Stellaris 5 (Leica Microsystems, Deerfield, IL, USA) confocal microscopes",0.8,Accept,Experimental Usage,Stellaris 5,Analysis Software,,,,,,,
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Images were reconstructed in 3D using Volocity software 7.0.0 (PerkinElmer, Waltham, MA, USA)",0.9,Accept,Experimental Usage,Volocity software 7.0.0,Analysis Software,7.0.0,,,,,,
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"sEV depletion was determined by version 3.3 Dev Build 3.3.104 Nanoparticle Tracking Analysis software (Malvern Panalytical Ltd., Malvern, UK)",0.9,Accept,Experimental Usage,Nanoparticle Tracking Analysis software version 3.3 Dev Build 3.3.104,Analysis Software,3.3 Dev Build 3.3.104,,,,,,
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"invaded cells were visualized using a Nikon Eclipse Ti-S microscope (Tokyo, Japan) and quantified using ImageJ software (NIH, Bethesda, MD, USA)",0.85,Accept,Experimental Usage,ImageJ software,Analysis Software,,,,,,,
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"The significance of differences was evaluated either by one-way ANOVA, followed by Tukey's post hoc test to correct for multiple comparisons, or by Student's t-test for two groups using GraphPad Prism version 8.0.1",0.8,Accept,Experimental Usage,GraphPad Prism version 8.0.1,Analysis Software,8.0.1,,,,,,
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Nanoparticle Tracking Analysis software (Malvern Panalytical Ltd., Malvern, UK) installed in NanoSight NS300 (Malvern Panalytical Ltd., Malvern, UK)",0.8,Accept,Experimental Usage,NanoSight NS300,Analysis Software,,,,,,,
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"imaged in a small animal MRI (Varian Unity/INOVA 4.7 Tesla scanner, Varian Inc., Palo Alto, CA)",0.8,Accept,Experimental Usage,Varian Unity/INOVA 4.7 Tesla scanner,Analysis Software,,,,,,,
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"surface area of the tumor on each sequential image was determined using the measurement tool on Image J software (NIH, Bethesda, MD)",0.9,Accept,Experimental Usage,Image J software,Analysis Software,,,,,,,
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"Three researchers independently segmented the 17 original tumors using Simpleware (Synopsys, Mountain View, CA) ""Paint by Threshold"" tool",0.85,Accept,Experimental Usage,Simpleware,Analysis Software,,,,,,,
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"All statistical analyses were performed using R (R Core Team), and visualization of volume differences",0.8,Accept,Experimental Usage,R,Analysis Software,,R,,,,,
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"visualization of volume differences, Dice similarity coefficients, and Hausdorff distances was conducted using ggplot2 and tidyverse",0.85,Accept,Experimental Usage,ggplot2,Package/Library,,R,,,,,
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"visualization of volume differences, Dice similarity coefficients, and Hausdorff distances was conducted using ggplot2 and tidyverse",0.85,Accept,Experimental Usage,tidyverse,Package/Library,,R,,,,,
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"effect of voxel size on segmentation precision was quantified through volume measurements, Dice similarity coefficients, and Hausdorff distances",0.75,Accept,Experimental Usage,Dice similarity coefficient,Analysis Software,,,,,,,
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"effect of voxel size on segmentation precision was quantified through volume measurements, Dice similarity coefficients, and Hausdorff distances",0.75,Accept,Experimental Usage,Hausdorff distance,Analysis Software,,,,,,,
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"Statistical significance was assessed using the Wilcoxon signed-rank test, comparing resampled tumor volumes across different voxel sizes",0.75,Accept,Experimental Usage,Wilcoxon signed-rank test,Analysis Software,,,,,,,
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,Analysis for pS6 staining intensity was performed using the Acumen eX3 laser-scanning fluorescence microplate cytometer,0.8,Accept,Experimental Usage,Acumen eX3 laser-scanning fluorescence microplate cytometer,Analysis Software,,,,,,,
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"Growth curves were plotted using GraphPad Prism 6.0 software (San Diego, CA)",0.85,Accept,Experimental Usage,GraphPad Prism 6.0,Analysis Software,6.0,,,,,,
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"The increase in fluorescent signal associated with exponential growth of PCR products is detected by the laser detector of the ABI Prism 7700 Sequence Detection System (Perkin-Elmer Applied Biosystems, Foster City, CA)",0.85,Accept,Experimental Usage,ABI Prism 7700 Sequence Detection System,Analysis Software,,,,,,,
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,using PE Biosystems analysis software according to the manufacturer's manuals,0.8,Accept,Experimental Usage,PE Biosystems analysis software,Analysis Software,,,,,,,
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"Primers for TBP, RPLP0 and the 489 target genes (List in annex; supplementary information) were chosen with the assistance of the Oligo 5.0 computer program (National Biosciences, Plymouth, MN)",0.85,Accept,Experimental Usage,Oligo 5.0 computer program,Analysis Software,5.0,,,,,,
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,Surveys were conducted via Qualtrics and included 25 statements organized into eight categories,0.8,Accept,Experimental Usage,Qualtrics,Web Application,,,,,,,
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,Audio recordings from the FGDs and individual interviews were then transcribed verbatim by Zoom's transcription feature,0.75,Accept,Experimental Usage,Zoom's transcription feature,Web Application,,,,,,,
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,The codes assigned to each quote were then reviewed for a final time by the first author as part of entering the coded transcripts using Dedoose.,0.85,Accept,Experimental Usage,Dedoose,Analysis Software,,,,,,,
PMID:40529476,10.1016/j.xjidi.2025.100380,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,,"Statistical analyses were performed using R 4.4.2 software (R Foundation for Statistical Computing, Vienna, Austria)",0.8,Accept,Experimental Usage,R 4.4.2 software,Analysis Software,4.4.2,R,,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.9,Accept,Experimental Usage,Sci-kit Learn,Package/Library,,Python,,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.85,Accept,Experimental Usage,python 3.5.1,Analysis Software,3.5.1,Python,,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,Densitometry was performed using Li-COR Image Studio Lite 5.0,0.9,Accept,Experimental Usage,Li-COR Image Studio Lite 5.0,Analysis Software,5.0,,,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We performed all preprocessing steps using R version 3.2.3,0.85,Accept,Experimental Usage,R version 3.2.3,Analysis Software,3.2.3,R,,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used the 'collapseRows()' function with the 'maxmean' method from the R package WGCNA,0.9,Accept,Experimental Usage,WGCNA,Package/Library,,R,,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"Ensuring a stable compute environment, we performed all analyses in a Docker image",0.85,Accept,Experimental Usage,Docker,Analysis Software,,,,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"All source code is available under a permissive open source license in the nf1_inactivation GitHub repository, https://github.com/greenelab/nf1_inactivation",0.95,Accept,Development,nf1_inactivation GitHub repository,Pipeline,,,https://github.com/greenelab/nf1_inactivation,,,,
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"samples were labeled for the GeneChip Human Transcriptome Array 2.0 (HTA 2.0, Affymetrix)",0.9,Accept,Experimental Usage,GeneChip Human Transcriptome Array 2.0,Other,,,,,,,
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,FACS analysis was performed using CELLQuest™ software (Becton Dickinson),0.85,Accept,Experimental Usage,CELLQuest™ software,Analysis Software,,,,,,,
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"PamChip peptide arrays (PamGene International BV, 's-Hertogenbosch, the Netherlands) measure the ability of active kinases",0.85,Accept,Experimental Usage,PamChip peptide arrays,Analysis Software,,,,,,,
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,software-based image analysis (BioNavigator software V.6.3 from PamGene),0.9,Accept,Experimental Usage,BioNavigator software V.6.3,Analysis Software,V.6.3,,,,,,
PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,,Statistical analyses were conducted using IBM SPSS Statistics (version 27.01),0.8,Accept,Experimental Usage,IBM SPSS Statistics,Analysis Software,27.01,,,,,,
PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,,Images from each device were analysed by a single investigator (J.L.) on a dedicated laptop using the recommended software provided by each imaging system manufacturer,0.85,Accept,Experimental Usage,Vectra software,Analysis Software,,,,,,,
PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,,3D model analysis using LifeViz App software,0.85,Accept,Experimental Usage,LifeViz App software,Analysis Software,,,,,,,
PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,,3D model analysis using Cherry Imaging Trace software,0.85,Accept,Experimental Usage,Cherry Imaging Trace software,Analysis Software,,,,,,,
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"Here, we introduce PERADIGM ( Phenotype Embedding similarity-based RAre DIsease Gene Mapping), a novel framework that leverages natural language processing techniques",0.95,Accept,Development,PERADIGM,Analysis Software,,Not specified,,,,,
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"We utilized the UK Biobank 200K dataset [ 4 , 50 ] in our analysis",0.85,Accept,Experimental Usage,UK Biobank 200K dataset,Database,,,,,,,
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,we implemented stringent quality control (QC) measures on the whole-exome sequencing (WES) data using PLINK [ 51 ],0.9,Accept,Experimental Usage,PLINK,Analysis Software,,,,,,,
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,We employed the Word2Vec embedding model to obtain static embedding vectors for the phenotypes,0.9,Accept,Experimental Usage,Word2Vec,Package/Library,,,,,,,
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"In our embedding analysis, we applied the CBOW Word2Vec model to embed the ICD-10 phenotype data from the UK Biobank",0.85,Accept,Experimental Usage,CBOW,Package/Library,,,,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,Bone samples were analyzed with low (6 µm voxel) or high (up to 1 µm voxel) resolution microCT from skyscan 1172,0.9,Accept,Experimental Usage,skyscan 1172,Analysis Software,,,,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"Raw data reconstruction occurred with NRecon, with a defined threshold of 0.00 to 0.10",0.85,Accept,Experimental Usage,NRecon,Analysis Software,,,,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,Quantitative evaluation was performed with CTan after definition of appropriated regions of interest,0.85,Accept,Experimental Usage,CTan,Analysis Software,,,,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"Histomorphometric analysis was performed with AxioVision Software (Zeiss, Germany)",0.85,Accept,Experimental Usage,AxioVision Software,Analysis Software,,,,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"Analysis of EDX images was performed with ImageJ (Rasband WS. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, imagej.nih.gov/ij/, 1997–2012)",0.9,Accept,Experimental Usage,ImageJ,Analysis Software,,,imagej.nih.gov/ij/,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"Both the camera and the tensile tester were controlled by customized software (Labview 7.0, National Instruments)",0.85,Accept,Experimental Usage,Labview 7.0,Analysis Software,7.0,,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,"DNA was sonicated using a Covaris S2 (Covaris, Woburn, MA, USA)",0.8,Accept,Experimental Usage,Covaris S2,Other,,,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,fastq files were mapped against the GRCh37 human genome assembly...using BWA mem,0.9,Accept,Experimental Usage,BWA mem,Analysis Software,,C,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,a sorted bam file was created with samtools,0.9,Accept,Experimental Usage,samtools,Analysis Software,,,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,Exhaustive coverage metrics were produced using a combination of bedtools and custom R,0.9,Accept,Experimental Usage,bedtools,Analysis Software,,,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,Variants...were called using VarScan2 with the following parameters,0.9,Accept,Experimental Usage,VarScan2,Analysis Software,,,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,variants were annotated with a combination of annovar and custom scripts,0.9,Accept,Experimental Usage,annovar,Analysis Software,,,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,bam-readcount was then used to compute additional quality parameters,0.9,Accept,Experimental Usage,bam-readcount,Analysis Software,,,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,Variants were filtered using the regioneR bioconductor package,0.9,Accept,Experimental Usage,regioneR,Package/Library,,R,,,,,
PMID:28051113,10.1038/srep39348,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",,CLC Genomics Workbench v6 (Qiagen) was used to analyze data from I2HCP V1,0.9,Accept,Experimental Usage,CLC Genomics Workbench v6,Analysis Software,v6,,,,,,
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"We used the Genemania algorithm to generate gene-gene association networks (genetic interaction, physical interaction, and pathways)",0.85,Accept,Experimental Usage,Genemania algorithm,Analysis Software,,,,,,,
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"Amplicon sequencing using the GS20 Flex pyrosequencing machine (Roche, Indianapolis, IN) was performed according to the manufacturer's protocol",0.8,Accept,Experimental Usage,GS20 Flex pyrosequencing machine,Other,,,,,,,
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,P values were generated with a random effects model analysis on log transformed tumor volume data using the SAS mixed procedure,0.8,Accept,Experimental Usage,SAS mixed procedure,Analysis Software,,SAS,,,,,
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"Medical records review was performed using the Research Patient Database Registry, an internal research tool providing access to demographic information",0.8,Accept,Experimental Usage,Research Patient Database Registry,Database,,,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Data were analyzed by the Seurat V3.0 package in the R programming environment,0.9,Accept,Experimental Usage,Seurat V3.0,Package/Library,V3.0,R,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The raw transcript counts were aligned to Refseq related to the build GRCh38-mm10 using STAR 2.4.2.8,0.9,Accept,Experimental Usage,STAR 2.4.2.8,Analysis Software,2.4.2.8,,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Differentially expressed genes between GFP+ and GFP- tumor populations were analyzed by paired experiment design in the DeSeq2 package,0.9,Accept,Experimental Usage,DeSeq2,Package/Library,,R,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The ssgesa was calculated by the GSVA package with default settings,0.9,Accept,Experimental Usage,GSVA package,Package/Library,,R,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Limma package was used for generating the human 621-MPNST signature,0.9,Accept,Experimental Usage,Limma package,Package/Library,,R,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,then dissociated by gentleMACS Octo Dissociator (Miltenyi Biotec) with 1 g/ml collagenase,0.8,Accept,Experimental Usage,gentleMACS Octo Dissociator,Other,,,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,GFP+ and GFP- cells from the same tumor were analyzed and sorted by the S3e sorter (BioRad),0.8,Accept,Experimental Usage,S3e sorter,Other,,,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Tumor volume was measured by in vivo luminescence using luciferase reporter IVIS Spectrum scanner (PerkinElmer),0.8,Accept,Experimental Usage,IVIS Spectrum scanner,Other,,,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Flow-cytometry was performed with a FACSVantage SE-dual laser, three-line flow-cytometer (Becton-Dickinson)",0.85,Accept,Experimental Usage,FACSVantage SE-dual laser flow-cytometer,Analysis Software,,,,,,,
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"Slides were examined by using an Axioplan 2 microscope (Carl Zeiss MicroImaging GmbH, Germany)",0.8,Accept,Experimental Usage,Axioplan 2 microscope,Other,,,,,,,
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"AUCs were compared with two-way ANOVA followed by Bonferroni post-tests, using GraphPad Prism version 5.01",0.85,Accept,Experimental Usage,GraphPad Prism version 5.01,Analysis Software,5.01,,,,,,
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"distributions were first checked for normality by using the Shapiro–Wilk's test with STATA 11 (StataCorp, College Station, TX)",0.85,Accept,Experimental Usage,STATA 11,Analysis Software,11,,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,"Briefly, the Schrödinger software suite release 2017–1 was used for system setup.",0.85,Accept,Experimental Usage,Schrödinger software suite release 2017–1,Analysis Software,2017-1,,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,Flexible ligand docking into TRAP1 allosteric site was performed using Glide with default settings in SP mode.,0.8,Accept,Experimental Usage,Glide,Analysis Software,,,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,Equilibration and production steps were performed using the AMBER16 MD engine,0.9,Accept,Experimental Usage,AMBER16,Analysis Software,16,,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,Descriptors were generated with in-house scripts using VMD (version 1.9.3) to calculate solvent accessible surface area,0.9,Accept,Experimental Usage,VMD (version 1.9.3),Analysis Software,1.9.3,,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,g_mindist tool of gromacs (version 4.6) to get residue–residue contacts,0.9,Accept,Experimental Usage,gromacs (version 4.6),Analysis Software,4.6,,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,The predictive power of the trained models was internally checked via 5-fold cross validation procedure available in MATLAB version 2019b,0.85,Accept,Experimental Usage,MATLAB version 2019b,Analysis Software,2019b,MATLAB,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,"GNB, KNB and GDF-SVM were trained on the original and extended training sets by using the Classification Learner app available in the Statistics and Machine Learning Toolbox of MATLAB",0.8,Accept,Experimental Usage,Classification Learner app,Plugin,,MATLAB,,,,,
PMID:33369425,10.1021/acs.jpcb.0c09742,Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.,,Linear regression models were generated on the predicted vs observed variables with the Curve Fitting tool of MATLAB,0.8,Accept,Experimental Usage,Curve Fitting tool of MATLAB,Plugin,,MATLAB,,,,,
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,The effects of mutations on protein functions were analyzed using the PredictSNP2 tool (https://loschmidt.chemi.muni.cz/predictsnp/),0.9,Accept,Experimental Usage,PredictSNP2,Web Application,,,https://loschmidt.chemi.muni.cz/predictsnp/,,,,
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,"The iStable-integrated server, accessible at predictor.nchu.edu.tw/iStable, features two machine learning-based tools",0.9,Accept,Experimental Usage,iStable,Web Application,,,,,,,
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,Align-GVGD (http://agvgd.hci.utah.edu/agvgd_input.php) is another tool that applies the Grantham difference,0.9,Accept,Experimental Usage,Align GVGD,Web Application,,,http://agvgd.hci.utah.edu/agvgd_input.php,,,,
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,"we utilized AlphaFold3 to simulate both the wild-type and mutant NF1 structures, revealing the significant effects",0.9,Accept,Experimental Usage,AlphaFold3,Analysis Software,,,,,,,
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,These mutations were subjected to further phenotyping analysis using SNPeffect 4.0,0.85,Accept,Experimental Usage,SNPeffect 4.0,Analysis Software,4.0,,,,,,
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,We selected the iMutant 2.0 and MUpro algorithms to predict the thermodynamic parameter changes,0.85,Accept,Experimental Usage,iMutant 2.0,Analysis Software,2.0,,,,,,
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,We selected the iMutant 2.0 and MUpro algorithms to predict the thermodynamic parameter changes,0.85,Accept,Experimental Usage,MUpro,Analysis Software,,,,,,,
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,"Densitometry analysis was performed with Gel-Pro Analyzer 4.0 software (Media Cybernetics; Silver Spring, MD)",0.85,Accept,Experimental Usage,Gel-Pro Analyzer 4.0 software,Analysis Software,4.0,,,,,,
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,All the analyses were implemented by the comprehensive statistical package R (http://cran.r-project.org/),0.8,Accept,Experimental Usage,R statistical package,Analysis Software,,R,http://cran.r-project.org/,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,analyzed for statistical significance using the Kolmogorov–Smirnov test (Mini Analysis),0.8,Accept,Experimental Usage,Mini Analysis,Analysis Software,,,,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,"two-sided testing (Prism, GraphPad Software, Inc., La Jolla, CA, USA",0.8,Accept,Experimental Usage,Prism,Analysis Software,,,,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,"and SPSS, IBM Corporation, Armonk, NY, USA)",0.8,Accept,Experimental Usage,SPSS,Analysis Software,,,,,,,
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,Synergy was calculated using the web-based SynergyFinder to analyze drug combination dose–response matrix data,0.85,Accept,Experimental Usage,SynergyFinder,Web Application,,,,,,,
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,Data were analyzed using ImageJ,0.8,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,Results were analyzed using the FlowJo software,0.8,Accept,Experimental Usage,FlowJo,Analysis Software,,,,,,,
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,Ki-67 quantification and image analysis was performed with Qupath to score Ki-67 in tumor tissue,0.8,Accept,Experimental Usage,Qupath,Analysis Software,,,,,,,
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"The statistical analyses were undertaken using a licensed version of SPSS (version 19.0, SPSS Inc, Chicago, IL, USA) compatible with Windows",0.8,Accept,Experimental Usage,SPSS version 19.0,Analysis Software,19.0,,,,,,
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,CHOPCHOP (https://chopchop.cbu.uib.no/) was used to identify the sgRNA sequence,0.9,Accept,Experimental Usage,CHOPCHOP,Web Application,,,https://chopchop.cbu.uib.no/,,,,
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,"images recorded with DanioVision tracking system (Noldus Information Technology, Wageningen, The Netherlands)",0.85,Accept,Experimental Usage,DanioVision tracking system,Analysis Software,,,,,,,
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,"Locomotor activity was analyzed using Ethovision 11 software (Noldus Information Technology, Wageningen, The Netherlands)",0.9,Accept,Experimental Usage,Ethovision 11,Analysis Software,11,,,,,,
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,Muscular birefringence was calculated by dividing the mean intensity by the selected area of the fish using ImageJ software,0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Sonographic measurement was performed using a Vevo 2100 micro-imaging system (VisualSonics, Amsterdam, Netherlands)",0.9,Accept,Experimental Usage,Vevo 2100 micro-imaging system,Analysis Software,,,,,,,
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Three-dimensional images of the xenografts were generated and analyzed using the Vevo software version 5.0.0 to calculate their size in volume,0.9,Accept,Experimental Usage,Vevo software version 5.0.0,Analysis Software,5.0.0,,,,,,
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Alignment and analysis was performed using a Galaxy server and open source Chipster software,0.8,Accept,Experimental Usage,Galaxy server,Web Application,,,,,,,
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Alignment and analysis was performed using a Galaxy server and open source Chipster software (http://chipster.csc.fi/),0.85,Accept,Experimental Usage,Chipster software,Analysis Software,,,http://chipster.csc.fi/,,,,
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,as well as R bioconductor (http://www.bioconductor.org/) tools for calculating similarity clusters on a Galaxy server,0.8,Accept,Experimental Usage,R bioconductor,Package/Library,,R,http://www.bioconductor.org/,,,,
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Libraries were sequenced on a Genome Analyzer IIx (Illumina, San Diego, CA)",0.85,Accept,Experimental Usage,Genome Analyzer IIx,Analysis Software,,,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,the network was built using the ARACNe-AP algorithm. The ARACNe-AP algorithm reconstructs gene regulatory networks from large-scale gene expression data,0.9,Accept,Experimental Usage,ARACNe-AP algorithm,Analysis Software,,,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,The differential expression and fold change calculations on the RNA-Seq datasets were performed using the R package DESeq2 version 1.18.1,0.9,Accept,Experimental Usage,DESeq2 version 1.18.1,Package/Library,1.18.1,R,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,Centrality measures were calculated using the igraph package in R,0.8,Accept,Experimental Usage,igraph package in R,Package/Library,,R,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,The concentration of the gDNA was estimated using the Qubit 2.0 Fluorometer (Invitrogen),0.8,Accept,Experimental Usage,Qubit 2.0 Fluorometer,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"The samples were then sonicated on the Covaris LE220 (Covaris Inc, Woburn, MA, USA) to achieve an average target size of 400 bp",0.8,Accept,Experimental Usage,Covaris LE220,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"QC analysis of the post-sonicated material was done using Caliper LabChip GX (Perkin Elmer, Hopkinton, MA, USA)",0.8,Accept,Experimental Usage,Caliper LabChip GX,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"the library concentration was estimated by utilizing a DNA 1,000 Chip on an Agilent 2,100 Bioanalyzer",0.8,Accept,Experimental Usage,"Agilent 2,100 Bioanalyzer",Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Each sample was then sequenced on an individual lane on an Illumina HiSeqX sequencer (Illumina, Inc., San Diego, CA, USA)",0.8,Accept,Experimental Usage,Illumina HiSeqX sequencer,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were mapped to the genome and variants identified using the Dragen program with default settings,0.9,Accept,Experimental Usage,Dragen program,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,The resulting VCF files were then sorted and updated to remove errors and analysed using the GATK pipeline,0.9,Accept,Experimental Usage,GATK pipeline,Pipeline,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Somatic mutations were called from BAM files exported by the Dragen alignment using the Java version of VarDict in paired mode,0.9,Accept,Experimental Usage,VarDict,Analysis Software,,Java,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Samples were analysed by GenomeStudio and exported to text,0.85,Accept,Experimental Usage,GenomeStudio,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"on an Illumina HiSeq2500 sequencer (Illumina, Inc., San Diego, CA, USA)",0.8,Accept,Experimental Usage,Illumina HiSeq2500 sequencer,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Post-processing of the sequencing reads from RNA-seq experiments for each sample was performed using HudsonAlpha's unique in-house RNA-seq data analysis pipeline,0.9,Accept,Experimental Usage,HudsonAlpha RNA-seq data analysis pipeline,Pipeline,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Raw reads were mapped to the reference human genome hg19 using TopHat v2.0 with the -p 4 and -r210 arguments,0.85,Accept,Experimental Usage,TopHat v2.0,Analysis Software,v2.0,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were quantified by both Cufflinks v0.9.3,0.85,Accept,Experimental Usage,Cufflinks v0.9.3,Analysis Software,v0.9.3,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were quantified by both Cufflinks v0.9.3 and FeatureCounts,0.8,Accept,Experimental Usage,FeatureCounts,Analysis Software,,,,,,,
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"All data is currently stored in the synapse web portal, and is accessible using code in the Cutaneous NF Github repository at http://www.github.com/Sage-Bionetworks/dermalNF",0.95,Accept,Development,Cutaneous NF Github repository,Web Application,,,http://www.github.com/Sage-Bionetworks/dermalNF,,,,
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,QuPath (v0.4.3) was used to quantify the percentage of cells with positive or negative immunostaining,0.95,Accept,Experimental Usage,QuPath (v0.4.3),Analysis Software,v0.4.3,Java,,,,,
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,"All statistical analyses were performed in R (version 4.3.1) using the 'survival', 'survminer', and 'stats' packages",0.85,Accept,Experimental Usage,R (version 4.3.1),Analysis Software,4.3.1,R,,,,,
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,The cBioportal website (cbioportal.org) was used to analyze The Cancer Genome Atlas (TCGA)—Firehose Legacy,0.9,Accept,Experimental Usage,cBioportal,Web Application,,Unknown,,,,,
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,A REDCap database was constructed from 542 patients with histologically-confirmed IDH-wild type GBM,0.85,Accept,Experimental Usage,REDCap,Database,,Unknown,,,,,
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,protein bands were quantified using the ImageJ software (https://imagej.nih.gov/ij/),0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,https://imagej.nih.gov/ij/,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"We investigated the proportions of people with NF1, NF2, or SWN in the National COVID Cohort Collaborative (N3C) electronic health record data set",0.85,Accept,Experimental Usage,National COVID Cohort Collaborative (N3C),Database,,,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,All cohorts were generated using custom SQL queries and subsequently analyzed in the N3C Data Enclave,0.8,Accept,Experimental Usage,N3C Data Enclave,Web Application,,,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"A Shapiro-Wilk test (base R v3.6.3, shapiro.test function) was used to test the normality of the distributions",0.85,Accept,Experimental Usage,Shapiro-Wilk test,Analysis Software,,R,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"A Shapiro-Wilk test (base R v3.6.3, shapiro.test function) was used to test the normality",0.9,Accept,Experimental Usage,R v3.6.3,Analysis Software,v3.6.3,R,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"compared to estimate the P value of the real observations (real P value) (using BSDA v1.2.0, z.test function)",0.85,Accept,Experimental Usage,BSDA v1.2.0,Package/Library,v1.2.0,R,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"resampled 10,000 times to produce 10,000 possible combinations of age-adjusted proportions (using gdata v2.18.0, resample function)",0.85,Accept,Experimental Usage,gdata v2.18.0,Package/Library,v2.18.0,R,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,The distributions of bootstrapped P values were visualized using R (ggplot2 v3.3.2),0.85,Accept,Experimental Usage,ggplot2 v3.3.2,Package/Library,v3.3.2,R,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"a nonparametric Wilcoxon rank-sum test (base R v3.6.3, wilcox.test function) was used to estimate the real P value",0.85,Accept,Experimental Usage,Wilcoxon rank-sum test,Analysis Software,,R,,,,,
PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,All real P values were adjusted to correct for the number of overlapping comparisons for each disease using the Benjamini-Hochberg (BH) method,0.85,Accept,Experimental Usage,Benjamini-Hochberg (BH) method,Analysis Software,,,,,,,
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,We acquired cell suspensions in a dual-laser (Argon 488 and dye laser 630 or HeNe 633) FACSCanto (Becton–Dickinson),0.8,Accept,Experimental Usage,FACSCanto (Becton–Dickinson),Analysis Software,,,,,,,
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,All the probe sets on Affymetrix Mouse Gene 2.0 ST array (Mogene-2_0-st-v1.na33.2.mm10),0.9,Accept,Experimental Usage,Affymetrix Mouse Gene 2.0 ST array,Analysis Software,,,,,,,
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,their batch effects were corrected using ComBat method implemented in Bioconductor's sva package,0.85,Accept,Experimental Usage,ComBat method,Package/Library,,R,,,,,
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,The Bioconductor/R limma package was used to define DEGs between two groups,0.9,Accept,Experimental Usage,limma package,Package/Library,,R,,,,,
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,Gene set enrichment analysis was performed using the WebGestalt webserver (http://bioinfo.vanderbilt.edu/webgestalt/),0.9,Accept,Experimental Usage,WebGestalt webserver,Web Application,,,http://bioinfo.vanderbilt.edu/webgestalt/,,,,
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,A modified version of NetWalk algorithm was used to handle bi-cellular interaction,0.85,Accept,Experimental Usage,NetWalk algorithm,Analysis Software,,,,,,,
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"18F-FDG PET/CT scans were all acquired to the same protocol in the same institution on one of two scanners (Discovery VCT or DST, GE Healthcare, Chicago, IL, USA)",0.8,Accept,Experimental Usage,Discovery VCT,Other,,,,,,,
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"18F-FDG PET/CT scans were all acquired to the same protocol in the same institution on one of two scanners (Discovery VCT or DST, GE Healthcare, Chicago, IL, USA)",0.8,Accept,Experimental Usage,DST,Other,,,,,,,
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"The reconstructed PET datasets were imported into in-house texture analysis software implemented in MATLAB (Release 2016a, The MathWorks, Inc., Natick, MA, USA)",0.9,Accept,Experimental Usage,MATLAB,Analysis Software,Release 2016a,MATLAB,,,,,
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"Statistical analysis was performed using SPSS (v22, Chicago, IL, USA) and MedCalc (v16.8.4, Ostend, Belgium) software",0.85,Accept,Experimental Usage,SPSS,Analysis Software,v22,,,,,,
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"Statistical analysis was performed using SPSS (v22, Chicago, IL, USA) and MedCalc (v16.8.4, Ostend, Belgium) software",0.85,Accept,Experimental Usage,MedCalc,Analysis Software,v16.8.4,,,,,,
PMID:37174087,10.3390/cancers15092621,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.,,"...All analyses were performed using Stata 15 (StataCorp, College Station, TX, USA)...",0.8,Accept,Experimental Usage,Stata 15,Analysis Software,15,,,,,,
PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,copy-number–based estimation of tumor fraction were then performed using the ichorCNA tool (Broad v.0.2.0),0.9,Accept,Experimental Usage,ichorCNA,Analysis Software,v.0.2.0,,,,,,
PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,Downsampling was repeated using seed values 0 to 4 in samtools v1.17,0.8,Accept,Experimental Usage,samtools,Command-line Tool,v1.17,,,,,,
PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,"Fragment lengths, extracted from bam files using Picard (v.4.0.1.2)",0.8,Accept,Experimental Usage,Picard,Command-line Tool,v.4.0.1.2,,,,,,
PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,We then used the Python sklearn library (v.1.3.2) decomposition module incorporating up to 20 components,0.85,Accept,Experimental Usage,Python sklearn,Package/Library,v.1.3.2,Python,,,,,
PMID:39093127,10.1158/1078-0432.CCR-24-0797,Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,were represented by heatmaps using ComplexHeatmap (v.2.14.0) with supervised clustering,0.85,Accept,Experimental Usage,ComplexHeatmap,Package/Library,v.2.14.0,R,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Images were captured with a Zeiss LSM 900 confocal microscope equipped with a 20X objective,0.8,Accept,Experimental Usage,Zeiss LSM 900 confocal microscope,Other,,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Image processing and analysis were performed using Image J software,0.8,Accept,Experimental Usage,Image J software,Analysis Software,,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Results were processed in GraphPad Prism 10 software and presented as mean +/- SEM,0.8,Accept,Experimental Usage,GraphPad Prism 10,Analysis Software,10,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,BCL files were processed using 10x Genomics Cell Ranger 7.0.1,0.9,Accept,Experimental Usage,10x Genomics Cell Ranger 7.0.1,Analysis Software,7.0.1,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,we designed two pipelines using Nextflow [10] and Singularity containerization [17],0.85,Accept,Experimental Usage,Nextflow,Workflow,,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,we designed two pipelines using Nextflow [10] and Singularity containerization [17],0.85,Accept,Experimental Usage,Singularity,Other,,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Each data set was analyzed individually from its raw count matrix using the Seurat V3 package [29],0.9,Accept,Experimental Usage,Seurat V3 package,Package/Library,V3,R,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Doublet cells were removed using the scDblFinder tool and scds in hybrid mode,0.85,Accept,Experimental Usage,scDblFinder,Package/Library,,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,"Sampling effect was removed on the PCA using the RunHarmony function from the harmony package [15, 16]",0.85,Accept,Experimental Usage,harmony package,Package/Library,,R,,,,,
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"The data were analyzed using SAS software Version 9.4 (SAS Institute, Cary, NC, USA), with the significance level set at 0.05",0.85,Accept,Experimental Usage,SAS software Version 9.4,Analysis Software,9.4,,,,,,
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"Higher order factor confirmatory analysis was performed to confirm that the dimensions created could be combined into one single score. PROC CALIS procedure, SAS 9.4, was employed",0.8,Accept,Experimental Usage,PROC CALIS procedure,Analysis Software,,,,,,,
PMID:33519543,10.3389/fpsyt.2020.585700,Autism Spectrum Disorder Symptom Profile Across the RASopathies.,,"Data were analyzed in SPSS version 25 (SPSS Inc., Chicago, USA)",0.85,Accept,Experimental Usage,SPSS version 25,Analysis Software,25,,,,,,
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Using the multispectral neural network (MSNN) modeling tool available in Analyze 12.0 (AnalyzeDirect, Overland Park, KS)",0.9,Accept,Experimental Usage,Analyze 12.0,Analysis Software,12.0,,,,,,
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Measurements were made on a commercially available image analysis software (MIM Encore 6.9.3, MIM Software INC, Cleveland, OH)",0.9,Accept,Experimental Usage,MIM Encore 6.9.3,Analysis Software,6.9.3,,,,,,
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Calculation of IVIM parameters were performed on a molecular kinetic modeling software (eLucidate, Paul R. Territo, Ph.D, Indiana University, Indianapolis, USA)",0.85,Accept,Experimental Usage,eLucidate,Analysis Software,,,,,,,
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,Using the multispectral neural network (MSNN) modeling tool available in Analyze 12.0,0.8,Accept,Experimental Usage,multispectral neural network (MSNN),Analysis Software,,,,,,,
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,DWI MRI image series from baseline and follow up scans are imported into the Clinical Trials Processor for de-identification,0.75,Accept,Experimental Usage,Clinical Trials Processor,Analysis Software,,,,,,,
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,for hybridization to the whole-genome Affymetrix GeneChip HU133 Plus 2.0 using the Affymetrix protocol,0.85,Accept,Experimental Usage,Affymetrix GeneChip HU133 Plus 2.0,Analysis Software,,,,,,,
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,We used Genome TraFac 3 for genome-wide detection of compositionally similar cis-clusters in gene orthologues,0.85,Accept,Experimental Usage,Genome TraFac 3,Analysis Software,,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Western blot band intensities were quantitated with ImageJ software,0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Variant calling of the germline samples was performed using The Genome Analysis Toolkit (https://gatk.broadinstitute.org),0.9,Accept,Experimental Usage,Genome Analysis Toolkit (GATK),Analysis Software,,,https://gatk.broadinstitute.org,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,somatic variant calling was performed using either MuTect (https://github.com/broadinstitute/mutect),0.9,Accept,Experimental Usage,MuTect,Analysis Software,,,https://github.com/broadinstitute/mutect,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Germline variant pathogenicity classification was performed by AutoGVP,0.85,Accept,Experimental Usage,AutoGVP,Analysis Software,,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Somatic variants were queried in cBioPortal (https://www.cbioportal.org/),0.85,Accept,Experimental Usage,cBioPortal,Web Application,,,https://www.cbioportal.org/,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,WES and WGS data processing was performed with a modified version of the Nextflow nf-core 'sarek' data processing pipeline (v2.7.1),0.95,Accept,Experimental Usage,nf-core sarek pipeline (v2.7.1),Pipeline,v2.7.1,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,The pipeline was modified to add DeepVariant as an additional variant-calling method,0.9,Accept,Experimental Usage,DeepVariant,Analysis Software,,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Whole exome variant calling was performed with FreeBayes,0.85,Accept,Experimental Usage,FreeBayes,Analysis Software,,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Whole exome variant calling was performed with FreeBayes, Mutect2, Strelka2",0.85,Accept,Experimental Usage,Strelka2,Analysis Software,,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,copy-number alterations were determined using Control-FREEC (whole genome data only),0.85,Accept,Experimental Usage,Control-FREEC,Analysis Software,,,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,NF1 variants were extracted from the annotated maf files from the WES data and plotted using the 'maftools' R package,0.85,Accept,Experimental Usage,maftools R package,Package/Library,,R,,,,,
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Transcriptomic data processing was performed using the nf-core 'rnaseq' data processing pipeline (v3.5),0.95,Accept,Experimental Usage,nf-core rnaseq pipeline (v3.5),Pipeline,v3.5,,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"OCR was assessed in real-time with the XF24 Extracellular Flux Analyzer (Agilent, North Billerica, MA, USA)",0.9,Accept,Experimental Usage,XF24 Extracellular Flux Analyzer,Analysis Software,,,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"Mass spectrometry analysis was carried out with an LC-MS/MS (Quattro Premier interfaced with an Acquity UPLC system, Waters)",0.9,Accept,Experimental Usage,LC-MS/MS (Quattro Premier),Analysis Software,,,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"Samples were analyzed on a FACSCanto II flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA)",0.9,Accept,Experimental Usage,FACSCanto II flow cytometer,Analysis Software,,,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,Data acquisition and analysis were performed using FACSDiva software,0.9,Accept,Experimental Usage,FACSDiva software,Analysis Software,,,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,colonies were stained with Crystal Violet 0.005% and analyzed with ImageJ software,0.9,Accept,Experimental Usage,ImageJ software,Analysis Software,,,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"Statistical significance was determined using Origin® 8 (OriginLab, Northampton, MA)",0.9,Accept,Experimental Usage,Origin® 8,Analysis Software,8,,,,,,
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"Based on a convolutional neural network (U-Net), the mean raw Raman spectra (n = 8,200) were processed and refined",0.85,Accept,Experimental Usage,U-Net convolutional neural network,Analysis Software,,Not specified,,,,,
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"Here, we introduce Shifted-Excitation Raman Spectroscopy in combination with deep neural networks for the future perspective",0.8,Accept,Experimental Usage,Shifted-Excitation Raman Spectroscopy,Analysis Software,,,,,,,
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"guiding the signals from the Raman probe to the spectrometer (Ventana-785-Raman, Ocean Optics, Rochester, New York, USA)",0.9,Accept,Experimental Usage,Ventana-785-Raman spectrometer,Analysis Software,,,,,,,
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"As a first step, principal component analysis (PCA) was utilized to reduce the number of spectral parameters",0.75,Accept,Experimental Usage,Principal component analysis (PCA),Analysis Software,,,,,,,
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,we employed a multiclass linear discriminant analysis (LDA),0.75,Accept,Experimental Usage,linear discriminant analysis (LDA),Analysis Software,,,,,,,
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,Extraction of the pure Raman spectra from the mean raw spectra...was performed using the SERDS and U-Net deep neural network data processing methods,0.8,Accept,Experimental Usage,SERDS,Analysis Software,,,,,,,
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,"FMRI data analyses were performed using the FMRIB software library (www.fmrib.ox.ac.uk/fsl), version 5.0",0.9,Accept,Experimental Usage,FMRIB software library (FSL),Analysis Software,5.0,,,,,,
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,Analyses of neuropsychological and clinical data were performed using SPSS software v. 21 (IBM),0.8,Accept,Experimental Usage,SPSS software v. 21,Analysis Software,21,,,,,,
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,The output from the subject-specific analyses was analyzed using a mixed-effects model with FMRIB's Local Analysis of Mixed Effects (FLAME),0.85,Accept,Experimental Usage,FMRIB's Local Analysis of Mixed Effects (FLAME),Analysis Software,,,,,,,
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,We used the generalized psychophysiological interaction (gPPI) method described in McLaren et al. (2012),0.8,Accept,Experimental Usage,generalized psychophysiological interaction (gPPI) method,Analysis Software,,,,,,,
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,all subjects' SCAP scans were run through the FSL motion outlier tool (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLMotionOutliers),0.8,Accept,Experimental Usage,FSL motion outlier tool,Analysis Software,,,,,,,
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,Brain regions were identified using the Harvard-Oxford cortical and subcortical probabilistic atlases,0.85,Accept,Experimental Usage,Harvard-Oxford cortical and subcortical probabilistic atlases,Database,,,,,,,
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,cDNA was submitted to qPCR in a Light-Cycler 480 Real-Time PCR System,0.8,Accept,Experimental Usage,Light-Cycler 480 Real-Time PCR System,Analysis Software,,,,,,,
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,scanned using the Odyssey Imaging System (LI-COR),0.8,Accept,Experimental Usage,Odyssey Imaging System (LI-COR),Analysis Software,,,,,,,
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,"sorted, after 3 days, using the BD FACSAria II",0.8,Accept,Experimental Usage,BD FACSAria II,Analysis Software,,,,,,,
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,cells were counted with the Countess Automated Cell Counter (Life Technologies),0.8,Accept,Experimental Usage,Countess Automated Cell Counter (Life Technologies),Analysis Software,,,,,,,
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,A BD LSRFortessa SORP cytometer was used to measure,0.8,Accept,Experimental Usage,BD LSRFortessa SORP cytometer,Analysis Software,,,,,,,
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"A multi-mode microplate reader (Spectramax ® M5: Molecular Devices, California, USA) was used to measure the UV-VIS absorbance.",0.85,Accept,Experimental Usage,Spectramax M5,Analysis Software,,,,,,,
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"The SpectraMax M5 reader is controlled and operated by using the SoftMax ® Pro Enterprise software, a leading data acquisition and analysis software",0.8,Accept,Experimental Usage,SoftMax Pro Enterprise software,Analysis Software,,,,,,,
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,Quantum mechanics/molecular mechanics (QM/MM) computations...were performed using the General Atomic and Molecular Electronic Structure System (GAMESS software),0.9,Accept,Experimental Usage,GAMESS software,Analysis Software,,,,,,,
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"Mutiwfn 3.7, VMD, and the GAMESS-optimized SEL-DDQ complex were used in the hirshfeld surface HS study",0.85,Accept,Experimental Usage,Mutiwfn 3.7,Analysis Software,3.7,,,,,,
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"Mutiwfn 3.7, VMD, and the GAMESS-optimized SEL-DDQ complex were used in the hirshfeld surface HS study",0.8,Accept,Experimental Usage,VMD,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The light scattering measurements were performed using DynaPro NanoStar (Wyatt Technology Corporation),0.8,Accept,Experimental Usage,DynaPro NanoStar,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"DYNAMIC software (V7.1.4) was used to obtain the normalized time autocorrelation function, polydispersity, and the absolute molecular mass",0.85,Accept,Experimental Usage,DYNAMIC software,Analysis Software,V7.1.4,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,CD experiments were performed on a J-180 JASCO circular dichroism spectropolarimeter equipped with a temperature controlled cell holder,0.75,Accept,Experimental Usage,J-180 JASCO circular dichroism spectropolarimeter,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,using the Spectra Manager control (V1. 17.00) and application (V1.3.00) software package (JASCO),0.8,Accept,Experimental Usage,Spectra Manager,Analysis Software,V1.17.00,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Data deconvolution and normalization were carried out using DichroWeb,0.85,Accept,Experimental Usage,DichroWeb,Web Application,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"Surface plasmon resonance (SRP) experiments were performed on a Biacore X100 (GE Life Sciences, NJ) at 25.0 °C",0.8,Accept,Experimental Usage,Biacore X100,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,ITC experiments were run in a MicroCal™ Auto-iTC 200 system at 25 °C,0.8,Accept,Experimental Usage,MicroCal™ Auto-iTC 200,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The data were analyzed using the manufacturer provided software Bindworks (version 3.1.5, Calorimetry Sciences Corp. Lindon, UT)",0.85,Accept,Experimental Usage,Bindworks,Analysis Software,version 3.1.5,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Data reduction followed standard procedures that are implemented in MantidPlot (http://www.mantidproject.org/),0.85,Accept,Experimental Usage,MantidPlot,Analysis Software,,,http://www.mantidproject.org/,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The length distribution function P(r), radius of gyration Rg, the forward scattering intensity I(0), and the maximum dimension Dmax were calculated from the scattering data using the program GNOM",0.85,Accept,Experimental Usage,GNOM,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The 3-D 'dummy bead' coordinates were generated using the program DAMMIN. Multiple calculations were performed using DAMMIN,0.85,Accept,Experimental Usage,DAMMIN,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,the generated 10 structures were averaged and filtered using the program DAMAVER and DAMFILT,0.85,Accept,Experimental Usage,DAMAVER,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,the generated 10 structures were averaged and filtered using the program DAMAVER and DAMFILT,0.85,Accept,Experimental Usage,DAMFILT,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The 3-D density map was generated from the averaged coordinates using the program Situs. The fitting and docking of the high-resolution structure to the density map were performed using Situs,0.85,Accept,Experimental Usage,Situs,Analysis Software,,,,,,,
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The fitting and docking of the high-resolution structure to the density map were performed using Situs or UCS Chimera,0.85,Accept,Experimental Usage,UCS Chimera,Analysis Software,,,,,,,
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"MR study was performed on a 4.7 Tesla microimaging system (Biospec, Bruker BioSpin MRI, Inc., Ertlingen, Germany)",0.8,Accept,Experimental Usage,Biospec 4.7 Tesla microimaging system,Analysis Software,,,,,,,
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"Thin sections were cut with an LKB8801 ultramicrotome and diamond knife, stained with Sato's lead",0.7,Accept,Experimental Usage,LKB8801 ultramicrotome,Other,,,,,,,
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"stained with Sato's lead, and examined in a Phillips 301 transmission electron microscope",0.7,Accept,Experimental Usage,Phillips 301 transmission electron microscope,Other,,,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,"EEG data were recorded using an ActiveTwo system (BioSemi, Amsterdam, Netherlands) with 64 EEG channels in standard 10–10 system locations",0.85,Accept,Experimental Usage,"ActiveTwo system (BioSemi, Amsterdam, Netherlands)",Analysis Software,,,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.9,Accept,Experimental Usage,MATLAB (2019a),Analysis Software,2019a,MATLAB,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.9,Accept,Experimental Usage,SPM12 (version 7771),Analysis Software,7771,,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Custom functions calling several functions from EEGLAB (version 13.6.5b) and FieldTrip (embedded in SPM release) were used,0.9,Accept,Experimental Usage,EEGLAB (version 13.6.5b),Package/Library,13.6.5b,,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Custom functions calling several functions from EEGLAB (version 13.6.5b) and FieldTrip (embedded in SPM release) were used,0.85,Accept,Experimental Usage,FieldTrip,Package/Library,,,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Post hoc analysis of Ribeiro et al.'s resting state theta effect in NF1 using G*Power suggests that n = 17 participants per group would result in 79% power,0.85,Accept,Experimental Usage,G*Power,Analysis Software,,,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,"spatially filtered using the Surface Laplacian, implemented using the laplacian_perrinX function in MATLAB",0.75,Accept,Experimental Usage,laplacian_perrinX function,Command-line Tool,,MATLAB,,,,,
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Statistical analyses were conducted using SPSS (Version 25),0.85,Accept,Experimental Usage,SPSS (Version 25),Analysis Software,25,,,,,,
PMID:41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,,completed an online screening survey administered via Qualtrics ( www.qualtrics.com ),0.85,Accept,Experimental Usage,Qualtrics,Web Application,,,,,,,
PMID:41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,,"The coded transcripts were entered into ATLAS.ti (Version 9; Kansas City, MO)",0.95,Accept,Experimental Usage,ATLAS.ti (Version 9),Analysis Software,Version 9,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Weighted Gene Co-expression Network Analysis, WGCNA ( 15 , 17 ) was applied to explore gene expression as an undirected co-expression network",0.85,Accept,Experimental Usage,Weighted Gene Co-expression Network Analysis (WGCNA),Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,analyzed the Affymetrix Genotyping Console software ( Affymetrix ),0.85,Accept,Experimental Usage,Affymetrix Genotyping Console,Analysis Software,,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,analyzed in GSE16581 R ( 21 ),0.75,Accept,Experimental Usage,R,Analysis Software,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,using functions of the affy package ( 22 ),0.85,Accept,Experimental Usage,affy package,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Array quality was determined with the arrayQualityMetrics package ( 23 ),0.85,Accept,Experimental Usage,arrayQualityMetrics package,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Cytoscape ( 26 ) was used to create a graphic representation of the pink-module,0.9,Accept,Experimental Usage,Cytoscape,Analysis Software,,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Using the CentiScape plug-in ( 27 ), we analyzed several network parameters",0.85,Accept,Experimental Usage,CentiScape plug-in,Plugin,,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,The ClueGO plug-in ( 28 ) was utilized to create pathway and Gene Ontology ( 29 ) enrichment networks,0.85,Accept,Experimental Usage,ClueGO plug-in,Plugin,,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Gene ontology analysis for hub genes was performed with DAVID web tool ( 33 , 34 )",0.85,Accept,Experimental Usage,DAVID web tool,Web Application,,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,with the function spn.lhs.tests implemented in the package snpStats ( 35 ),0.85,Accept,Experimental Usage,snpStats package,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,mQTL putative genes were obtained from the HaploReg v2 web browser ( 36 ),0.85,Accept,Experimental Usage,HaploReg v2,Web Application,v2,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,mQTL enrichment in TFBS was studied using oPPOSUM Single Site Analysis tool ( 37 ),0.85,Accept,Experimental Usage,oPPOSUM Single Site Analysis tool,Analysis Software,,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,The PPI database STRING ( 39 ) was used to test for known interactions among the proteins,0.85,Accept,Experimental Usage,STRING,Database,,,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,batches were removed with the ComBat function implemented in the package sva ( 42 ),0.8,Accept,Experimental Usage,ComBat function,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Linear models of the limma package ( 43 ) were applied to determine differential gene expression,0.85,Accept,Experimental Usage,limma package,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"rntransform , package GenABEL ( 45 )] was applied to the dependent variables",0.8,Accept,Experimental Usage,GenABEL package,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Gene-expression standard deviation was determined with the function rowSds , part of the package matrixStats ( 25 )",0.8,Accept,Experimental Usage,matrixStats package,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Variance inflation factors (VIFs) for lineal models were calculated with the VIF function implemented in the package fmsb ( 46 ),0.8,Accept,Experimental Usage,fmsb package,Package/Library,,R,,,,,
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Expression missing values were imputed with functions of the package impute ( 47 ),0.8,Accept,Experimental Usage,impute package,Package/Library,,R,,,,,
PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,The task was programmed in-house using E-Prime software.,0.8,Accept,Experimental Usage,E-Prime software,Analysis Software,,,,,,,
PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,Memory span was assessed using a computerized Corsi block task on the Psychology Experiment Building Language (PEBL; Mueller and Piper 2014).,0.85,Accept,Experimental Usage,Psychology Experiment Building Language (PEBL),Analysis Software,,,,,,,
PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"Images were segmented using SPM12 v7771 (Wellcome Trust Centre for Neuroimaging, University College London, United Kingdom)",0.85,Accept,Experimental Usage,SPM12 v7771,Analysis Software,v7771,,,,,,
PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"Images were segmented using SPM12 v7771 (Wellcome Trust Centre for Neuroimaging, University College London, United Kingdom) through MATLAB vR2020b",0.8,Accept,Experimental Usage,MATLAB vR2020b,Analysis Software,vR2020b,MATLAB,,,,,
PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"For visualization purposes, all thresholded SPM maps were imported into MRIcroGL (https://www.nitrc.org/projects/mricrogl)",0.85,Accept,Experimental Usage,MRIcroGL,Analysis Software,,,https://www.nitrc.org/projects/mricrogl,,,,
PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,We then used marsbar (Brett et al. 2002) to extract gray matter volumes within this region,0.8,Accept,Experimental Usage,marsbar,Package/Library,,,,,,,
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,"Cell Ranger 5.0.1 (10x Genomics, https://www.10xgenomics.com/) was used to process the raw sequencing data.",0.9,Accept,Experimental Usage,Cell Ranger 5.0.1,Analysis Software,5.0.1,,,,,,
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,The gene expression matrix from Cell Ranger was used as input to the Seurat R package (v4.0.2) for downstream analysis (53).,0.9,Accept,Experimental Usage,Seurat R package,Package/Library,v4.0.2,R,,,,,
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,Data were acquired by the facility core and analyzed using Proteome Discoverer 2.4 (Thermo Fisher Scientific)...,0.9,Accept,Experimental Usage,Proteome Discoverer 2.4,Analysis Software,2.4,,,,,,
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,Cells were processed in the Chromium Single Cell Gene Expression (10x Genomics) to build the 3′ transcriptome libraries...,0.85,Accept,Experimental Usage,Chromium Single Cell Gene Expression,Workflow,,,,,,,
PMID:38499890,10.1186/s41687-024-00714-y,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,The statistical analyses were conducted using SPSS version 28.0,0.85,Accept,Experimental Usage,SPSS version 28.0,Analysis Software,28.0,,,,,,
PMID:41023593,10.1186/s10020-025-01353-9,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,Mice were randomized into treatment groups using the randomizr package that arranges animals to achieve the best-case distribution,0.85,Accept,Experimental Usage,randomizr package,Package/Library,,R,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,NF1 germline and somatic mutations were detected by NF1 gDNA sequencing using the I2HCP NGS custom panel,0.8,Accept,Experimental Usage,I2HCP NGS custom panel,Analysis Software,,,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,Sequencing reads were then mapped with bwa mem against GRCh38,0.85,Accept,Experimental Usage,bwa mem,Analysis Software,,,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,We called variants with strelka2 and annotated them with annovar,0.85,Accept,Experimental Usage,strelka2,Analysis Software,,,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,We called variants with strelka2 and annotated them with annovar,0.85,Accept,Experimental Usage,annovar,Analysis Software,,,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,RNA-Seq data from real and in silico mixed samples was aligned with Salmon v1.8.0,0.9,Accept,Experimental Usage,Salmon v1.8.0,Analysis Software,v1.8.0,,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,We imported transcript-level estimates into R and summarized them to gene level using tximport,0.85,Accept,Experimental Usage,tximport,Package/Library,,R,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,used DESeq2 to perform differential expression analysis,0.85,Accept,Experimental Usage,DESeq2,Package/Library,,R,,,,,
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,We finally used clusterProfiler to determine Gene Ontology and KEGG pathway enrichment,0.85,Accept,Experimental Usage,clusterProfiler,Package/Library,,R,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Gene expression analysis was conducted on the nCounter Sprint Profiler (NanoString Technologies, Inc.)",0.9,Accept,Experimental Usage,nCounter Sprint Profiler,Analysis Software,,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Quality control, normalization, differential expression and pathway analysis were performed using nSolver Advanced Analysis Software (version 4.0)",0.9,Accept,Experimental Usage,nSolver Advanced Analysis Software version 4.0,Analysis Software,4.0,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Raw count matrices with sample metadata deposited on GEO were reanalyzed using the Omics Playground v2.7.18 Platform,0.9,Accept,Experimental Usage,Omics Playground v2.7.18,Analysis Software,v2.7.18,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Publicly available RNA sequencing data was also obtained from the TARGET TCGA GTEx database using the UCSC Xena browser (RRID:SCR_018938),0.9,Accept,Experimental Usage,UCSC Xena browser,Web Application,,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Principal Component Analysis (PCA) was conducted in IDEP.92 using log2 transformed, normalized counts as input",0.9,Accept,Experimental Usage,IDEP.92,Web Application,0.92,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Heatmaps in Figure 5B and C were generated using Morpheus,0.85,Accept,Experimental Usage,Morpheus,Web Application,,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,were generated using the ComplexHeatmap R/Bioconductor package (RRID:SCR_017270),0.9,Accept,Experimental Usage,ComplexHeatmap R/Bioconductor package,Package/Library,,R,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Data preprocessing and visualization was performed using Scanpy (RRID:SCR_018139) in Python,0.9,Accept,Experimental Usage,Scanpy,Package/Library,,Python,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,An scVI model was trained on the raw counts with sample and quality metrics,0.85,Accept,Experimental Usage,scVI model,Package/Library,,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,the decoupler package was used to perform over-representation analysis (ORA) of cell type markers,0.85,Accept,Experimental Usage,decoupler package,Package/Library,,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,the infercnvpy package (https://github.com/icbi-lab/infercnvpy) was used to detect copy number variations,0.85,Accept,Experimental Usage,infercnvpy package,Package/Library,,,https://github.com/icbi-lab/infercnvpy,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Quantitative immunohistochemical analysis for BIRC5 and CENPF was conducted using the Cytonuclear IHC module of HALO Image Analysis software (version 2.0.5),0.9,Accept,Experimental Usage,HALO Image Analysis software version 2.0.5,Analysis Software,2.0.5,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Bisulfite-treated DNA from all tumor samples was then processed for methylation profiling using the Illumina Infinium HumanMethylationEPIC (EPIC) array,0.9,Accept,Experimental Usage,Illumina Infinium HumanMethylationEPIC (EPIC) array,Analysis Software,,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Raw IDAT data files were processed using the minfi Bioconductor package (version 3.3),0.95,Accept,Experimental Usage,minfi,Package/Library,3.3,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Subgroups were identified using ConsensusClusterPlus Bioconductor package,0.9,Accept,Experimental Usage,ConsensusClusterPlus,Package/Library,,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,We performed supervised analysis of methylation data using limma based modeling approach (Bioconductor),0.9,Accept,Experimental Usage,limma,Package/Library,,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"We used Rtsne package in Bioconductor to generate tSNE plots based on the top 10,000 most variably methylated CpG sites",0.9,Accept,Experimental Usage,Rtsne,Package/Library,,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"To generate compound CNV plots using the DNA methylation data, we used the conumee package in Bioconductor",0.9,Accept,Experimental Usage,conumee,Package/Library,,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Haplotype Caller, MuTect1 v1.1.7 and Strelka v1.0.13 were run to create raw variant call files (VCFs)",0.9,Accept,Experimental Usage,Haplotype Caller,Analysis Software,,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Haplotype Caller, MuTect1 v1.1.7 and Strelka v1.0.13 were run to create raw variant call files",0.95,Accept,Experimental Usage,MuTect1,Analysis Software,v1.1.7,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Haplotype Caller, MuTect1 v1.1.7 and Strelka v1.0.13 were run to create raw variant call files",0.95,Accept,Experimental Usage,Strelka,Analysis Software,v1.0.13,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Raw VCF files were annotated with Variant Effect Predictor v92,0.95,Accept,Experimental Usage,Variant Effect Predictor,Analysis Software,v92,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Additional analysis was applied to detect allele specific copy number profiles, loss of heterozygosity, and to estimate ploidy/cellularity using Sequenza for matched tumor/normal pairs",0.95,Accept,Experimental Usage,Sequenza,Analysis Software,v 2.1.2,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,WGS data were aligned against hg19 using BwaMem v0.7.12,0.95,Accept,Experimental Usage,BwaMem,Analysis Software,v0.7.12,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Structural variant (SV) prediction for tumor and matched normal pairs was carried out using Delly (version 0.8.1),0.95,Accept,Experimental Usage,Delly,Analysis Software,0.8.1,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,SVs were validated and visualized using MAVIS (version 2.2.6),0.95,Accept,Experimental Usage,MAVIS,Analysis Software,2.2.6,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,We used FusionCatcher to detect novel gene fusions,0.9,Accept,Experimental Usage,FusionCatcher,Analysis Software,,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,The quality assessment of the raw reads was carried out using the FastQC tool (version 0.11.5),0.9,Accept,Experimental Usage,FastQC,Analysis Software,0.11.5,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"The reads were aligned to the human reference genome, hg38 using the star aligner (version 2.4.2a)",0.95,Accept,Experimental Usage,STAR aligner,Analysis Software,2.4.2a,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,The RNASeq reads were counted over gene exons using HtSeq (version 0.11.0),0.95,Accept,Experimental Usage,HtSeq,Analysis Software,0.11.0,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,DEseq2 (DESeq2_1.26.0) was used to normalize and difference in library preparation methods was corrected by limma,0.95,Accept,Experimental Usage,DESeq2,Package/Library,1.26.0,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Differential gene expression analysis was performed using the R package edgeR in BioConductor,0.95,Accept,Experimental Usage,edgeR,Package/Library,,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Pathways analysis was performed using DEG from indicated pairwise analysis by the Gene Set Enrichment Analysis (GSEA) software from the Broad Institute (version 3.0),0.95,Accept,Experimental Usage,GSEA,Analysis Software,3.0,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Highly related pathways were grouped into a theme and labeled by AutoAnnotate (version 1.2) in Cytoscape,0.9,Accept,Experimental Usage,AutoAnnotate,Plugin,1.2,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,labeled by AutoAnnotate (version 1.2) in Cytoscape (Version 3.7.2),0.95,Accept,Experimental Usage,Cytoscape,Analysis Software,3.7.2,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,GSEA results were visualized using the Enrichment Map app (Version 3.1) in Cytoscape,0.9,Accept,Experimental Usage,Enrichment Map,Plugin,3.1,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,We used CIBERSORT Bioconductor package to perform deconvolution and estimate the abundances of cell types,0.9,Accept,Experimental Usage,CIBERSORT,Package/Library,,R,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Using SureDesign (Agilent Technologies Inc.), probes were generated to cover the exons and the UTR regions",0.85,Accept,Experimental Usage,SureDesign,Analysis Software,,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Amplicon reads were aligned against the human reference genome hg19 with BWA MEM,0.9,Accept,Experimental Usage,BWA MEM,Analysis Software,,,,,,,
PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,electrophoresis data were analyzed using GeneMapper software (Life Technologies),0.9,Accept,Experimental Usage,GeneMapper software,Analysis Software,,,,,,,
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,Ketotifen was quantified in plasma and nerve tissue samples from ketotifen-treated Nf1;flox/flox PostnCre+ mice (n = 3) by HPLC-MS/MS (Agilent 1200 HPLC and ABI 3200 MS/MS),0.9,Accept,Experimental Usage,Agilent 1200 HPLC,Analysis Software,,,,,,,
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,Ketotifen was quantified in plasma and nerve tissue samples from ketotifen-treated Nf1;flox/flox PostnCre+ mice (n = 3) by HPLC-MS/MS (Agilent 1200 HPLC and ABI 3200 MS/MS),0.9,Accept,Experimental Usage,ABI 3200 MS/MS,Analysis Software,,,,,,,
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,"GraphPad Prism 5.0 and 6.0 was used to perform all statistical analyses. Comparison of the means for nerve root volume, tumor number, KI-67 proliferation index",0.85,Accept,Experimental Usage,GraphPad Prism 5.0,Analysis Software,5.0,,,,,,
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,"GraphPad Prism 5.0 and 6.0 was used to perform all statistical analyses. Comparison of the means for nerve root volume, tumor number, KI-67 proliferation index",0.85,Accept,Experimental Usage,GraphPad Prism 6.0,Analysis Software,6.0,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,All resulting FASTQ files passed quality control by FastQC (RRID:SCR_014583; https://www.bioinformatics.babraham.ac.uk/projects/fastqc/),0.8,Accept,Experimental Usage,FastQC (RRID:SCR_014583),Analysis Software,,,https://www.bioinformatics.babraham.ac.uk/projects/fastqc/,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,Sequencing reads were trimmed with Cutadapt (RRID:SCR_011841; ref. 70) to keep only 22-mer shRNA guide sequences,0.8,Accept,Experimental Usage,Cutadapt (RRID:SCR_011841),Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,that were subsequently mapped to the shRNA library guide sequence reference file using bowtie2 (RRID:SCR_016368; ref. 71),0.8,Accept,Experimental Usage,bowtie2 (RRID:SCR_016368),Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,shRNA read counts were quantified by edgeR (RRID:SCR_012802; ref. 72),0.8,Accept,Experimental Usage,edgeR (RRID:SCR_012802),Package/Library,,R,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,Ranking of each set of five shRNAs per gene in the library was done for depletion with HiTSelect (20),0.8,Accept,Experimental Usage,HiTSelect,Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"All data are plotted with GraphPad (Prism, RRID:SCR_002798)",0.8,Accept,Experimental Usage,"GraphPad (Prism, RRID:SCR_002798)",Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"RNA sequencing reads were 3′ trimmed for base quality 15 and adapter sequences using version 0.4.5 of TrimGalore (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore, RRID:SCR_011847)",0.8,Accept,Experimental Usage,TrimGalore (RRID:SCR_011847),Analysis Software,0.4.5,,https://www.bioinformatics.babraham.ac.uk/projects/trim_galore,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,and then aligned to human genome assembly hg19 with STAR v2.6 (RRID:SCR_004463) using default parameters,0.8,Accept,Experimental Usage,STAR v2.6 (RRID:SCR_004463),Analysis Software,v2.6,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,Transcripts per million (TPM) data were generated via TPMCalculator (78) using default parameters,0.8,Accept,Experimental Usage,TPMCalculator,Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,Read count tables were generated with HTSeq v0.9.1 (RRID:SCR_005514),0.8,Accept,Experimental Usage,HTSeq v0.9.1 (RRID:SCR_005514),Analysis Software,v0.9.1,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,Normalization and expression dynamics were evaluated with DESeq2 (RRID:SCR_000154) using library size factor normalization,0.8,Accept,Experimental Usage,DESeq2 (RRID:SCR_000154),Package/Library,,R,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,These library size factors were also used with deepTools v3.1 (RRID:SCR_016366) to create normalized bigwigs using bamCoverage,0.8,Accept,Experimental Usage,deepTools v3.1 (RRID:SCR_016366),Analysis Software,v3.1,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"Pathway enrichment (gene sets and GO) was performed on each cluster using Homer v4.5 (http://homer.ucsd.edu, RRID:SCR_010881)",0.8,Accept,Experimental Usage,Homer v4.5 (RRID:SCR_010881),Analysis Software,v4.5,,http://homer.ucsd.edu,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"we extracted LTRs, SINEs, and LINEs from the repetitive elements annotated by the RepeatMasker (RRID:SCR_012954)",0.8,Accept,Experimental Usage,RepeatMasker (RRID:SCR_012954),Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"and used featureCounts (v1.5.0-p1, RRID:SCR_012919; ref. 79) to count RNA-seq fragments mapped to them",0.8,Accept,Experimental Usage,"featureCounts (v1.5.0-p1, RRID:SCR_012919)",Analysis Software,v1.5.0-p1,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"were subject to k-means clustering via pheatmap (v.1.0.12, RRID:SCR_016418), separately for the three classes of REs",0.8,Accept,Experimental Usage,"pheatmap (v.1.0.12, RRID:SCR_016418)",Package/Library,v.1.0.12,R,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,The methylKit (RRID:SCR_005177; ref. 81) R package was used to filter all samples for CpGs with 10 to 400× coverage,0.8,Accept,Experimental Usage,methylKit (RRID:SCR_005177),Package/Library,,R,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,DMRs were annotated via the annotatr (82) R package,0.8,Accept,Experimental Usage,annotatr,Package/Library,,R,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"For intergenic DMRs, the nearest gene was identified by the closest function in BEDTools suite (RRID:SCR_006646; ref. 83)",0.8,Accept,Experimental Usage,BEDTools suite (RRID:SCR_006646),Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,Genomation (84) R package (RRID:SCR_003435) was used to annotate CpGs and tiles (regions) with their location,0.8,Accept,Experimental Usage,Genomation (RRID:SCR_003435),Package/Library,,R,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,and then plotted as violin plots via ggplot2 (RRID:SCR_014601; ref. 85) package in R,0.8,Accept,Experimental Usage,ggplot2 (RRID:SCR_014601),Package/Library,,R,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"PCA of methylation data at all tiles (regions) was generated in Partek Genomics Suite (v 7.0, RRID:SCR_011860)",0.8,Accept,Experimental Usage,"Partek Genomics Suite (v 7.0, RRID:SCR_011860)",Analysis Software,v 7.0,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,and subsequent ChIP-seq profiles were visualized either by Integrative Genomics Viewer (87) software,0.8,Accept,Experimental Usage,Integrative Genomics Viewer,Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"All data were processed and analyzed with FCS Express 7 Research Edition (De Novo Software, Inc.; RRID:SCR_016431)",0.8,Accept,Experimental Usage,"FCS Express 7 Research Edition (De Novo Software, Inc.; RRID:SCR_016431)",Analysis Software,7 Research Edition,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"Resulting data were processed and cropped with GIMP (GNU Image Manipulation Program, RRID:SCR_003182) open-source software",0.8,Accept,Experimental Usage,"GIMP (GNU Image Manipulation Program, RRID:SCR_003182)",Analysis Software,,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,MSK-IMPACT (66) was used to evaluate mutations for 341 cancer genes in human MPNST cell lines and tumors,0.8,Accept,Experimental Usage,MSK-IMPACT,Analysis Software,,,,,,,
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...response data (dat0–dat10) and concentration (C0–C10, in μM) were downloaded and analyzed using a 4-parameter fit in SigmaPlot...",0.8,Accept,Experimental Usage,SigmaPlot,Analysis Software,,,,,,,
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,...analyzed using a 4-parameter fit in SigmaPlot and with the DREA web tool (see Supplemental Materials). The DREA web tool recreates our final compound rankings...,0.85,Accept,Development,DREA web tool,Web Application,,,,,,,
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,...Primary files [15] were accessed from Single Agent Screens through Synapse https://doi.org/10.7303/syn4939906...,0.8,Accept,Experimental Usage,Synapse,Database,,,https://doi.org/10.7303/syn4939906,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Here, we optimized our random forest-based predictor RENOVO for NF1 variant interpretation. RENOVO was developed using an approach of 'database archaeology'",0.95,Accept,Development,RENOVO-NF1,Analysis Software,,R,https://github.com/mazzalab-ieo/renovo,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,ClinVar data for NF1 variants were extracted from the ClinVar version 2024-07-03 available at: https://ftp.ncbi.nlm.nih.gov/pub/clinvar/,0.9,Accept,Experimental Usage,ClinVar,Database,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Constitutional NF1 variants were determined by standard techniques using targeted NGS panel including NF1, NF2, SPRED1, SMARCB1 and LZTR1 genes on Ion Torrent",0.85,Accept,Experimental Usage,Ion Torrent,Analysis Software,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Together with NGS, MLPA method was performed to rule out large deletions/duplications in NF1 gene",0.8,Accept,Experimental Usage,MLPA,Analysis Software,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,The effects on genes and proteins of the variants identified were predicted based on the Mutation Taster (http://www.mutationtaster.org),0.9,Accept,Experimental Usage,Mutation Taster,Web Application,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"HGMD (Human Genome Mutation Database—Institute of Medical Genetics, Cardiff, Wales, UK; http://www.hgmd.cf.ac.uk/ac/index.php",0.9,Accept,Experimental Usage,HGMD,Database,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,LOVD. (Leiden Open Variation Database; http://www.LOVD.nl.NF1),0.9,Accept,Experimental Usage,LOVD,Database,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,Novel variants with amino acid changes were further examined for their disease causing. potential using PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/bgi.shtml),0.9,Accept,Experimental Usage,PolyPhen-2,Web Application,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,with the Human Splicing Finder (HSF; http://www.umd.be/HSF/),0.9,Accept,Experimental Usage,Human Splicing Finder,Web Application,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,and the ESE Finder (http://rulai.cshl.edu/cgibin/tools/ESE3/esefinder.cgi?process=home) tools,0.9,Accept,Experimental Usage,ESE Finder,Web Application,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,predicted the functional consequence of missense variants using ANNOVAR which included prediction scores from 20 prediction algorithms,0.9,Accept,Experimental Usage,ANNOVAR,Analysis Software,,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,the GnomAD v.2.1.1 (https://gnomad.broadinstitute.org) and 1000 genomes databases were used,0.9,Accept,Experimental Usage,GnomAD,Database,v.2.1.1,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"1000 genomes (https://www.internationalgenome.org, release 2015 aug) databases were used",0.9,Accept,Experimental Usage,1000 Genomes,Database,2015 aug,,,,,,
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"For threshold optimization, we used cutpointR version 1.1.2, maximizing the 'accuracy' metric",0.85,Accept,Experimental Usage,cutpointR,Package/Library,1.1.2,R,,,,,
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,Imaging was performed with a 9.4-T BioSpec 94/20 USR MRI (Bruker BioSpin MRI),0.8,Accept,Experimental Usage,BioSpec 94/20 USR MRI,Analysis Software,,,,,,,
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,Diffusion-weighted images were preprocessed using ExplorDTI (68),0.9,Accept,Experimental Usage,ExplorDTI,Analysis Software,,,,,,,
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,"template, B0, for both controls and Plp-Nf1 fl/+ animals was created using Advanced Normalization Tools (ANTs) (70)",0.9,Accept,Experimental Usage,Advanced Normalization Tools (ANTs),Analysis Software,,,,,,,
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,The control template was registered to the Allen Brain Atlas (71),0.85,Accept,Experimental Usage,Allen Brain Atlas,Database,,,,,,,
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,"...the NF Research Tools Database, is an open-access database that enables the exploration and discovery of information about NF type 1-relevant animal models, cell lines, antibodies...",0.95,Accept,Development,NF Research Tools Database,Database,,,https://tools.nf.synapse.org/,,,,
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...This schema was processed with the 'schematic' Python library to generate a MySQL database as well as data intake spreadsheets...,0.85,Accept,Experimental Usage,schematic Python library,Package/Library,,Python,,,,,
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...We then built the application using the React JavaScript library and the Synapse React Client...,0.8,Accept,Experimental Usage,React JavaScript library,Package/Library,,JavaScript,,,,,
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...We then built the application using the React JavaScript library and the Synapse React Client...,0.85,Accept,Experimental Usage,Synapse React Client,Package/Library,,,,,,,
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...This schema was processed with the 'schematic' Python library to generate a MySQL database as well as data intake spreadsheets...,0.8,Accept,Experimental Usage,MySQL database,Database,,,,,,,
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...We constructed a JSON-LD schema from the data model to make it machine-readable (version 2.0.0 at the time of writing...,0.85,Accept,Development,JSON-LD schema,Other,2.0.0,,https://github.com/nf-osi/nf-research-tools-schema,,,,
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...but all database tables and a variety of 'joined' tables are available for anyone to access on the Synapse collaborative science platform...,0.9,Accept,Experimental Usage,Synapse collaborative science platform,Web Application,,,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Raw FASTQ files were analyzed using the Salmon v1.4 alignment tool,0.9,Accept,Experimental Usage,Salmon v1.4,Analysis Software,v1.4,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Reads were aligned to hg38 using BWA-MEM2 v2.1,0.9,Accept,Experimental Usage,BWA-MEM2 v2.1,Analysis Software,v2.1,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Base quality score recalibration (BQSR) was performed with GATK v4.1.9.0 BaseRecalibrator,0.9,Accept,Experimental Usage,GATK v4.1.9.0,Analysis Software,v4.1.9.0,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,To assess the cell type of origin in the organoid models we used the tumor deconvolution algorithm MCP-Counter,0.9,Accept,Experimental Usage,MCP-Counter,Analysis Software,,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,raw fastq files obtained by RRBS were analyzed using BSBolt,0.9,Accept,Experimental Usage,BSBolt,Analysis Software,,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Differentially methylated regions were detected using metilene v0.2-8,0.9,Accept,Experimental Usage,metilene v0.2-8,Analysis Software,v0.2-8,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Structural variants and copy number variation were called using DELLY v1.1.3,0.9,Accept,Experimental Usage,DELLY v1.1.3,Analysis Software,v1.1.3,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Germline variants are annotated using InterVar (update-2021-08-version),0.9,Accept,Experimental Usage,InterVar,Analysis Software,update-2021-08-version,Unknown,,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Our RNAseq analyses leverage the rare disease workflows at https://github.com/Sage-Bionetworks/rare-disease-workflows/tree/main/rna-seq-workflow,0.85,Accept,Experimental Usage,rare disease workflows,Workflow,,Unknown,https://github.com/Sage-Bionetworks/rare-disease-workflows/tree/main/rna-seq-workflow,,,,
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,All computational tools used to generate Figures 4 and 5 for this manuscript are available on https://github.com/PNNL-CompBio/cNFOrganoidAnalysis,0.9,Accept,Development,cNFOrganoidAnalysis,Analysis Software,,Unknown,https://github.com/PNNL-CompBio/cNFOrganoidAnalysis,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,All tumor or tissue samples were mechanically lysed using a TissueLyser II (QIAGEN) with stainless steel beads at 30 Hz for 90 seconds,0.8,Accept,Experimental Usage,TissueLyser II (QIAGEN),Other,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,RNA quality was assessed by chip-based electrophoresis on a BioAnalyzer 2100 using the RNA 6000 Nano Kit,0.8,Accept,Experimental Usage,BioAnalyzer 2100,Other,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Preprocessing and normalization were performed in R using the minfi Bioconductor package,0.85,Accept,Experimental Usage,minfi,Package/Library,,R,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"To identify DNA methylation groups, ConsensusClusterPlus (Bioconductor v3.10) was used",0.85,Accept,Experimental Usage,ConsensusClusterPlus,Package/Library,v3.10,R,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Raw FASTQ files were aligned to the reference genome with Bowtie2,0.85,Accept,Experimental Usage,Bowtie2,Analysis Software,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Whole exome data were analyzed following Genome Analysis Toolkit (GATK) best practices,0.85,Accept,Experimental Usage,Genome Analysis Toolkit (GATK),Analysis Software,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,"Somatic variants (point mutations, small indels) were identified from matched tumor-normal samples and using a panel of normal (PoN) samples with Mutect2",0.85,Accept,Experimental Usage,Mutect2,Analysis Software,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Variants were annotated using Snpeff,0.85,Accept,Experimental Usage,Snpeff,Analysis Software,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Reads were mapped to the appropriate reference genome (hg19) using HISAT2 with default parameters,0.85,Accept,Experimental Usage,HISAT2,Analysis Software,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Transcript abundance estimation in transcripts per million (TPM) and differential expression analysis were performed using DESeq2,0.85,Accept,Experimental Usage,DESeq2,Package/Library,,R,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,the resulting FASTQ files were processed using the CellRanger analysis suite for alignment to the hg38 reference genome,0.85,Accept,Experimental Usage,CellRanger,Analysis Software,,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,All downstream analyses were performed in Seurat using the default pipeline,0.85,Accept,Experimental Usage,Seurat,Package/Library,,R,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Harmony was used to perform data integration across datasets within a given experiment,0.85,Accept,Experimental Usage,Harmony,Package/Library,,R,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,cluster number optimization was performed by comparing multiple cluster resolutions using Clustree,0.85,Accept,Experimental Usage,Clustree,Package/Library,,R,https://github.com/lazappi/clustree,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,InferCNV was used in an attempt to delineate tumor from non-tumor cells based on single-nuclear CNVs,0.85,Accept,Experimental Usage,InferCNV,Package/Library,,R,,,,,
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Statistical analysis was performed using GraphPad Prism 8,0.8,Accept,Experimental Usage,GraphPad Prism 8,Analysis Software,8,,,,,,
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,quantified by densitometry and normalized to glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) or vinculin loading controls using ImageJ,0.8,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"PET images were spatially processed using the Statistical Parametric Mapping toolbox (SPM8, Wellcome Trust Centre for Neuroimaging, 2008)",0.95,Accept,Experimental Usage,Statistical Parametric Mapping toolbox (SPM8),Analysis Software,SPM8,,,,,,
PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"implemented within Matlab 7.12.0 (MathWorks, Natick, MA, USA)",0.9,Accept,Experimental Usage,Matlab 7.12.0,Analysis Software,7.12.0,MATLAB,,,,,
PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,we used the Gaussian Process regression (GPR) implementation available within kernlab R library,0.9,Accept,Experimental Usage,kernlab R library,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.85,Accept,Experimental Usage,tidyverse,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.9,Accept,Experimental Usage,PLIER,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.85,Accept,Experimental Usage,synapser,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.85,Accept,Experimental Usage,tximport,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.85,Accept,Experimental Usage,immunedeconv,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.85,Accept,Experimental Usage,viper,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,raw fastq files were downloaded from Synapse and transcripts were quantified using the Salmon pseudo-alignment tool [36] with Gencode V29 transcriptome.,0.9,Accept,Experimental Usage,Salmon,Analysis Software,,,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Variant call format (VCF) files were processed using ""vcf2maf"" (https://github.com/mskcc/vcf2maf)",0.85,Accept,Experimental Usage,vcf2maf,Command-line Tool,,,https://github.com/mskcc/vcf2maf,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Salmon output files (quant.sf) files were imported into an R session and converted to HUGO gene names using the ""tximport"" [35] and ""org.Hs.eg.db"" [40] packages.",0.85,Accept,Experimental Usage,org.Hs.eg.db,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"We analyzed transcriptomic data from NF in the context of latent variables from MultiPLIER, a machine learning resource designed to aid in rare disease analyses [27].",0.9,Accept,Experimental Usage,MultiPLIER,Analysis Software,,,https://github.com/greenelab/multi-plier,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"The main algorithm was implemented using the ""caret"" and ""randomforest"" packages in R [44, 45].",0.85,Accept,Experimental Usage,caret,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"The main algorithm was implemented using the ""caret"" and ""randomforest"" packages in R [44, 45].",0.85,Accept,Experimental Usage,randomforest,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [29, 30, 31].",0.9,Accept,Experimental Usage,CIBERSORT,Analysis Software,,,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [29, 30, 31].",0.9,Accept,Experimental Usage,MCP-counter,Analysis Software,,,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,We applied the metaVIPER algorithm [32] to infer protein regulatory activity based on the tissue gene expression profiles.,0.9,Accept,Experimental Usage,metaVIPER,Analysis Software,,,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"A heatmap and subclusters of latent variables that had similar VIPER protein predictions were generated using the ""pheatmap"" R package [47].",0.85,Accept,Experimental Usage,pheatmap,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Then, we used gene set enrichment analysis (via the ""clusterProfiler"" R package [48]) to assess whether drug targets were enriched",0.85,Accept,Experimental Usage,clusterProfiler,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Results were plotted using ""ggplot"" and ""enrichplot"" packages [33, 50].",0.85,Accept,Experimental Usage,ggplot,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Results were plotted using ""ggplot"" and ""enrichplot"" packages [33, 50].",0.85,Accept,Experimental Usage,enrichplot,Package/Library,,R,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,All data analyzed in this article are stored on the NF Data Portal [24] (http://nfdataportal.org),0.9,Accept,Experimental Usage,NF Data Portal,Database,,,,,,,
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,Drug-wise target lists were obtained from the Drug Target Explorer database [49].,0.85,Accept,Experimental Usage,Drug Target Explorer database,Database,,,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"GSE108524, compiled using the GPL17586 platform of the Affymetrix GeneChip Human Genome HTA_2_0 Array, contains 31 human samples",0.85,Accept,Experimental Usage,GSE108524,Database,,,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"GSE141801, compiled using the GPL13667 Affymetrix Human Genome U219 Array, contains samples from 9 recurrent irradiated VSs",0.85,Accept,Experimental Usage,GSE141801,Database,,,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,Data standardization was performed using the R 4.0.3,0.9,Accept,Experimental Usage,R 4.0.3,Analysis Software,4.0.3,R,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"WGCNA, an R package, was used to conduct WGCNA",0.95,Accept,Experimental Usage,WGCNA,Package/Library,,R,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,The pickSoftThreshold tool was employed for the soft-thresholding power measurement,0.8,Accept,Experimental Usage,pickSoftThreshold,Command-line Tool,,R,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,we performed FEA of the strongly associated modules using the clusterProfiler package of the R software,0.9,Accept,Experimental Usage,clusterProfiler,Package/Library,,R,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,The key module genes were uploaded to STRING (https://string-db.org/) to generate the PPI axis,0.95,Accept,Experimental Usage,STRING,Database,,,https://string-db.org/,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,the results were visualized using the Cytoscape (v3.8.2) software,0.95,Accept,Experimental Usage,Cytoscape,Analysis Software,v3.8.2,,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"we retrieved miRNA information from the miRTarBase database, including, over 50,000 experimentally validated miRNA-target associations",0.9,Accept,Experimental Usage,miRTarBase,Database,,,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,DEGs were identified between NF2-Vs and normal nerves using the R package limma,0.9,Accept,Experimental Usage,limma,Package/Library,,R,,,,,
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,we uploaded our list of up- and down-regulated genes into the connectivity map (CMap) database,0.9,Accept,Experimental Usage,connectivity map (CMap),Database,,,,,,,
PMID:28848060,10.1136/jmedgenet-2017-104519,Genetic Severity Score predicts clinical phenotype in NF2.,,Statistical analyses were undertaken using SPSS V.23,0.8,Accept,Experimental Usage,SPSS V.23,Analysis Software,V.23,,,,,,
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"Variants were validated by Sanger sequencing and analyzed using CLC-workbench (Qiagen, Hilden, Germany)",0.9,Accept,Experimental Usage,CLC-workbench,Analysis Software,,,,,,,
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Analyses of in silico protein modifications by the exon skipping were performed using the web-server version of PredictProtein,0.95,Accept,Experimental Usage,PredictProtein,Web Application,,,https://www.PredictProtein.org,,,,
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Statistical analysis was carried out using GraphPad Prism software v7,0.9,Accept,Experimental Usage,GraphPad Prism software v7,Analysis Software,v7,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Ganglia were imaged on a SP5 Leica confocal microscope and the number of EdU-positive nuclei was quantified,0.8,Accept,Experimental Usage,SP5 Leica confocal microscope,Analysis Software,,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,measure the ganglia volume using confocal stacks and the Amira software as previously described,0.85,Accept,Experimental Usage,Amira software,Analysis Software,,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,counted by 20× microscopic fields using the cell counting feature of MetaMorph software package,0.85,Accept,Experimental Usage,MetaMorph software package,Analysis Software,,,,,,,
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,"DNA content was analyzed using a FACScalibur instrument (BD Biosciences, San Jose, CA)",0.85,Accept,Experimental Usage,FACScalibur instrument,Analysis Software,,,,,,,
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,"A minimum of 10^4 cells/sample were analyzed to determine the percentage of apoptotic cells and cells in G1, S, and G2/M phase (MODFIT; Variety Software, Topsham, ME)",0.85,Accept,Experimental Usage,MODFIT,Analysis Software,,,,,,,
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,Images were immediately acquired with an Axiovert 200M fluorescence microscope (Carl Zeiss),0.8,Accept,Experimental Usage,Axiovert 200M fluorescence microscope,Analysis Software,,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,CRISPRscan (https://www.crisprscan.org/) was used to identify gRNA target sequences in exon 1 of the tgfb3 gene,0.9,Accept,Experimental Usage,CRISPRscan,Web Application,,,https://www.crisprscan.org/,,,,
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"Stimuli were generated with MATLAB (R2008a, MathWorks, Natick, MA, USA) and presented with the stimulation software STIM 2",0.85,Accept,Experimental Usage,"MATLAB (R2008a, MathWorks, Natick, MA, USA)",Analysis Software,R2008a,MATLAB,,,,,
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"presented with the stimulation software STIM 2 (Neuroscan, Charlotte, NC, USA) with a display resolution of 1,280 × 1,024 × 32",0.9,Accept,Experimental Usage,"STIM 2 (Neuroscan, Charlotte, NC, USA)",Analysis Software,2,,,,,,
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,Data analysis was performed with Scan 4.5 (Neuroscan). We started the analysis by correcting the eye blinking artifacts,0.9,Accept,Experimental Usage,Scan 4.5 (Neuroscan),Analysis Software,4.5,,,,,,
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"All statistical analyses were performed with IBM SPSS Statistics, version 19, software (IBM Corporation, Armonk, NY, USA)",0.85,Accept,Experimental Usage,"IBM SPSS Statistics, version 19",Analysis Software,19,,,,,,
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,"The phenotype of C6 cells was analyzed using flow cytometry with the MACSQuant flow cytometer (Miltenyi, San Diego, CA, USA)",0.85,Accept,Experimental Usage,MACSQuant flow cytometer,Analysis Software,,,,,,,
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,The results were analyzed using the MACSQuantify software (https://www.miltenyibiotec.com),0.85,Accept,Experimental Usage,MACSQuantify software,Analysis Software,,,,,,,
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,"Electronic image files were processed using MATLAB software (MathWorks Inc., R2019a, USA)",0.8,Accept,Experimental Usage,MATLAB software,Analysis Software,R2019a,MATLAB,,,,,
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,Results and values are represented in all figures with mean ± standard error using GraphPad software,0.75,Accept,Experimental Usage,GraphPad software,Analysis Software,,,,,,,
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,The conserved gene regulation networks and the correlation between drug responses and the gene network were determined using the WGCNA package v1.69,0.85,Accept,Experimental Usage,WGCNA package v1.69,Package/Library,v1.69,R,,,,,
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,The IDACombo package was used to predict the combination efficacy using the drug screen data with the default settings,0.8,Accept,Experimental Usage,IDACombo package,Package/Library,,R,,,,,
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,Drug synergy was evaluated using the Bliss independence model via the SynergyFinder online platform (https://synergyfinder.org/),0.85,Accept,Experimental Usage,SynergyFinder,Web Application,,,https://synergyfinder.org/,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,"Mouse and human sequences were mapped to the mm10 and hg38 genomes, respectively, with STAR aligner.",0.85,Accept,Experimental Usage,STAR aligner,Analysis Software,,,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,Gene-level quantification was determined using RSEM and based on GENCODE M22 gene annotation.,0.85,Accept,Experimental Usage,RSEM,Analysis Software,,,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,Differential expression was modeled using the voom method in the limma R package.,0.85,Accept,Experimental Usage,limma R package,Package/Library,,R,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,ComBat was used to correct for batch and species differences.,0.8,Accept,Experimental Usage,ComBat,Analysis Software,,,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,we used uniform manifold approximation and projection (UMAP) based on Pearson's distance,0.8,Accept,Experimental Usage,UMAP,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,The publically accessible variant databases included were Leiden Open Variation Database (LOVD) ( www.lovd.nl ),0.85,Accept,Experimental Usage,Leiden Open Variation Database (LOVD),Database,,,www.lovd.nl,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,ClinVar NCBI ( www.ncbi.nlm.nih.gov/clinvar ),0.85,Accept,Experimental Usage,ClinVar NCBI,Database,,,www.ncbi.nlm.nih.gov/clinvar,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,the Human Gene Mutation Database (HGMD) ( www.hgmd.cf.ac.uk/ac/all.php ),0.85,Accept,Experimental Usage,Human Gene Mutation Database (HGMD),Database,,,www.hgmd.cf.ac.uk/ac/all.php,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Clinical Interpretation of Variants in Cancer (CIViC) ( https://civicdb.org/home ),0.85,Accept,Experimental Usage,Clinical Interpretation of Variants in Cancer (CIViC),Database,,,https://civicdb.org/home,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Mastermind Genomic Search Engine ( https://www.genomenon.com/mastermind ),0.85,Accept,Experimental Usage,Mastermind Genomic Search Engine,Web Application,,,https://www.genomenon.com/mastermind,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,An extra literature mining step was conducted using LitVar to capture any missing variants,0.85,Accept,Experimental Usage,LitVar,Web Application,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variants were imported into the clinical prediction software Alamut Visual version 2.15 (SOPHiA GENETICS),0.9,Accept,Experimental Usage,Alamut Visual version 2.15,Analysis Software,2.15,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Results from the following tools were exported from Alamut and factored into classification analysis: Align‐GVGD,0.85,Accept,Experimental Usage,Align-GVGD,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"Results from the following tools were exported from Alamut and factored into classification analysis: Align‐GVGD (Mathe et al., 2006 ), SIFT",0.85,Accept,Experimental Usage,SIFT,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"SIFT (Kumar et al., 2009 ), PolyPhen‐2",0.85,Accept,Experimental Usage,PolyPhen-2,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"PolyPhen‐2 (Adzhubei et al., 2010 ), MutationTaster2",0.85,Accept,Experimental Usage,MutationTaster2,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"MutationTaster2 (Schwarz et al., 2014 ), SpliceSiteFinder‐like tool",0.85,Accept,Experimental Usage,SpliceSiteFinder-like tool,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"SpliceSiteFinder‐like tool (Zhang, 1998 ), MaxEntScan",0.85,Accept,Experimental Usage,MaxEntScan,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variant frequencies and ExAC constraint metrics were obtained from gnomAD v2.1.1 ( gnomad.broadinstitute.org ),0.9,Accept,Experimental Usage,gnomAD v2.1.1,Database,v2.1.1,,gnomad.broadinstitute.org,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,UCSC LiftOver tool was used for any genomic co‐ordinate conversions between genome builds GRCh37/hg19 and GRCh38/hg38,0.85,Accept,Experimental Usage,UCSC LiftOver tool,Web Application,,,genome.ucsc.edu/cgi-bin/hgLiftOver,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Maximum credible population allele frequency was determined using the alleleFrequencyApp ( cardiodb.org/allelefrequencyapp ),0.85,Accept,Experimental Usage,alleleFrequencyApp,Web Application,,,cardiodb.org/allelefrequencyapp,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"The DECIPHER database (Firth et al., 2009 ) was used to investigate possible mutational hotspots or identify regional constraint",0.85,Accept,Experimental Usage,DECIPHER database,Database,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,meta‐predictor REVEL (Rare Exome Variant Ensemble Learner) was used as the deciding score for evidence use (PP3 and BP4),0.85,Accept,Experimental Usage,REVEL (Rare Exome Variant Ensemble Learner),Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"ClinPred (Alirezaie et al., 2018 ) meta‐predictor scores were also produced for variants",0.85,Accept,Experimental Usage,ClinPred,Analysis Software,,,,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"COSMIC ( www.cancer.sanger.ac.uk ) (Tate et al., 2019 ) was used in the investigation of variants that were observed in somatic samples",0.85,Accept,Experimental Usage,COSMIC,Database,,,www.cancer.sanger.ac.uk,,,,
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,CanVar‐UK cancer predisposition gene variant database ( www.canvaruk.org ) was used in the search for further variant information,0.85,Accept,Experimental Usage,CanVar-UK cancer predisposition gene variant database,Database,,,www.canvaruk.org,,,,
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"Quantitation was performed using the Beta Imager 2000Z Digital Beta Imaging System (Biospace, France)",0.9,Accept,Experimental Usage,Beta Imager 2000Z Digital Beta Imaging System,Analysis Software,,,,,,,
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"Beta Imager 2000Z Digital Beta Imaging System (Biospace, France) and the Beta-Vision Plus program",0.85,Accept,Experimental Usage,Beta-Vision Plus program,Analysis Software,,,,,,,
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,data acquired as 1h dynamic scans using the Siemens Focus F220 and Inveon scanners,0.9,Accept,Experimental Usage,Siemens Focus F220,Analysis Software,,,,,,,
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,Acquisition Sinogram Image PROcessing using IDL's Virtual Machine™ (ASIPro VM™),0.85,Accept,Experimental Usage,ASIPro VM,Analysis Software,,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,Sequencing of libraries was achieved to an average unique read depth of greater than 500X using Sequencing by Synthesis (SBS) 2 × 100 base pairs (bp) paired-end cluster generation on the Illumina HiSeq 2500 plataform,0.85,Accept,Experimental Usage,Illumina HiSeq 2500 platform,Analysis Software,,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,FASTQ files were generated from Binary Cluster Files (.bcl) using the Illumina bcl2fastq v1.8.4 software with parameters set as per vendor's specifications,0.9,Accept,Experimental Usage,Illumina bcl2fastq v1.8.4 software,Analysis Software,v1.8.4,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,FASTQ files were aligned to the human genome reference hg19 (GRCh37) using the Burrows-Wheeler Aligner v0.7.10 algorithm with default settings,0.9,Accept,Experimental Usage,Burrows-Wheeler Aligner v0.7.10,Analysis Software,v0.7.10,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,BAM files (.bam) were generated using Picard Tools v1.119,0.9,Accept,Experimental Usage,Picard Tools v1.119,Analysis Software,v1.119,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,variant calling was performed using in-house variant caller algorithm (MDLVC v5.0),0.9,Accept,Experimental Usage,MDLVC v5.0,Analysis Software,v5.0,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,cross referenced with HaplotypeCaller (Genome Analysis Tool Kit 3.3) under discovery mode,0.9,Accept,Experimental Usage,HaplotypeCaller (Genome Analysis Tool Kit 3.3),Analysis Software,3.3,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"All variant calls were inspected using Integrated Genomics Viewer v2.3.4 (IGV; Broad Institute, MIT Harvard, Cambridge, MA)",0.9,Accept,Experimental Usage,Integrated Genomics Viewer v2.3.4 (IGV),Analysis Software,v2.3.4,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"Statistical analyses were performed using GraphPad Prism version 8.0 (San Diego, CA)",0.85,Accept,Experimental Usage,GraphPad Prism version 8.0,Analysis Software,8.0,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"Statistical analyses were performed using GraphPad Prism version 8.0 (San Diego, CA), SAS version 9.4 (Cary, NC)",0.85,Accept,Experimental Usage,SAS version 9.4,Analysis Software,9.4,,,,,,
PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"Statistical analyses were performed using GraphPad Prism version 8.0 (San Diego, CA), SAS version 9.4 (Cary, NC), and R version 3.3.2",0.85,Accept,Experimental Usage,R version 3.3.2,Analysis Software,3.3.2,R,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,pass registration procedures as defined by FMRIPrep,0.85,Accept,Experimental Usage,FMRIPrep,Pipeline,,,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,we ran group-based ICA using melodic v3.15,0.9,Accept,Experimental Usage,melodic v3.15,Analysis Software,v3.15,,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,We then compared each component to canonical RSNs using spatial correlation (FSLCC),0.85,Accept,Experimental Usage,FSLCC,Analysis Software,,,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,group differences were estimated using the randomise tool with threshold-free cluster enhancement,0.85,Accept,Experimental Usage,randomise,Analysis Software,,,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,using the Harvard-Oxford subcortical atlas in FSLeyes,0.85,Accept,Experimental Usage,FSLeyes,Analysis Software,,,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,We used fMRI Expert Analysis Tool (FEAT) to model extracted time series,0.9,Accept,Experimental Usage,fMRI Expert Analysis Tool (FEAT),Analysis Software,,,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,using the prcomp function in R,0.8,Accept,Experimental Usage,prcomp,Package/Library,,R,,,,,
PMID:35087195,10.1038/s41380-021-01422-5,Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.,,using a predictive mean matching for mixed types and the Multiple Imputation by Chained Equations (MICE) package in R,0.9,Accept,Experimental Usage,Multiple Imputation by Chained Equations (MICE),Package/Library,,R,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Sequence reads were mapped using the Burrow-Wheeler aligner,0.8,Accept,Experimental Usage,Burrow-Wheeler aligner,Analysis Software,,,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,final alignments generated after multiple quality controls steps applied using the Genome Analysis Toolkit,0.8,Accept,Experimental Usage,Genome Analysis Toolkit,Analysis Software,,,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"quality controls steps applied using the Genome Analysis Toolkit, Samtools and Picard",0.8,Accept,Experimental Usage,Samtools,Analysis Software,,,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"quality controls steps applied using the Genome Analysis Toolkit, Samtools and Picard",0.8,Accept,Experimental Usage,Picard,Analysis Software,,,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Sequence reads were mapped to the human reference genome (b37) using TopHat,0.8,Accept,Experimental Usage,TopHat,Analysis Software,,,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Gene expression levels were calculated using BEDtools software,0.8,Accept,Experimental Usage,BEDtools software,Analysis Software,,,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Differential expression analysis was performed using EdgeR software implemented in the R statistical framework,0.85,Accept,Experimental Usage,EdgeR software,Package/Library,,R,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"Gene Ontology and Pathway enrichment were performed using Partek Genomics Suite software (Partek, St. Louis, MO)",0.85,Accept,Experimental Usage,Partek Genomics Suite software,Analysis Software,,,,,,,
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"Flow cytometry was performed using an INFLUX cell sorter (BD Biosciences, CA, USA)",0.85,Accept,Experimental Usage,INFLUX cell sorter,Other,,,,,,,
PMID:40304934,10.1186/s41687-025-00877-2,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,,"Qualitative concept elicitation data from transcripts were coded, analyzed using NVivo software, and thematic analysis was conducted",0.85,Accept,Experimental Usage,NVivo software,Analysis Software,,,,,,,
PMID:22961690,10.1002/pbc.24281,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,,"Post-processing was performed using CADvue software (iCAD, Inc. Nashua, NH) employing the Tofts pharmacokinetic model to quantify vascular permeability as K trans...",0.8,Accept,Experimental Usage,CADvue software,Analysis Software,,,,,,,
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,gRNAs for zebrafish nf2a and nf2b (Table S1) were designed using CHOP-CHOP,0.9,Accept,Experimental Usage,CHOP-CHOP,Web Application,,,,,,,
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"At least 10,000 high-quality reads were analyzed for each sample using CRISPResso2 (Clement et al., 2019)",0.9,Accept,Experimental Usage,CRISPResso2,Analysis Software,,,,,,,
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Quantifications for meningeal proliferation (Fig. 4H), Schwann cell hyperplasia (Fig. 5J,K), and nf2b HCR signal in cranial neural crest cells and pLLn SCs (Fig. S1L, M) were performed using ImageJ cell counter feature",0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,cell viability was the endpoint as assessed by Zeiss Axio Observer,0.85,Accept,Experimental Usage,Zeiss Axio Observer,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"images were further analyzed using Cellpose (Stringer et al., 2021) and ImageJ",0.9,Accept,Experimental Usage,Cellpose,Analysis Software,,Python,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"images were further analyzed using Cellpose (Stringer et al., 2021) and ImageJ (NIH)",0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,WES sequencing FASTQ files were trimmed using Trimmomatic v 0.39,0.9,Accept,Experimental Usage,Trimmomatic v 0.39,Analysis Software,v 0.39,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,aligned against reference sequence hg38 via BWA-MEM,0.85,Accept,Experimental Usage,BWA-MEM,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,GATK V4.2 base quality score recalibration (BQSR) was used to process BAM files,0.9,Accept,Experimental Usage,GATK V4.2,Analysis Software,V4.2,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"For PDX sequence data, Xenosplit was used to filter mouse-derived reads",0.9,Accept,Experimental Usage,Xenosplit,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Somatic single nucleotide variants (SNVs) and small insertions or deletions (indels) were detected using VarScan2,0.85,Accept,Experimental Usage,VarScan2,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"detected using VarScan2, Strelka2, MuTect2, and Pindel",0.85,Accept,Experimental Usage,Strelka2,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"detected using VarScan2, Strelka2, MuTect2, and Pindel",0.85,Accept,Experimental Usage,MuTect2,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"detected using VarScan2, Strelka2, MuTect2, and Pindel",0.85,Accept,Experimental Usage,Pindel,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Variant filtering and annotation were done using Variant Effect Predictor (VEP),0.9,Accept,Experimental Usage,Variant Effect Predictor (VEP),Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Somatic variant plots were created with maftools v2.10.0,0.9,Accept,Experimental Usage,maftools v2.10.0,Package/Library,v2.10.0,R,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,CNVkit V2.0 was used to infer and visualize copy number,0.9,Accept,Experimental Usage,CNVkit V2.0,Analysis Software,V2.0,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,which includes quantitation with the Salmon algorithm,0.85,Accept,Experimental Usage,Salmon algorithm,Analysis Software,,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Gene counts and transcript counts were normalized by using the DESeq2 package,0.9,Accept,Experimental Usage,DESeq2 package,Package/Library,,R,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Immunohistochemical staining for FAP was performed on a Ventana BenchMark ULTRA platform using the iVIEW DAB detection system,0.8,Accept,Experimental Usage,Ventana BenchMark ULTRA,Analysis Software,,,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"performed on a Ventana BenchMark ULTRA platform using the iVIEW DAB detection system (Roche, Mannheim, Germany)",0.8,Accept,Experimental Usage,iVIEW DAB detection system,Analysis Software,,,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"RNA fusion profiling was performed using the TruSight RNA Pan-Cancer Panel (Illumina, San Diego, CA, US)",0.85,Accept,Experimental Usage,TruSight RNA Pan-Cancer Panel,Analysis Software,,,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Furthermore, Illumina EPIC DNA methylation profiling was performed with application of the Heidelberg sarcoma classifier",0.85,Accept,Experimental Usage,Illumina EPIC DNA methylation profiling,Analysis Software,,,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Illumina EPIC DNA methylation profiling was performed with application of the Heidelberg sarcoma classifier,0.85,Accept,Experimental Usage,Heidelberg sarcoma classifier,Analysis Software,,,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Expression matrices and corresponding phenotype metadata were processed using the GEOquery and Biobase R packages,0.9,Accept,Experimental Usage,GEOquery,Package/Library,,R,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Expression matrices and corresponding phenotype metadata were processed using the GEOquery and Biobase R packages,0.9,Accept,Experimental Usage,Biobase,Package/Library,,R,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"We processed the data using Seurat (Version: 5.3.0, https://satijalab.org/seurat/) in R (Version: 4.4.0)",0.95,Accept,Experimental Usage,Seurat,Package/Library,5.3.0,R,https://satijalab.org/seurat/,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"To explore differentiation trajectories among tumor clusters, we applied Slingshot (Version: 2.12.0)",0.9,Accept,Experimental Usage,Slingshot,Package/Library,2.12.0,R,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Raw UMI count matrices were loaded via Read10X, filtered to remove cells",0.85,Accept,Experimental Usage,Read10X,Package/Library,,R,,,,,
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Scans were obtained on a dedicated PET/CT scanner (Biograph mCT 40; Siemens Healthineers, Erlangen, Germany)",0.8,Accept,Experimental Usage,Biograph mCT 40,Analysis Software,,,,,,,
PMID:32642740,10.1093/noajnl/vdaa003,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,,All analyses were done with R statistical software version 3.5.1,0.85,Accept,Experimental Usage,R statistical software version 3.5.1,Analysis Software,3.5.1,R,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Single nuclei generated from PN were analyzed using 10 × Genomics Chromium 3′ gene expression,0.85,Accept,Experimental Usage,10x Genomics Chromium 3' gene expression,Analysis Software,,,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Raw sequencing reads were processed using CellRanger (10 × Genomics),0.9,Accept,Experimental Usage,CellRanger,Analysis Software,,,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Raw sequencing reads were processed using CellRanger (10 × Genomics) and Seurat 3.1.0,0.95,Accept,Experimental Usage,Seurat 3.1.0,Package/Library,3.1.0,R,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Cells from individual subpopulations were reanalyzed separately using Harmony alignment,0.85,Accept,Experimental Usage,Harmony,Package/Library,,R,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Presto was used for determining differential expression and marker gene identification,0.85,Accept,Experimental Usage,Presto,Package/Library,,,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,CellChatDB (version 1.5.0) was used to infer ligand–receptor interactions between and within individual subpopulations,0.9,Accept,Experimental Usage,CellChatDB,Database,1.5.0,R,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"Sequencing data were processed with Space Ranger (10 × genomics, v1.2.1)",0.9,Accept,Experimental Usage,Space Ranger,Analysis Software,v1.2.1,,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,followed by analysis in R using the Seurat (v4.0.1) tool suite,0.95,Accept,Experimental Usage,Seurat v4.0.1,Package/Library,v4.0.1,R,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"Clustree packages were utilized to cluster, process, filter and integrate newly generated ST data",0.85,Accept,Experimental Usage,Clustree,Package/Library,,R,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"ontological analysis using DAVID (Database for Annotation, Visualization, and Integrated Discovery: https://david.ncifcrf.gov ; version 6.8)",0.9,Accept,Experimental Usage,DAVID,Web Application,6.8,,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,ST cluster overlays on H&E image were produced in the Loupe Browser (10 × Genomics),0.85,Accept,Experimental Usage,Loupe Browser,Analysis Software,,,,,,,
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"mounted on spatial transcriptomic capture slides (Visium, 10 × Genomics)",0.85,Accept,Experimental Usage,Visium spatial transcriptomics,Analysis Software,,,,,,,
PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,Selumetinib plasma concentration–time data were analyzed using noncompartmental methods implemented in R (version 3.6) R Studio PKNCA package (version 0.9.3),0.9,Accept,Experimental Usage,R Studio PKNCA package (version 0.9.3),Package/Library,0.9.3,R,,,,,
PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,A capillary western blot assay was performed on a Wes system (ProteinSimple 004–600) according to the manufacturer's instructions,0.85,Accept,Experimental Usage,Wes system (ProteinSimple 004–600),Analysis Software,,,,,,,
PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,"Analysis of transcript biomarkers of MEK inhibition was performed using the Fluidigm platform by Reverse Transcription, preamplification with pooled primers and Real Time-PCR",0.8,Accept,Experimental Usage,Fluidigm platform,Analysis Software,,,,,,,
PMID:37681415,10.1172/jci.insight.168445,Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation.,,Statistical analyses were performed using GraphPad Prism 8,0.8,Accept,Experimental Usage,GraphPad Prism 8,Analysis Software,8,,,,,,
PMID:37681415,10.1172/jci.insight.168445,Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation.,,Data were processed and scaled using MOSFLM and SCALA in the CCP4 package,0.85,Accept,Experimental Usage,MOSFLM,Analysis Software,,,,,,,
PMID:37681415,10.1172/jci.insight.168445,Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation.,,Data were processed and scaled using MOSFLM and SCALA in the CCP4 package,0.85,Accept,Experimental Usage,SCALA,Analysis Software,,,,,,,
PMID:37681415,10.1172/jci.insight.168445,Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation.,,Data were processed and scaled using MOSFLM and SCALA in the CCP4 package,0.85,Accept,Experimental Usage,CCP4 package,Package/Library,,,,,,,
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"Statistical analysis was performed using GraphPad PRISM (v6.0a, La Jolla, CA)",0.8,Accept,Experimental Usage,GraphPad PRISM,Analysis Software,v6.0a,,,,,,
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,Structural properties were extracted from force-displacement curves by custom Matlab algorithms,0.75,Accept,Experimental Usage,Matlab algorithms,Analysis Software,,MATLAB,,,,,
PMID:34377779,10.1212/NXG.0000000000000616,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,,"individual-level analyses (Reliable Change Index, RCI) were used...using a Reliable Change Index (RCI) methodology",0.8,Accept,Experimental Usage,Reliable Change Index,Analysis Software,,,,,,,
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,"mRNA expression of murine Met, miR34a and Ppib were measured using TaqMan technology and an ABI Prism 7900 Sequence Detection System",0.85,Accept,Experimental Usage,ABI Prism 7900 Sequence Detection System,Analysis Software,,,,,,,
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,The percentage of CD24-staining cells was determined using a FACscan Flow Cytometer (Becton Dickinson) and quantitated using FlowJo analysis software,0.85,Accept,Experimental Usage,FlowJo analysis software,Analysis Software,,,,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,These validation samples were enriched for NF1 RNA using NuGEN SPET for RNA,0.85,Accept,Experimental Usage,NuGEN SPET for RNA,Analysis Software,,,,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,enriched for NF1/SPRED1 using Agilent SureSelect RNA Target Enrichment,0.85,Accept,Experimental Usage,Agilent SureSelect RNA Target Enrichment,Analysis Software,,,,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Paired-end sequencing (2x150bp) was performed on a NextSeq500 instrument (Illumina),0.9,Accept,Experimental Usage,NextSeq500 instrument (Illumina),Analysis Software,,,,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,RNAseq reads were mapped with the STAR mapper (Version 2.4.1d),0.9,Accept,Experimental Usage,STAR mapper (Version 2.4.1d),Analysis Software,2.4.1d,,,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Duplicate read pair detection was carried out with Picard tools,0.85,Accept,Experimental Usage,Picard tools,Analysis Software,,,https://github.com/broadinstitute/picard,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,an in-house developed tool (QURNAs) was used to calculate the enrichment score (ERS) for each splicing event,0.95,Accept,Development,QURNAs,Pipeline,,,https://dataverse.nl/dataset.xhtml?persistentId=hdl:10411/LY8ZQ4,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Alamut v2.15 (Interactive Biosoftware) was used to identify true splice-donor and acceptor sites,0.9,Accept,Experimental Usage,Alamut v2.15 (Interactive Biosoftware),Analysis Software,v2.15,,,,,,
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,further inspected in the BAM file in a genome browser (IGV and Alamut),0.85,Accept,Experimental Usage,IGV,Analysis Software,,,,,,,
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,The CNV analysis tool exome hidden Markov model (XHMM) was used for exon CNV calling.,0.85,Accept,Experimental Usage,exome hidden Markov model (XHMM),Analysis Software,,,,,,,
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,FASTQ files were first aligned to the human reference genome (hg19) by the Burrows-Wheeler Aligner (bwa-0.7.15),0.85,Accept,Experimental Usage,Burrows-Wheeler Aligner (bwa-0.7.15),Command-line Tool,0.7.15,,,,,,
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,PCR duplications that cause bias in copy-number analysis were filtered out using Sambamba (v0.6.6),0.85,Accept,Experimental Usage,Sambamba (v0.6.6),Command-line Tool,v0.6.6,,https://github.com/biod/sambamba,,,,
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,SNVs/indel variants and SNPs were called using version 3.8 of the Genome Analysis Toolkit (GATK).,0.85,Accept,Experimental Usage,Genome Analysis Toolkit (GATK),Analysis Software,3.8,,,,,,
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,Raw image files were processed using CASAVA v1.82 for base calling and generating the raw sequencing data.,0.8,Accept,Experimental Usage,CASAVA v1.82,Analysis Software,v1.82,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Pathogenic variants were collected from the Leiden Open Variation Database (LOVD) database,0.85,Accept,Experimental Usage,Leiden Open Variation Database (LOVD),Database,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,each variant's allele frequency in three different databases of healthy populations: The 1000 Genomes Project,0.8,Accept,Experimental Usage,1000 Genomes Project,Database,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,"The 1000 Genomes Project, The Exome Aggregation Consortium (ExAC) and the Genome Aggregation Database",0.8,Accept,Experimental Usage,Exome Aggregation Consortium (ExAC),Database,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,The Exome Aggregation Consortium (ExAC) and the Genome Aggregation Database (gnomAD),0.8,Accept,Experimental Usage,Genome Aggregation Database (gnomAD),Database,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Variant annotation was performed using SnpEff and included annotations gathered in dbNSFP,0.9,Accept,Experimental Usage,SnpEff,Analysis Software,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Variant annotation was performed using SnpEff and included annotations gathered in dbNSFP,0.85,Accept,Experimental Usage,dbNSFP,Database,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,NF1 protein domain annotation was performed using Interpro and Nextprot,0.8,Accept,Experimental Usage,Interpro,Database,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,NF1 protein domain annotation was performed using Interpro and Nextprot,0.8,Accept,Experimental Usage,Nextprot,Database,,,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Models were trained and validated using the H2O R package,0.85,Accept,Experimental Usage,H2O R package,Package/Library,,R,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,The webserver was developed using the shiny web application framework,0.8,Accept,Development,shiny web application framework,Package/Library,,R,,,,,
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,"published on shinyapps.io, a cloud-service platform used to publish applications developed using shiny",0.75,Accept,Development,shinyapps.io,Web Application,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Genotyping for the CALM1 samples was performed on Illumina Infinium HumanOmni‐1Quad bead‐chips.,0.85,Accept,Experimental Usage,Illumina Infinium HumanOmni-1Quad bead-chips,Other,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Genotyping for the replication cohort CALM2 samples was performed on Illumina Infinium Omni2.5 bead‐chips.,0.85,Accept,Experimental Usage,Illumina Infinium Omni2.5 bead-chips,Other,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"multidimensional scaling (MDS) analysis estimating pairwise identity by descent (IBD) for all pairs of founders using independent SNPs in PLINK (Purcell et al., 2007)",0.9,Accept,Experimental Usage,PLINK,Analysis Software,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"LitfOver (Hinrichs et al., 2006) was used to convert genome positions in the CALM1 cohort (NCBI build 36, UCSC hg18) to corresponding positions in the CALM2 cohort",0.85,Accept,Experimental Usage,LitfOver,Analysis Software,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Targeted sequencing of candidate loci was carried out in 171 European–American samples using the AmpliSeq/IonTorrent platform,0.85,Accept,Experimental Usage,AmpliSeq/IonTorrent platform,Other,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Quality control for targeted gene sequencing data was done using SNP & Variation Suite v8.3.4 (http://goldenhelix.com/products/SNP_Variation/index.html),0.95,Accept,Experimental Usage,SNP & Variation Suite v8.3.4,Analysis Software,v8.3.4,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"tests of association between each SNP and log‐transformed CALM number, adjusted for age, sex, and body surface area, were performed with EMMAX (Kang et al., 2010)",0.9,Accept,Experimental Usage,EMMAX,Analysis Software,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Meta‐analyses between the CALM1 and CALM2 cohort studies were performed with METAL (Willer, Li, & Abecasis, 2010)",0.9,Accept,Experimental Usage,METAL,Analysis Software,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"The second approach for corroboration of SNP associations used ComPaSS‐GWAS (Sabourin et al., 2018), a method based on complementary pairs stability selection",0.9,Accept,Experimental Usage,ComPaSS-GWAS,Analysis Software,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Haploview 4.2 (Barrett, Fry, Maller, & Daly, 2005) was used to generate LD plots across the genome based on D' and r2 values",0.95,Accept,Experimental Usage,Haploview 4.2,Analysis Software,4.2,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Custom tracks on the UCSC Genome browser (http://genome.ucsc.edu) were used to screen NIH Roadmap Epigenomics and ENCODE experimental data,0.85,Accept,Experimental Usage,UCSC Genome browser,Web Application,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,The online tools HaploReg (http://www.broadinstitute.org/mammals/haploreg/haploreg.php) and RegulomeDB were used as complementary analyses,0.85,Accept,Experimental Usage,HaploReg,Web Application,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,The online tools HaploReg and RegulomeDB (http://regulome.stanford.edu) were used as complementary analyses,0.85,Accept,Experimental Usage,RegulomeDB,Web Application,,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"eQTL results for all CALM‐associated SNPs and collated genes based on 749 normal skin tissues were then extracted from GTEx (V7, dbGaP Accession phs000424.v7.p2)",0.85,Accept,Experimental Usage,GTEx,Database,V7,,,,,,
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,the influence of a SNP on metabolite levels in blood was evaluated by extraction of association results for each SNP and metabolites in blood from the Metabolomics GWAS,0.85,Accept,Experimental Usage,Metabolomics GWAS,Database,,,,,,,
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,"Protein-protein interactions were quantified using the BIAcore 1000 system (Pharmacia Biacore AB, Uppsala, Sweden/GE Healthcare)",0.85,Accept,Experimental Usage,BIAcore 1000 system,Analysis Software,,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Mice were placed in a cesium-137 source (J.L. Shepherd & Associates, San Fernando, CA) animal irradiator and shielded with an iron collimator",0.85,Accept,Experimental Usage,"cesium-137 source (J.L. Shepherd & Associates, San Fernando, CA) animal irradiator",Other,,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Photographs of histology were taken with an Olympus BX41 microscope, using Olympus UplanFl 10X/0.3 and 20X/0.5 objectives",0.8,Accept,Experimental Usage,Olympus BX41 microscope,Other,,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,An attached Olympus DP72 camera and Adobe Photoshop CS2 were used to capture the images,0.8,Accept,Experimental Usage,Olympus DP72 camera,Other,,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,An attached Olympus DP72 camera and Adobe Photoshop CS2 were used to capture the images,0.85,Accept,Experimental Usage,Adobe Photoshop CS2,Analysis Software,CS2,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,Complete blood counts were performed on blood samples obtained at the time of sacrifice by cardiac puncture and analyzed immediately on a Hemavet provided by the UCSF Mouse Pathology Core,0.85,Accept,Experimental Usage,Hemavet,Analysis Software,,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,The UCSF Genome Core using Peak Scanner software from Applied Biosystems performed PCR fragment analyses,0.9,Accept,Experimental Usage,Peak Scanner software from Applied Biosystems,Analysis Software,,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Assay C2557613_10 was used to genotype using the Taq amplification method in a 7900 HT Fast Real-Time PCR system (Applied Biosystems, USA)",0.85,Accept,Experimental Usage,"7900 HT Fast Real-Time PCR system (Applied Biosystems, USA)",Analysis Software,,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Allelic discrimination plots generated by SDS3.0, an Applied Biosystems program used to make genotyping calls",0.85,Accept,Experimental Usage,SDS3.0,Analysis Software,3.0,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"The Catalogue of Somatic Mutations in Cancer Database (COSMIC, www.sanger.ac.uk/genetics/CGP/cosmic, Wellcome Trust Sanger Institute, United Kingdom) was used to search for references",0.9,Accept,Experimental Usage,COSMIC Database,Database,,,www.sanger.ac.uk/genetics/CGP/cosmic,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,All analyses were performed using Prizm v.4 (GraphPad),0.85,Accept,Experimental Usage,Prizm v.4 (GraphPad),Analysis Software,v.4,,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,Raw fastq files were processed using nf-core/rnaseq (v3.11.2),0.9,Accept,Experimental Usage,nf-core/rnaseq (v3.11.2),Pipeline,v3.11.2,Unknown,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,quantified using salmon: v1.10.1,0.9,Accept,Experimental Usage,salmon (v1.10.1),Analysis Software,v1.10.1,Unknown,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,ComBat from sva R package (v3.42.0) was used for batch correction,0.9,Accept,Experimental Usage,sva R package (v3.42.0),Package/Library,v3.42.0,R,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The batch corrected data was then analyzed using the immunedeconv (v2.1.0) package,0.9,Accept,Experimental Usage,immunedeconv (v2.1.0),Package/Library,v2.1.0,R,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The quanTIseq algorithm ( 37 ) was used for assessing fractions of specific immune cell types from bulk RNA sequencing data,0.85,Accept,Experimental Usage,quanTIseq algorithm,Analysis Software,,Unknown,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The analysis results were visualized using ggplot2 (v3.4.4) and ggridges (v0.5.5) libraries,0.9,Accept,Experimental Usage,ggplot2 (v3.4.4),Package/Library,v3.4.4,R,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The analysis results were visualized using ggplot2 (v3.4.4) and ggridges (v0.5.5) libraries,0.9,Accept,Experimental Usage,ggridges (v0.5.5),Package/Library,v0.5.5,R,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,"analyzed with the HALO imaging analysis software (Indica Labs, Corrales, NM)",0.9,Accept,Experimental Usage,HALO imaging analysis software,Analysis Software,,Unknown,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,Data were analyzed using BDdiva and FCS Express Software,0.85,Accept,Experimental Usage,BDdiva,Analysis Software,,Unknown,,,,,
PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,Data were analyzed using BDdiva and FCS Express Software,0.85,Accept,Experimental Usage,FCS Express Software,Analysis Software,,Unknown,,,,,
PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,,the data were processed using Freesurfer (https://surfer.nmr.mgh.harvard.edu version 5.3)...processed using Freesurfer (version 7.2.0),0.9,Accept,Experimental Usage,FreeSurfer,Analysis Software,"5.3, 7.2.0",,,,,,
PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,,"we used ComBat harmonization, which corrects for between-scanner and multi-site collection of imaging data",0.8,Accept,Experimental Usage,ComBat harmonization,Analysis Software,,,,,,,
PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,,"We used Freesurfer's, statistical modeling tool, mri_glmfit (http://surfer.nmr.mgh.harvard.edu/fswiki/mri_glmfit)",0.85,Accept,Experimental Usage,mri_glmfit,Analysis Software,,,,,,,
PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,,"To control for multiple comparisons, we used Freesurfer's tool mri_glmfit-sim, which generates cluster-corrected regions",0.85,Accept,Experimental Usage,mri_glmfit-sim,Analysis Software,,,,,,,
PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,,"For all subcortical analyses, we used Desikan ROI parcellation and conducted univariate regressions",0.8,Accept,Experimental Usage,Desikan ROI parcellation,Analysis Software,,,,,,,
PMID:38621478,10.1016/j.bpsc.2024.04.003,Influences of RASopathies on Neuroanatomical Variation in Children.,,"we calculated Cohen's d effect size between groups (NS vs. TD, and NF1 vs. TD) for each ROI of SA and CT in RStudio",0.75,Accept,Experimental Usage,RStudio,Analysis Software,,R,,,,,
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"All statistical analyses were performed using GraphPad Prism 8 software (GraphPad Software, Inc., USA)",0.85,Accept,Experimental Usage,GraphPad Prism 8,Analysis Software,8,,,,,,
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,"size (diameter/cell growth) and number (clonogenic expansion) of the resulting secondary neurospheres was determined using Metamorph analysis software (Molecular Devices, Sunnyvale CA)",0.85,Accept,Experimental Usage,Metamorph analysis software,Analysis Software,,,,,,,
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,Statistical significance (p<0.05) was determined using the appropriate test as described in figure legends using GraphPad Prism 5.0 software,0.8,Accept,Experimental Usage,GraphPad Prism 5.0,Analysis Software,5.0,,,,,,
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Lengths, areas and the number of cells were quantified using the ImageJ software package",0.85,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,FACSDiva v6.1 and FlowJo software v10.0.8 (BD Biosciences) were used to collect and analyze data,0.85,Accept,Experimental Usage,FACSDiva v6.1,Analysis Software,v6.1,,,,,,
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,FACSDiva v6.1 and FlowJo software v10.0.8 (BD Biosciences) were used to collect and analyze data,0.85,Accept,Experimental Usage,FlowJo software v10.0.8,Analysis Software,v10.0.8,,,,,,
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,The IC50s for each of the cell lines were determined using GraphPad Prism v8.3 (nonlinear regression and dose–response curve fitting),0.85,Accept,Experimental Usage,GraphPad Prism v8.3,Analysis Software,v8.3,,,,,,
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,Tissues were scored for extent and intensity of staining using the HALO image analysis software v3.2,0.85,Accept,Experimental Usage,HALO image analysis software v3.2,Analysis Software,v3.2,,,,,,
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Image acquisition was performed using a Zeiss LSM 880 with Airyscan confocal microscope (Zeiss, Oberkochen, Germany) and analyses performed with ZEN imaging software v2.3",0.85,Accept,Experimental Usage,ZEN imaging software v2.3,Analysis Software,v2.3,,,,,,
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"Resulting FASTQ files were analyzed with CLC Genomics Workbench 22 (QIAGEN, Hilden, Germany)",0.9,Accept,Experimental Usage,CLC Genomics Workbench 22,Analysis Software,22,,,,,,
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,numerical and graphical analysis was done using the CosinorPy Python package,0.9,Accept,Experimental Usage,CosinorPy Python package,Package/Library,,Python,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,A MultiClamp 700B patch-clamp amplifier and pCLAMP 9.2 software (MDS Analytical Technologies) were used to acquire data,0.85,Accept,Experimental Usage,MultiClamp 700B,Analysis Software,,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,A MultiClamp 700B patch-clamp amplifier and pCLAMP 9.2 software (MDS Analytical Technologies) were used to acquire data,0.9,Accept,Experimental Usage,pCLAMP 9.2,Analysis Software,9.2,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,A 2-noise-burst stimulation protocol was designed in MATLAB (Version R2008a),0.8,Accept,Experimental Usage,MATLAB,Analysis Software,R2008a,MATLAB,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"To acquire high resolution z-stack images of the calyces, a laser scanning confocal microscope (LSM 700; Zeiss)",0.85,Accept,Experimental Usage,LSM 700,Analysis Software,,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,The number of swellings per calyx was counted on 3D-rendered (Volocity 4.2; Improvision) images of calyces,0.9,Accept,Experimental Usage,Volocity 4.2,Analysis Software,4.2,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,images of calyx terminals were binary thresholded using the built-in thresholding function of ImageJ 1.46 (isodata algorithm),0.9,Accept,Experimental Usage,ImageJ 1.46,Analysis Software,1.46,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics),0.85,Accept,Experimental Usage,Igor 6.22A,Analysis Software,6.22A,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics) NeuroMatic (version 2.00, kindly provided by Dr. J. Rothman)",0.85,Accept,Experimental Usage,NeuroMatic,Package/Library,2.00,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,All WES/WGS/RNA-seq samples were trimmed and quality controlled via Trim Galore (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/),0.85,Accept,Experimental Usage,Trim Galore,Analysis Software,,,https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,WES and WGS data were aligned against reference sequence hg38 via BWA-MEM,0.85,Accept,Experimental Usage,BWA-MEM,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,"For PDX sequence data, Disambiguate v1.0 was used to filter out mouse-derived reads",0.9,Accept,Experimental Usage,Disambiguate v1.0,Analysis Software,v1.0,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Structural variants (SVs) and large indels were detected using Manta,0.85,Accept,Experimental Usage,Manta,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,SNVs and small indels were detected using VarScan2,0.85,Accept,Experimental Usage,VarScan2,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2",0.85,Accept,Experimental Usage,Strelka2,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2",0.85,Accept,Experimental Usage,MuTect2,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.85,Accept,Experimental Usage,Pindel,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,includes best-practices variant filtering and annotation with Variant Effect Predictor (VEP; version 95),0.9,Accept,Experimental Usage,Variant Effect Predictor (VEP),Analysis Software,version 95,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Waterfall somatic variant plots were created with GenVisR,0.85,Accept,Experimental Usage,GenVisR,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Mouse-derived reads were filtered using Xenosplit,0.85,Accept,Experimental Usage,Xenosplit,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,RNA reads were quantified by using the expectation-maximization (EM) quantification on PartekFlow,0.85,Accept,Experimental Usage,PartekFlow,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Gene counts and transcript counts were normalized by using the DESeq2 package,0.85,Accept,Experimental Usage,DESeq2,Package/Library,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,CNVkit was used to infer and visualize copy number from high-throughput WGS data,0.85,Accept,Experimental Usage,CNVkit,Analysis Software,,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,The standard 10X Genomics Cell Ranger (version 3.1.0) pipeline was used to extract FASTQ files,0.9,Accept,Experimental Usage,Cell Ranger,Pipeline,version 3.1.0,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,filtered_feature_bc_matrix was imported using the Read10X function in Seurat (version 3.0),0.9,Accept,Experimental Usage,Seurat,Package/Library,version 3.0,R,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Copy number variations of each PDX were inferred from scRNA-seq using the R package inferCNV,0.9,Accept,Experimental Usage,inferCNV,Package/Library,,R,https://github.com/broadinstitute/infercnv,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,The Uphyloplot2 (https://github.com/harbourlab/UPhyloplot2) was used to visualize the clonality,0.9,Accept,Experimental Usage,UPhyloplot2,Analysis Software,,,https://github.com/harbourlab/UPhyloplot2,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"To align the reads, we employed HISAT2 version 2.2.1 against the GRCh38 human genome",0.9,Accept,Experimental Usage,HISAT2 version 2.2.1,Analysis Software,2.2.1,,,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Read counts were normalized by StringTie version 2.2.1,0.9,Accept,Experimental Usage,StringTie version 2.2.1,Analysis Software,2.2.1,,,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Differential expression analysis was analyzed by DEGseq version 1.48.0,0.9,Accept,Experimental Usage,DEGseq version 1.48.0,Package/Library,1.48.0,R,,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,the GSEA KEGG method with ClusterProfiler version 4.2.2 was applied,0.9,Accept,Experimental Usage,ClusterProfiler version 4.2.2,Package/Library,4.2.2,R,,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,protein–protein interaction analysis using STRING version 11.5,0.9,Accept,Experimental Usage,STRING version 11.5,Web Application,11.5,,https://string-db.org/,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,The data were analyzed by v10.8 of FlowJo™ software,0.9,Accept,Experimental Usage,FlowJo™ software v10.8,Analysis Software,10.8,,,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The analysis was performed with Seahorse Wave Pro software (Agilent Technologies, Santa Clara, CA, USA)",0.9,Accept,Experimental Usage,Seahorse Wave Pro software,Analysis Software,,,,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,The analysis was performed using GraphPad Prism version 9,0.9,Accept,Experimental Usage,GraphPad Prism version 9,Analysis Software,9,,,,,,
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"RNA sequencing was carried out on a NovaSeq 6000 system, and the read quality was checked with FASTQC",0.8,Accept,Experimental Usage,FASTQC,Analysis Software,,,,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Fragmented gDNAs were tested for size distribution and concentration using an Agilent Tapestation 4200 and Qubit dsDNA High Sensitivity kit.,0.9,Accept,Experimental Usage,Agilent Tapestation 4200,Analysis Software,,,,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"The samples were then sequenced on an Illumina NextSeq550Dx, which generated paired-end reads of 151 bp.",0.9,Accept,Experimental Usage,Illumina NextSeq550Dx,Analysis Software,,,,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Candidate somatic variants, consisting of point mutations, insertions, and deletions were sorted out with Varsome Clinical Software v.12.3.2 (Saphetor, Lausanne, Switzerland).",0.95,Accept,Experimental Usage,Varsome Clinical Software v.12.3.2,Analysis Software,v.12.3.2,,,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The VAF plot was generated using Plotly v4.9.3 in the R environment (available from https://plotly-r.com).,0.85,Accept,Experimental Usage,Plotly v4.9.3,Package/Library,v4.9.3,R,https://plotly-r.com,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Finally, to determine the profiles of the alterations in the number of copies, the CNV calling was also performed using the CNVKit version 0.9.11.",0.9,Accept,Experimental Usage,CNVKit version 0.9.11,Analysis Software,0.9.11,,,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The output was then visualized using ggplot2 v3.5.1 (https://ggplot2.tidyverse.org).,0.85,Accept,Experimental Usage,ggplot2 v3.5.1,Package/Library,v3.5.1,R,https://ggplot2.tidyverse.org,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Kaplan–Meier survival curves were generated using GEPIA (http://gepia.cancer-pku.cn/) on the TCGA-SARC, TCGA-LUAD and TCGA-LUSC RNA-seq expression dataset.",0.9,Accept,Experimental Usage,GEPIA,Web Application,,,http://gepia.cancer-pku.cn/,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Gene Ontology (GO) and pathway enrichment analysis was performed using Cluster Profiler v.4.0, selecting statistically significant terms and pathways.",0.9,Accept,Experimental Usage,Cluster Profiler v.4.0,Package/Library,v.4.0,R,,,,,
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Visualization of intersecting sets was performed with UpSetR Version 1.4.0 (R package).,0.85,Accept,Experimental Usage,UpSetR Version 1.4.0,Package/Library,1.4.0,R,,,,,
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"We compared the performance of logistic regression, XGBoost, and random forest models utilizing each feature set.",0.85,Accept,Experimental Usage,XGBoost,Analysis Software,,,,,,,
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"Yellowbrick, a ML visualization library, was used for this purpose.",0.8,Accept,Experimental Usage,Yellowbrick,Package/Library,,Python,,,,,
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"HoloViews, a data analysis and visualization library, was used to generate the shared feature plots.",0.8,Accept,Experimental Usage,HoloViews,Package/Library,,Python,,,,,
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"We used Phecode and CCSR, aggregation and reduction methods that group ICD-10 codes into standardized, clinically meaningful concepts",0.75,Accept,Experimental Usage,Clinical Classifications Software Refined,Analysis Software,,,,,,,
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"We used Phecode and CCSR, aggregation and reduction methods that group ICD-10 codes into standardized, clinically meaningful concepts",0.75,Accept,Experimental Usage,Phecode,Analysis Software,,,,,,,
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Viability of MPNST cell lines S462, NSF1, and T265 in response to increasing doses (0-120 μM) of 3-BrPA was analyzed by CellTiter-Blue® assay",0.8,Accept,Experimental Usage,CellTiter-Blue® assay,Analysis Software,,,,,,,
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"statistical hypothesis testing were performed by the software package MATLAB®, version R2007a (The MathWorks, Inc., Natick, MA, USA)",0.8,Accept,Experimental Usage,MATLAB® version R2007a,Analysis Software,R2007a,MATLAB,,,,,
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Ki67 labelling was analysed conventionally as well as using analysis software pathoZoom® (smart in media, Köln, Germany)",0.8,Accept,Experimental Usage,pathoZoom®,Analysis Software,,,,,,,
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,Analyses were performed using standard protocols according to the manufacturer's instructions on an autostainer (DAKO Autostainer Link 48),0.75,Accept,Experimental Usage,DAKO Autostainer Link 48,Other,,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,data analyzed using SynergyFinder (RRID: SCR-019318),0.9,Accept,Experimental Usage,SynergyFinder,Analysis Software,,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,Densitometry quantification was performed using ImageJ (RRID: SCR_003070),0.9,Accept,Experimental Usage,ImageJ,Analysis Software,,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,"data analyzed using FlowJo v10 (Becton Dickinson, RRID: SCR_008520)",0.9,Accept,Experimental Usage,FlowJo v10,Analysis Software,v10,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,quantified reads to the GENCODE M19 transcriptome using 'salmon' (1.4.0) aligner (RRID: SCR_017036),0.85,Accept,Experimental Usage,salmon,Analysis Software,1.4.0,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,Differential gene expression analysis was then conducted with DESeq2 (1.24.0) (RRID: SCR_015687),0.9,Accept,Experimental Usage,DESeq2,Analysis Software,1.24.0,R,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,DEGs were mapped to their human orthologs and were further analyzed using CIBERSORT (RRID: SCR_016955),0.9,Accept,Experimental Usage,CIBERSORT,Analysis Software,,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,DEGs were analyzed using 'iPathwayGuide' software (Advaita Bioinformatics),0.85,Accept,Experimental Usage,iPathwayGuide,Analysis Software,,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,The volume of tumour spheroids was measured using ImageJ (v1.48) software,0.9,Accept,Experimental Usage,ImageJ (v1.48),Analysis Software,v1.48,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"HALO (Indica Labs) or Aperio (Leica Biosystems, Wetzlar, Germany) Image Analysis software was used",0.9,Accept,Experimental Usage,HALO (Indica Labs),Analysis Software,,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"HALO (Indica Labs) or Aperio (Leica Biosystems, Wetzlar, Germany) Image Analysis software was used",0.9,Accept,Experimental Usage,Aperio Image Analysis (Leica Biosystems),Analysis Software,,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"then the cells were allowed to recover for 2 h prior to beginning imaging with the Incucyte system (Essen Bioscience, Ann Arbor, MI, USA)",0.85,Accept,Experimental Usage,Incucyte system (Essen Bioscience),Analysis Software,,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"The animals were then randomised based on tumour size using matched distribution analysis from Studylog system software (Pacifica, CA, USA)",0.85,Accept,Experimental Usage,Studylog system software (Pacifica),Analysis Software,,,,,,,
PMID:33085177,10.1002/mgg3.1530,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,,"Rasch analysis was conducted using the RUMM2030 programme (Andrich et al., 2010)",0.85,Accept,Experimental Usage,RUMM2030,Analysis Software,,,,,,,
PMID:33085177,10.1002/mgg3.1530,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,,patients were recruited through the Children's Tumor Foundation Patient Registry (https://nfregistry.patientcrossroads.org),0.8,Accept,Experimental Usage,Children's Tumor Foundation Patient Registry,Database,,,,,,,
PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,Oxygen consumption rate (OCR) was measured in schwannoma and normal Schwann cells 24 h post protein delivery using an XF96 Extracellular Flux Analyzer,0.9,Accept,Experimental Usage,XF96 Extracellular Flux Analyzer (Agilent Technologies),Analysis Software,,,,,,,
PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,"Fluorescence images were collected using an inverted confocal microscope (Cat. no. LSM780 NLO, Carl Zeiss AG, Dublin, CA, USA)",0.85,Accept,Experimental Usage,LSM780 NLO confocal microscope (Carl Zeiss AG),Analysis Software,,,,,,,
PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,"All nuclei per well were imaged and counted using a Cytation 5 instrument equipped with Gen5 software (Biotek, Agilent)",0.85,Accept,Experimental Usage,"Cytation 5 instrument equipped with Gen5 software (Biotek, Agilent)",Analysis Software,,,,,,,
